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ABSTRACT 
The T4 gene (T) encoding polynuOleotide kinase 
(pnk) has been cloned in X vectors on a single T4 EcoRI 
fragment (fragment 21) and expression of active pnk has 
been achieved. Induction of a XEWSc1857 prophage 
in which the pT gene can be transcribed from the late 
A promoter, p R11leads to more than 100 fold amplification 
of pnk activity in relation to infection with T4 wild-type 
phage. The pnk polypeptide constitutes about 7% of the 
total soluble cell protein in the induced lysogen. 
The purified enzyme, as expected, is both a 5'-kinase 
and a 3'-phosphatase. The amino acid sequence of the ORF 
encoding pnk was deduced from the DNA sequence of fragment 
21, both for the active pnk polypeptide and for an 
inactive pnk polypeptide encoded by a deletion mutant 
including fragment 21, which apparently induced neither 
5'-kinase or 3 1 -phosphatase activity. The latter poly-
peptide lacked a Pro-Gly dipeptide within a part of the 
sequence which shared homology with the adenine nucleotide 
binding sites of several proteins. The dipeptide is 
within the region corresponding in adenylate kinase to 
a flexible loop thought to take part in a conformational 
change after AMP binds to the enzyme. The loss of 
amino acids from a similar ioop may prevent the defective 
pnk enzyme from binding adenine nucleotide substrates, 
or may constrict a conformational change and prevent the 
enzyme from achieving an activated state. A second region 
of the pnk sequence shares homology with phosphoglycerate 
kinase, yeast inorganic pyrophosphatase, and histone 2b 
from various species. 
ABBREVIATIONS 
bp 	- base pair 
DE 	- delayed early (gene) 
g30 	- gene 30 
gp30 	- protein product of gene 30 
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kb 	- kilobase 
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moi 	- multiplicity of infection 
ORF 	- open reading frame 
pfu 	- plaque forming unit 
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rbs 	- ribosome binding site 
SDS-PAGE--sodium dodecyls•uI•phate...... -. 
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TEMED 	- N,N,N' ,N'-tetramethylethylenediamine 
UV 	- ultraviolet light 
Xg 	- 5-bromo-4-chloro-3 indolyl- 
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AMP5 - koir 	VpptQ 
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C H A P T E R 
INTRODUCTION 
1.1. BACTERIOPHAGE T4 
Bacteriophage T4 is a complex DNA virus with a total 
genome length (Figure 1.1) of 166,000 nucleotide pairs 
(Kim and Davidson, 1974). About 140 genes have now been 
identified (Wood and Revel, 1976) and many are functionally 
characterised. 
The phage consists of particles or virions each made 
up of a protein coat or capsid that surrounds and protects 
the viral genome. T4 is a member of the class of urophages 
which are characterised by a large head filled with 
double-stranded DNA and a tail through which the DNA is 
extruded during infection (Figure 1.2). An unusual feature 
of T4 DNA is that its genetic map is circular even though 
the DNA of each virion is linear (Streisinger et al., 
1964). Mature phage DNA also displays about 3% terminal 
redundancy (Thomas and Rubenstein, 1964) . Since T-even 
phage package their DNA from concatemeric DNA molecules 
by a headfulmechanism'(Ritchie and - White; 1972) rather 
than.by cutting at specific sites, the above features 
ensure that a whole genome is packaged. T4 compensates 
for deletions of non-essential regions of the genome by 
increasing the length of the terminal repeats. 
The DNA of T-even phages contains hydroxymethyloytosine 
(HMC) instead of cytosine (Wyatt and Cohen, 1953). 
These residues are glucosylated / 3ftco 1 l -h-c-- 
(Lehmann and Pratt, 1960). In addition some 
adenine residues are methylated (Hattman, 1970). 
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The genetic map of bacteriophage T4 
correlated with the restriction map, from 
Kutter and Rüger (1983). Regions indicated 
by shading in the outer circle are where 
restriction mapping has been used to help 
locate genes. 
The genes of T4 can be divided according to their 
function into two main classes: cell metabolism and 
phage particle assembly (Figure 1.3). In addition they are 
classified by the timing of appearance of their products 
as immediate-early (IE), delayed-early (DE), quasi-late 
(Q) or true-late (L) , (O'Farrell and Gold, 1973) . The 
direction of trarfscription has been determined for a number 
of genes, and evidence from mRNA hybridisation to separated 
T4 DNA strands indicates that probably all early and 
quasi-late genes are transcribed in an anticlockwise direction 
in relation to the T4 map (Figure 1.1), whereas late genes 
are transcribed in a clockwise direction (Guha et al., 1971). 
Most metabolic functions are controlled by genes with 
early or quasi-late characteristics while most assembly 
functions are controlled by late genes (Wood and Revel, 
1976) 
Essential genes (designated mainly by numbers or 
lower casesingle letters) 	bentifie.d. by 
conditionally lethal mutations (Epstein et al., 1963) and 
include 22 of the metabolic functions and all but 10 of 
the assembly functions. Those genes non-essential 
on normal laboratory E.coli strains are designated by 
two or three letter symbols. Most of these are in the 
metabolic category and many seem to augment the phage 
burst size e.g. by providing more abundant substrates 
for DNA replication,or by helping the phage to deal with 
the host's intracellular environment. However, many of 








A diagram of bacteriophage T4 showing the 
major structural components. 
essential functions which can be carried out by alternative 
host pathways. Comparison of Figures 1.1 and 1.3 show 
that T4 genes exhibit considerable clustering according 
to function. This may be a result of selective pressure 
since it minimises recombination between genes encoding 
proteins that must interact structurally (Stahl and Murray, 
1966). On the basis of identified genes, 15% of the genome 
is used to code for essential metabolic functions, 39% 
for non-essential functions and 36% for particle assembly 
(Wood and Revel, 1976) 
1.2 STAGES IN INFECTION OF E.COLI BY BACTERIOPHAGE T4 
When T4 phage infect a cell only DNA and a few 
auxiliary proteins are injected (Hershey and Chase, 1952), 
so for the first few minutes there are no complete 
infective particles. After this initial eclipse period, 
phage particles appear and increase steadily in number 
until each cell contains 200-400 phage. The host cell 
eventually bursts releasing them. 
Details of phage structure and multiplication, 
which have been elucidated mainly through conditional 
mutants (Epstein et al., 1963) are described below. 
Once inside the cell, the viral genome stops host DNA 
synthesis and gene expression and eventually the host 
genome is destroyed. The cell is instructed to make new 
virions by the T4 genome which encodes both the enzymes 
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Functional classification of T4 genes, 
from Wood and Revel (1976). Genes whose 
functions are at least generally known are 
listed in boxes representing different 
functional categories. Some genes known to 
have dual functions are listed under two 
functional categories. 
1.2.a. Attachment 
The tail fibres (Figure 1.2) are the site of 
specific recognition for attachment to the host cell 
(Simon and Anderson, 1967). The host cell receptors 
are the lipopolysaccharide molecules of the outer 
cell wall (Wilson et al., 1970), however irreversible 
attachment and penetration occurs only at about 
200 sites (Bayer, 1968) . Once the phage is attached, 
the sheath contracts and drives the tail tube into 
the cell envelope. 
The infecting phage DNA enters the cell 
accompanied by several minor proteins including 
gp2 and gp64 which are probably attached to the 
termini of DNA molecules thereby protecting then 
against bacterial nucleases (Silverstein and 
Goldberg, 1976) . 2-5 min after infection,host DNA, 
RNA and protein synthesis virtually terminate and 
subsequent macromo1ecu1ar synthesis is-almost entirely 
phage mediated. Inhibition of host gene expression 
occurs at both the transcriptional and post-trans-
cript1orioI levels, and although host DNA continues to 
be transcribed for several minutes there is an 
immediate block on induction of all inducible host 
specific enzymes e.g. -galactosidase (Monod and 
Woliman, 1947) 
T4 produces a series of nucleases which degrade 
cytosine-containing DNA after infection. The product 
of the gene denA is endonuclease II which nicks 
A 
double-stranded DNA. at the 5' side of cytosines 
(Sadowski and Hurwitz, 1969) . 	An exonuclease 
activity, probably host encoded, appears to 
enlarge the nick to a gap so that the phage gene 
product of denB, endonuclease Iv, can cut to the 
5' side of cytosines in the single-stranded region 
produced (Sadowski and Bakyta, 1972). These fragments 
are finally degraded to mononucleotides presumably 
by a phage encoded exonuclease. This process of 
host DNA degradation serves to avoid transcriptional 
competition and enrich the nucleotide pool. 
1.2 .b. DNA replication 
The conversion of cytosine to HMC occurs at 
the mononucleotide level (Figure 1.4). HMC-DNA 
is synthesised without glucosylation, then phage 
encoded enzymes glucosylate HMC groups in the DNA 
(Revel and Luria, 1970) 
Replication of T-even phage DNA-i•s- semi- - 
conservative and dispersive i.e. segments of the 
infecting DNA strands are distributed among several 
progeny (Kozinski, 1961). Circularisation of 
the genome does not seem to be necessary for successful 
replication (Kozinski and Doermann, 1975). 	If 
all of the required phage genes are functional, 
replication starts about 6 min after infection and 
occurs bi-directionally, probably from multiple 
origins (Delius et al., 1971; Howe, et al. 1973; 
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Figure 1.4 
The enzymatic biosynthesis of T4 phage DNA. 
Reactions catalysed by virus coded functions are 




Deoxycytidine and deoxyuridine 
tn- and diphosphatase 
Thymidylate synthetase 
Dihydrofolate reductase 








synthesis requires an RNA primer provided by E.coli 
RNA polymerase (Luder and Mosig, 1982). A T4 primase 
primes the Okazaki fragments of the lagging strand 
which are joined on to the growing strand by DNA 
ligase. 
In vitro synthesis of DNA requires a number 
of purified phage encoded proteins. gp43 (the DNA 
polymerase) gp4l/61, gp44/62, gp45 and gp32 together 
with the four NTP5, dNTPs and Mg replicate DNA at 
close to the in viv.o rate (Alberts et al., 1975). 
gp44 and gp62 form a complex with ATPase activity 
which gp45 stimulates (Piperno et al., 1978; 
Mace and Alberts, 1984) . gp32 is a helix-destabilising 
protein which associates with single-stranded DNA. 
These accessory proteins probably help the polymerase 
to overcome 'pausing' at hairpin structures in the 
DNA (Huang et al., 1981). 	gp4l and gp6l are part 
of the T4 primase(Liu and Alberts, 1981; SIlver 
and Nossal, 1982). 
The first round of replication is initiated 
de novo at origin sequences, but when replication 
reaches an end of the molecule, the template strand 
for lagging strand synthesis is single-stranded at 
the 3' end and this segment will be able to invade 
a homologous region of another molecule or the 
terminally redundant sequences of the same molecule 
(Danenberg and Mosig, 1983) . These invasions form 
new recombinational forks eventually generating a 
complex network of branched and looped T4 DNA 
(Altman and Lerman, 1970; Hamilton and Pettijohn, 
1976) . Reinitiation from origin sequences is 
rare, as modification of RNA polymerase during 
infection interferes not only with recognition of 
early promoters but also of replication origins 
(Rabussay, 1982). Most secondary initiations must 
start from recombinational intermediates where T4 
primase can prime the synthesis of Okazaki pieces. 
Packaging of DNA is probably also initiated from 
recombinational orreplicative forks (Mosig, etal., 1981) 
and requires concatemeric molecules created by 
recombination. All of the DNA in the T4 replicating 
pool may be part of a single intracellular con-
catemerof great complexity (Kemper and Brown, 
1976) 
1.2.c Gene expression 
Transcription canbe divided .into.two..main - 
phases, the pre-replicative period spanning the time 
from infection to the onset of DNA replication about 
6 min later, and the post-replicative period which 
starts when DNA replication is initiated. Although 
host RNA polymerase is used throughout infection 
(Haselkorn et al., 1969; Goff and Weber, 1970), 
it is subject to chemical alterations and binds 
several T4 proteins. During the pre-replicative 
period host DNA, RNA and protein synthesis are shut 
off and early viral gene products appear. Those. 
e 
I 
gene products that appear for the first. time after 
DNA replication starts are termed true-late, while 
those already being synthesised during the pre-
replicative period but becoming more abundant 
afterwards are called quasi-late (O'Farrell and 
Gold, 1973) 
(i) Pre-replicative transcription 
T4 gpalt is injected with T4 DNA (Rohrer 
et al., 1975) and catalyses the transfer of 
ADP-ribose to one of the a subunits of the 
polymerase enzyme in a reversible process 
termed alteration which is complete 30 sec after 
the start of infection. A second event 
catalysed by the phage mod gene product starts 
1-2 min into infection and involves the 
irreversible ADP-ribosylation of all a subunits 
(Goff, 1974) . Neither process is required 
for T4 development,..bu.t.alteratjon...iowers the .........-
affinity of the polymerase for the a subunit 
(Rabussay et al., 1972) , and modification of 
the a subunits is directly responsible for 
a lowered rate of initiation at E.coli 
promoters (Mailhainmer et al., 1975). 
Immediately after T4 infection, transcription 
of a class of genes called immediate early 
(IE) is initiated at early promoters by 
unmodified polymerase or its altered form. 
This transcriptiOn does not require protein 
Ii 
synthesis. Transcription of a second class of 
early genes termed delayed early (DE) starts 
about 2 min after infection and does require 
protein synthesis (Young, 1975). Two 
different mechanisms regulate DE gene trans-
cription. IE genes are proximal and DE genes 
distal to early promoters (Salser et al., 1970) 
and they are separated by potential Rho-dependent 
transcriptional termination sites (Goldberg, 
1970; Jayaraman, 1972; Richardson, 1970) 
Readthrough of such terminators would allow 
expression of distal DE genes. This may be 
analogous to early transcription in A where 
Rho mediates termination of RNA chains in the 
absence of A gpN which allows RNA polymerase 
to transcribe past the termination sites. It 
is not known whether T4 codes for an N-like 
anti-termination protein. 'Secondly-r some DE 
genes may be transcribed only on activation of 
a new class of promoters termed middle promoters 
(Mattson et al., 1974; Mattson et al., 1978). 
Middle transcription units therefore may 
encompass middle genes which are only accessible 
from middle promoters, and IE and DE genes 
which are also accessible from early promoters. 
Thus many pre-replicative genes are expressed 
in two modes, early from initiation at early 
promoters and later from middle promoters. 
Typically these are genes whose products are 
required throughout infection (Brody, et al., 
1971) . Pre-replicative transcription units are 
found mainly in two large blocks on the T4 map 
between 158-75 kb and 123-147 kb (Wood and 
Revel, 1976). Early genes code for functions 
involved in phage specific nucleotide and 
nucleic acid metabolism, binding to cell membranes, 
and alteration of host transcriptional and trans-
lational machinery. Pre-replicative transcription 
units are oriented in the same direction and almost 
all RNA synthesis in this period is 1-strand specific 
(or counterclockwise in relation to the T4 map) 
(O'Farrell et al., 1980). 
IE promoters are recognised by relatively 
unmodified E.coli RNA polymerase, and the 
sequences of some IE promoters (Table 1.1) show 
strong homology with -10 and -35 regionsof - 
E.coli promoters (Rosenberg and Court, 1979). 
Early transcription units produce truncated RNA 
molecules in the presence of chloramphenicol 
(Young, 1975) . Therefore protein synthesis seems 
to be necessary for anti-termination at IE-DE gene 
junctions. In addition, synthesis of T4 gpmot 
is necessary for initiation of DE transcription 
(Mattson et al. 1974; Mattson et al. 1978). 
The -10 promoter regions of some genes expressed 
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Table 1.1 
Sequences of the non-transcribed strand of some 
presumed early and middle T4 promoters, from Brody 
et al. (1983) . A line above the sequence indicates 
a possible homology to the E.coli consensus sequence. 
The conserved sequence seen in middle promoters is 
doubly underlined. 
promoters (Rosenberg and Court, 1979) . However 
the -35 regions show less homology to E.coli 
sequences and a new -35 region consensus sequence 
has been defined; ATGCTT, which starts between 
-35 and -30 (Brody et al., 1983) (Table 1.1). 
This new consensus may comprise the mot 
recognition site. In addition mot dependence of 
DE gene transcription is enhanced by modification 
of the ct subunits of RNA polymerase early in 
infection which weakens the a-core interaction 
(Khesin, et al., 1976; Schachner et al., 1971). 
(ii) Post-replicative transcription 
The post-replicative period starts 5-6 
min into infection when T4 DNA replication is 
initiated. Transcription of true-late genes 
begins 1-2 min later (Young et al.., 1980). By 
about 9 min into infection host transcription is 
no longer detctab1e (Kennell, 1970) and 
) 
several minutes after this, true-late transcripts 
become the dominant species and a number of re-
replicative genes are shut off. True-late 
proteins include phage coat proteins and those 
required for phage assembly. Their mRNA is mainly 
transcribed from the r-strand (Guha et al. 1971) 
Quasi-late genes continue to be transcribed 
into the post-replicative period and are usually 
those required throughout infection e.g. gp32 
(Krisch et al., 1974). All quasi-late genes 
11 
probably have the same polarity as early genes 
i.e. are transcribed from the 1-strand (Jayaraman 
and Goldberg, 1970). They are regulated in a 
non-uniform manner (Guha et al., 1971). 
Transcription of true-late genes depends 
upon both modifications of the RNA polymerase 
and on a modified DNA template created during 
replication. Three T4 coded proteins are 
essential for late gene transcription in vivo; 
gp33, gp45 and gp55. These proteins copurify 
with the RNA polymerase but gp33 binds more 
loosely and it is possible to separate it by 
phosphocellulose chromatography (Horvitz, 1973) 
In vitro transcription systems have shown that 
T4 modified or host core polymerase transcribe 
late T4 genes in the absence of the a factor 
(Rabussay and Geiduscheck, 1977b). Amber mutations 
in gp33 and gp55 generate transcription defects 
and it had been assumed that gp33 and gp55 together 
would be a a factor substitute. However, 
Kassavetis and Geiduschek (1984) have found that 
T4 gp55 alone confers T4 late promoter specificity 
in the absence of a. gp33 competes with the a 
factor for the same binding site on the core 
polymerase and may assist gp55 by blocking the 
a-core interaction. Two proteins of apparent 
M 
r  15 kd and 10 kd (Stevens, 1972) also bind to 
late RNA polymerase. The 10 kd protein has an 
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anti-a activity (Stevens, 1977) and interacts 
physically with o and the core polymerase (Khesin 
et al., 1972). In addition the irreversible ADP-
ribosylation of the polymerase a. subunits has 
achieved a maximum about 5 min into infection and 
this again seems to lower the affinity between a 
and the core polymerase (Khe.sin et al., 1976) 
The DNA template for late gene expression 
must contain HMC, however a cytosine content of 
up to 20% does not affect true-late transcription 
I 	(Kutter and Wiberg, 1969). The specificity for 
transcription of HMC-DNA is conferred by a T4 
protein aic encoded by the T4 alc/unf gene 
(Snyder et al., 1976) whose mechanism of action 
is unknown. Multiple mutants unable to make 
HMC-DNA are blocked in late transcription. 
This block is relieved by a mutation in alc/unf. 
In addition, late transcription is coupled to 
DNA replication (Riva et al. 1970a) . If 
replication is not allowed to start, late 
transcription is blocked, and blocking 
replication after it has started also suppresses 
late gene transcription (Lembach et al., 1969; 
Riva et al., 1970a). gp45 is essential for late 
gene transcription (Wu et al., 1975) and 
- 	 although it does not copurify with RNA polymerase, 
gp45 will bind specifically to irnmobilised modified 
core polymerase (Ratner, 1974). 	gp45 is also 
part of the T4 replisome, suggesting that the T4 
replication proteins affect late transcription 
directly through their interaction with gp45. 
It is possible to uncouple late transcription 
from replication in certain T4 multiple mutants 
altered in DNA polymerase, DNA ligase and gene 
46 encoded exonuclease (Cascino et al., 1970; 
Riva et al., 1970b; Wu et al., 1975). Here 
the block in replication is accompanied by the 
introduction of breaks in the DNA. T4 late genes 
must somehow be made competent for transcription 
and this may occur during replication. It has 
been suggested that late promoters cannot be 
recognised in intact double-stranded DNA and have 
to be made accessible at replicative forks, perhaps 
through the interaction of gp45 (Ratner, 1974) 
or by melting of the DNA caused by nicks or gaps 
(Rabussay and Geiduschek, 1977b). Mutations 
which lead to replication-independent late 
transcription may be able to imitate such 
gaps. 
Several T4 late promoters have now been 
mapped (Christensen and Young, 1982). An AT-rich 
upstream consensus (TATAAATA) spans the position 
of the E.coli -10 promoter consensus sequence, 
but they do not seem to share a -35 consensus 
sequence (Elliot and Geiduschek, 1984) . This 
suggests that special initiation factors are 
required for their recognition, however it is 
unknown how the RNA polymerase binding proteins 
are involved in promoter recognition except that 
gp55 confers late promoter specificity in 
the absence of a, and various other factors reduce 
the affinity of a for core polymerase. If 
binding of a to RNA polymerase results in 
initiation at early or middle promoters, access 
of a to the core may be controlled to prevent 
overproduction of early or middle RNA at the 
expense of late transcripts. 
1.2.d Translation 
T4 uses the host's translational machinery 
but again it employs a number of strategies to bias 
the system towards translation of T4 mRNA. T4 is 
able to block the translation of E.coli transcripts. 
The lac operon is transcribed during the first few 
minutes of infection but most of the ttàncript is 
not associated with ribosomes (Kennell, 1970). 
Furthermore, T4 infection prevents continued growth 
of pre-induced polysomes, indicating that T4 infection 
interferes with reassociation of ribosomes to host 
mRNA. Ribosomes from T4 infected cells are much 
less efficient at translating E.coli mRNA and 
bind much more poorly, than those from uninfected cells 
(Hsu and Weiss, 1969; Dube and Rudland, 1970). 
Not all mRNA species of an organism are 
translated at the same rate. The strength of ribosome 
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binding regions and accessibility of these regions 
are of major importance. In T4 infections, mRNA 
availability for translation is also regulated by 
the sequence of appearance of mRNA5. Initiation 
of translation in T4 infections utilises an AUG 
codon and a Shine-Dalgarno sequence (Gold et al., 
1981). Mutations which narrow spacing between the 
Shine-Dalgarno sequence and the AUG codon on T4 
nIB mRNA severely reduce translation efficiency 
(Pribnowet_al., 1981; Nelson et al. 1981),whereas 
increasing the spacing only has a small effect. 
Secondary or higher order structures can make the 
binding site more or less accessible to ribosomes. 
T4 nIB is transcribed in two modes, early and middle, 
to give either polycistronic or monocistronic message 
(Daegelen et al. 1982) and the monocistronic form 
is more active in protein synthesis. 
In addition, the T4A geneproductis known 
to regulate the utilisation of many T4 early 
transcripts (Trimble and Maley, 1976). Reg A phage 
overproduce translational products of many early 
mRNAs e.g. gpe, and others are underproduced 
(Wiberg et al., 1973). A possible role for reg A 
protein is as a translational repressor which can 
recognise a structural feature common to all the 
mPNAs it affects. This feature may be a short 
sequence within the ribosome binding domain (Karam 
et al., 1981). 	A seems to affect early mRNA 
stability, which is greatly increased in reg A 
infections (Wiberg Pt al.,1973). This may however 
be an indirect consequence of inhibition of 
translation of reg A controlled mRNAs since the mRNA 
of T4 gene 1 is stable even though it is sensitive 
to inhibition by reg A (Trimble and Maley, 1976). 
T4 codes for a number of components used in 
translation or which modify existing host translational 
components. None of these functions is essential for 
T4 development but some are lethal on certain 
bacterial strains (Guthrie and McClain, 1973). 
These include: a function that modifies existing 
tRNAs e.g. specific cleavage of host leucyl-tRNA 
(Yudelevich, 1971), functions that influence host 
tNA modifying enzymes (Boezi et al., 1967), a 
function which alters valyl-tRNA synthetase (Muller 
and Marchin, 1975), functions that alter translation 
inhibitory factors (Rabussay and Geiduschek1 1977a) 
and also eight phage encoded tRNA species (McClain 
et al., 1972). These may help to bias the hosts 
translational machinery towards translation of T4 
mRNA and T4 message codon usage. 
1.2.e Particle assembly and cell lysis 
T4 phage particle assembly is not programmed 
in time by successive expression of phage genes. 
All structural proteins seem to be synthesised 
simultaneously and accumulate as precursor pools from 
which are first constructed sub-assemblies and finally 
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complete virions. Overall assembly has been deduced 
by.in vivo studies of mutant phage and by complementation 
in in vitro assembly (Edgar and Wood, 1966). 
Essentially capsid assembly consists of four major 
sub-assembly processes (Casjens and King, 1975). 
The base plate assembles first, and upon this 
assemble the tail tube and sheath. The shell of the 
phage head, composed mainly of gp23, is assembled 
separately. Once formed, the head and tail parts 
combine spontaneously. Formation of the tail 
fibres is independent of the rest of the virion, and 
they are attached to the base plate after the head 
and tail are joined. 
DNA packaging occurs by a headful mechanism 
using concatemeriä DNA as a substrate (Ritchie and 
White, 1972). Sequence specific cuts are not 
required as daughter molecules are circularly 
permuted and are 3% longer than the whole genome so 
that a complete genome is always packaged. A mutant 
with temperature-sensitive gp49 forms empty heads 
at non-permissive temperatures which become filled 
on lowering the temperature (Luftig et al., 1971). 
Gene 49 is the structural gene for T4 endonuclease 
VII (Kemper et al., 1981) which is able to remove 
recombinational (Holliday) structures from DNA 
(Mizuuchi et al., 1982) . In the absence of gp49 
branched DNA accumulates (Kemper and Brown, 1976) 
which is partially packaged, presumably until 
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interrupted by a branch which would normally be 
removed by gp49. The mechanism of packaging 
termination is not understood. 
A late gene product gpe is a lysozyine which 
cleaves bacterial cell wall peptidoglycáns (Tsugita, 
1971). Although lysozyme accumulates in the cell 
from just after the start of replication, it can 
only function if it has access to the bacterial 
cell wall. This is provided by the T4 gene t 
product (Josslin, 1970) which damages the cytoplasmic 
membrane. Cell lysis occurs usually about 30 mm 
after the start of infection liberating a few 
hundred progeny (Ellis and Delbrück, 1939). 
T4 exhibits lysis inhibition, where normal 
lysis is inhibited by secondary infection by T4 
phage after the primary infection. The superinfecting 
phage are effective in lysis inhibition even if they 
have been killed by X-rays. The delay in lysis is 
a few hours long and about 1000 progeny are released. 
The cause seems to be a change in the cell membrane 
rendering it insensitive to gpt activity (Josslin, 
1971). This phenomenon can often be used to 
increase the yield of phage in high titre lysates. 
Mutants in the rI, rII and EIII genes (Emrich, 1968) 
are not subject to lysis inhibition, and mutations 
in t resulting in lysis defective phage are 
suppressed by nil mutations. 	nil apparently 
prevents or delays gpt activity and hence delays lysis. 
In r11 phage, lysis is not subject to delay and occurs 
more rapidly than in wild. type infections. 
1.3 RESTRICTION ANALYSIS AND CLONING OF THE T4 
GENOME 
1.3.a. 	Preparation of cytosine-containing DNA 
Wild-type T4 DNA cannot be cleaved by commonly 
used restriction endonucleases due to the presence 
of glucosylated HMC residues (Li 'et al., 1975; Kaplan 
and Nierlich, 1975). Presumably these residues 
protect target sites and prevent recognition, 
therefore DNA must be non-glucosylated in which 
case it is partially susceptible to some enzymes, or 
the HMC must be replaced by cytosine which is not 
a substrate for T4 glucosyl transferase (Kornberg 
etal., 1961). Three enzymes have recently been 
reported which cleave HMC-containing T4 DNA; TaqI,, 
Ahalil and ECORV, however their restriction patterns 
are different...for.,T4 cytosine or.HMC- containing 
DNA (Kutter and Riiger, 1983). 
T4 HMC glucosylation is prevented by mutations 
in the structural genes for the a and glucosyl 
transferases agt and agt (Georgopolous, 1967), or 
by using a host deficient in the UDP glucose 
phosphorylase, 921U (Hattman and Fukasawa, 1963). 
Glucosylation protects T4 DNA from restriction by the 
rgl system of E .coli and the P1 phage system (Revel and Luria, 1970). 
Non-glucosylated T4.A is particularly susceptible 
to digestion by EcRI (Kaplan and Nierlich, 1975) 
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T4 DNA containing cytosine can be made in 
several ways. A temperature-sensitive mutant of 
g56 (the dCTPase) forms DNA free of cytosine at 
37 °C, is lethal at 42 °C, but at 39 °C it produces phage 
with 20% of HMC..replaced by cytosine (Kutter and 
Wiberg, 1969). Introduction of a denB mutation 
(endonuclease IV) prevents fragmentation of the 
cytosine containing DNA, and in order to make 
viable phage, strains must also have a mutation in 
the alc/unf gene. This allows transcription of 
late genes coding for capsid proteins from cytosine 
containing DNA. g56, denB, alc mutants can make 
viable phage in which cytosine replaces 40-70% of the 
HNC (Snyder et al. 1976) . The cytosine content in 
the DNA can be raised to over 95% by including a 
denA (endonuclease II) mutation further reducing 
degradation of cytosine containing DNA (Warner, 
et al., 1970), or by introducing a gene 42 (dCMP - 
hydroxymethylase) mutation (Morton et al., 1978; 
Wilson et al. 1977) . T4 20% cytosine DNA is 
susceptible to partial cleavage by EcoRI but not 
Hindill, and susceptibility increases with the. 
percentage of cytosine. DNA which is non-glucosylated 
or partially HMC-containing is useful for generating 
partial restriction digests (Wilson et al. 1977; 
Mattson et al. 1977). 100% cytosine-containing 
T4 DNA is susceptible to all restriction endonucleases 
tried so far. 
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1.3.b Mapping of the T4 genome 	 - 
Most early restriction mapping of the T4 
genome was achieved by ordering restriction sites 
contained on cloned T4 fragments carrying known 
genetic markers (e.g. Mattson et al., 1977; \Telten 
et al., 1976; Wilson et al., 1977). These data 
together with analysis of digests of T4 cytosine DNA 
using a variety of multiple and partial digests 
(e.g. Takahashi et al., 1979; Kiko et al., 1979; 
Carison and Nicolaisen, 1979; Kutter et al., 1980; 
O'Farrell et al., 1980; Ruger et al., 1979) have 
accumulated to provide a map that covers most of 
the genome. Figure 1.1 presents the genetic map 
of T4 correlated with the restriction map (Wood 
and Revel, 1976; Mosig, 1983) . The construction 
of a purely genetic map of T4 is complicated by 
the extensive recombination undergone by T4 DNA 
molecules and local variationsin recombination 
frequency (Stahiet_al., 1964). Initially, the 
positions of many genes were determined by two-point 
crosses giving recombinational distances between 
conditionally lethal mutants (Edgar and Wood, 1966; 
Edgar et al., 1964; Stahl et al., 1964). The first 
estimates of physical distances between markers 
based on marker rescue with incomplete genomes 
(Mosig, 1968) showed that the recombinational map 
was distorted in some regions. Wood and Revel (1976) 
refined the relationship between the physical and 
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genetic distances by adjusting the map dis.tances in 
several regions based on physical measurements of 
the sizes and locations of. various deletions determined 
by heteroduplex mapping (Kim and Davidson, 1974) and 
the known molecular weights of gene products 
(O'Farrell et al., 1973; Vanderslice and Yegian, 
1974) 
The availability of a detailed restriction map 
is invaluable in the in vitro study of transcription 
of the T4 genome. 	Gram et al. (1984) used RNA 
polymerase from uninfected E.coli to transcribe 
normal T4 DNA and T4 cytosine-containing DNA. 
labelled transcripts were separated by polyacrylamide 
gel electrophoresis. Transcripts were hybridised 
to re'striction fragments and analysis of labelled 
bands allowed location of major transcripts larger 
than 0.5 kb. Transcripts from overlapping 
restriction fragments were analysed to give precise 
locations of promoters and Rho-dependent terminators 
relative to restriction sites, and t8 determine 
directions of transcription. A total of 31 strong 
promoter sites and 14 terminators were mapped. 
A number of T4 in vivo promoters have also been 
located by Si nuclease mapping (e.g. Kassavetis and 
Geiduscheck, 1982) . The pattern of transcription 
revealed that overlapping transcripts are observed 
throughout infection and that tandem promoters, 
first reported in the tRNA. region by Goldfarb (1981a) 
seem to be a common feature of the T4 early regions. 
This may improve the efficiency of T4 gene transcription 
relative to the host genome, or it may ensure that 
genes are transcribed in appropriate amounts during 
changes in the properties of the RNA polymerase 
(Goldfarb 1981b) 
1.3.c The molecular cloning of genes in the pseT 
region 
Cloning of sections of T4 DNA has already 
assisted in the study of gene expression and mapping 
of the genome ; and has proved a valuable source 
of biochemically important enzymes e.g. DNA ligase 
(Wilson and Murray, 1979; Murray et al., 1979) and 
RNA ligase (Rand and. Gait, 1984). Several groups 
have reported cloning of T4 DNA restriction fragments 
in A and plasmid vectors, and have demonstrated 
the presence of numerous genesmainly by marker 
rescue analysis (Velten and Abelson 1980; Wilson 
et al., 1977; Vorozheikina et al., 1980). 	There 
is a bias against cloning of early genes which might 
be expected since early genes usually encode functions 
involved in DNA metabolism or host shut-off and would 
be detrimental to the host. In addition early genes 
are transcribed by relatively unmodified E.coli RNA 
polymerase, whereas expression of the late genes 
requires modification of the polymerase in order to 
recognise late promoter. 
Wilson and Murray (1979) reported cloning of 
the intact functional DNA ligase gene (g30) in A 
vectors using 50% cytosine DNA digested with EcoRI 
or Hindlil. 	Fragments were isolated in integration 
proficient Red+  A replacement vectors or integration 
deficient Red A replacement vectors respectively. 
Recombinants including the T4 ligase gene were 
identified by their ability to complement the 
ligase deficient strain of E.coli, ligts7. At 37 °C 
Lts7 produces insufficient ligase to allow Red A 
mutants to .form plaques, and above 39 °C the its7 
bacteria fail to grow completely. Therefore AT4 
lig phage were detected as Red A able to form plaques 
on ligts7 at 37 °C, or where the integration proficint 
vector was used, by the ability of a prophage to 
rescue host colonies at over 39°C. Lysogens of 
x T4 hg phage in a suppressor-free host supported 
growth ofT4 g30 amber mutants at high - plating 
efficiency (1_10l) , indicating that a functional 
g30 was expressed by the A recombinant. Restriction 
analysis showed that g30 lies within a 1.9 kb Hindlil 
fragment or 3 EcoRl fragments (0.4, 0.5 and 2.2 kb). 
While g30 is expressed only from A promoters in 
recombinants carrying the 1.9 kb Hindlil fragment, 
recombinants carrying all three EcoRI fragments include 
a T4 promoter able to initiate g30 expression. This 
promoter is present on the 1.9 kb fragment, but for 
unknown reasons it does not function. The g30 polypeptide 
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is transcribed anticlockwise in relation. to the T4 
map (Wood and Revel, 1976) as would be expected for 
a T4 early gene. 
Murray et al. (1979) demonstrated that active 
ATP-dependent DNA ligase can be isolated following 
heat induction of E.coli cells lysogenic for X T4 
lig phage. This provides a genetic means of purifying 
ligase from other T4 proteins such as nucleases, 
and also results in amplification of expression. 
Mileham et al. (1980) reported cloning and 
organisation of the f rd-DNA ligase region of T4. 
Probes made from x T4 lig and x T4 td DNAs were 
hybridised to restriction fragments of 100% 
cytosine DNA. A single 11.5 kb Hindlil fragment 
was identified which hybridised to both probes and 
therefore covered the region between them including 
the RNA ligase and polynucleotide kinase genes. The 
region fromfrdto g30 comprises 4..HindIIIand14 
EcoRI fragments (Figure 1.5) . Hybridisation of 
labelled fragments to partial EcoRI digests allowed 
unambiguous ordering of the EcoRI fragments. The 
11.5 kb Hindill fragment was never cloned but six 
of the eight component EcoRI fragments and a 
deletion derivative (2.7 kb) of a seventh (3.1 kb) 
were recovered as x recombinants. The EcoRI 
fragment (1.3 kb) and the deleted part of the 3.1 kb 
fragment which were not recovered may contain DNA 
encoding functions detrimental to the host or phage. 
Figure 1.5 
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Organisation of the f rd-DNA ligase region 
of the T4 genome. The figure shows: the physical 
distance in kilobase pairs from the rIIA-rIIB 
join = 0 (Wood and Revel, 1976); the map position 
of T4 deletion mutant ETAl as determined by 
heteroduplex mapping (Kutter et al. 1984); a 
genetic map of T4 showing the gene order in the 
f rd-DNA ligase region, rectangles represent 
lengths of genes whose products have been 
identified and sized by SDS polyacrylamide gel 
electrophoresis, or by DNA sequencing; the 
direction of transcription in this region 
(Wilson and Murray, 1979; Mileham et al. 1980); 
a restriction map of the region showing fragment 
sizes (kb) for digestion with EcoRI, Hindill, 
Pa11 PstI, Smal, XbaI. The unlabelled EcoRI 
fragment has a size of 109 base pairs. 
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Other deleterious functions may require combinations 
of two or more fragments for their expression. Several 
genes are present in this region whose expression may 
be detrimental including denA, an endonuclease which 
attacks cytosine containing DNA, alc/unf which confers 
HMC-DNA specificity on transcription by the E.coli 
RNA polymerase, and the r III gene whose product may 
be involved in a -host membrane interaction. A 
functional nil gene cannot be cloned in plasmids 
(Selzer et al., 1978) . In addition the presence of 
a strong promoter on a cloned fragment may interfere 
with transcription and replication of the vector. 
The location of pT is defined by the pseT 
deletion mutant ET Al which deletes all known 
markers within this gene (Sirotkin et al., 1978). 
Mileham et al. (1980) using hybridisation of 
labelled EcoRI fragments to digests of T4 100% cytosine 
DNA, determined --- that - the - seT---i --- de -1etion - spans- -3- - 	- 
EcoRI fragments of 2.27, 0.1 and 1.1 kb (Figure 1.5). 
Either of the larger fragments could encode the 
polynucleotide kinase subunit (which has an apparent 
Mr of 33 kd), but if the gene extended over more 
than one EcoRI fragment, partial digests of T4 DNA 
should provide fragments including an intact 2T gene. 
More recently Rand and Gait (1984) obtained a 
clone containing an intact functional RNA ligase gene. 
RNA ligase (gp63) (Snopek et al., 1977) again has 
many practical applications in experimental biochemistry 
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(Uhienbeck and Gumport, 1982). Previous attempts 
to clone an intact gene 63 were unsuccessful and 
failure to obtain marker rescue of a g63 amber mutant 
with any of the x recombinants from the f rd-DNA ligase 
region had led Mileham et al. (1980) to conclude 
that the 1.3 kb EcoRI fragment might contain g63. 
An 8.2 kb BglII fragment (Figure 1.5) large enough 
to be sure of containing g63 was fragmented into 
200-600 bp sections (Rand and Gait, 1984) which 
were cloned in M13 and the whole sequence of the 
fragment obtained. An open reading frame of the 
correct size occurred at the genetic map location 
of g63 (Wood and Revel, 1976; O'Farrell et al., 
1980) and extended over the junction of the 1.3 and 
1.7 kb EcoRI fragments with the 3' end in the 1.3 kb. 
One of the short fragments in M13 contained the 3' 
end of the open reading frame and this sequence was 
fused to asuitable restrictionfragment;pu-r±fi•ed------
from T4 DNA, which contained the 5' region of 
the open reading frame. Most of the DNA surrounding 
the reconstituted g63 was removed by restriction 
before cloning g63 into mp8. The resulting clone 
expressed a functional RNA ligase. Rand and Gait 
(1984) suggest that a promoter is located in the 
1.3 kb EcoRI fragment, 3' to g63, and a strong T4 
promoter recognised by RNA polymerase in vitro 
maps in this region (Gram et al., 1984). Expression 
of the mutant T4 aló/urif gene downstream of this 
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promoter (Kutter et al.,1984) may explain why the 
1.3 kb fragment could not be cloned intact. 
1.4 EXPRESSION OF GENE PRODUCTS FROM A RECOMBINANTS 
1.4.a The A genome 
The temperate coliphage A has about 50 genes, only 
half of which are essential for phage growth and 
plaque formation. Figure 1.6 shows the A genetic 
map and transcriptional circuits (Friedman and 
Gottesman 1983; Arber, 1983) . The left hand region 
includes all the genes (A to J) whose products are 
necessary for head and tail formation and DNA 
packaging. The region from J to the phage attachment 
site att contains non-essential genes coding for 
proteins of unknown function. Genes to the right 
of att govern site-specific (mt and xis) and 
generalised (redA and redB) recombination of A phage 
- 	 DNA. The product of theN gene is a regulatory 	. 
protein necessary to activate transcription of A 
genes including 0, P and Q. None Of the genes in 
the region between J and N is essential for plaque 
formation. Gene cI encodes the A repressor protein 
which switches off transcription of phage genes in 
the lysogenic state (Ptashne, 1971). To the right 
of CI are genes which are essential for plaque 
formation. The 0 and P genes are required for 
replication of phage DNA, and the Q gene product for 
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A genetic map of A including some key 
markers and transcriptional circuits, from 
Murray (1983). Black regions in the top 
diagram are non-essential, dotted lines indicate 
the end points of the immunity regions of the 
434 	21 Aimm and Aiimn phages, 
0L  and o are the 
ci repressor binding sites.. The bottom diagram 
indicates organisation of the phage control 
region including sites at which transcription 
is initiated and terminated. Heavy arrows 
represent the major transcripts, filled circles 
are major promoters and open circles are major 
termination sites. (I) the immediate early 
transcripts initiated ator 	terminate at tL 
and tRl respectively in the absence of the N gene 
product. Some transcripts-escape- t 1 -but 
terminate at t R2 	(ii) in the presence of N protein, 
early transcripts initiated at p continue through 
and those fromcontinue through tRi and 
(Iii) late transcription of the circular genome 
is dependent on the Q gene product and continues 
through genes S R and A and eventually J. 
products are necessary for lysis of the host cell. 
All the essential, and many of the non-essential 
genes are transcribed from the three major A promoters 
2L' ER and  ER'•  Following infection, transcription 
proceeds leftward from 2L  through gene N and rightward 
from 2R  through gene cr0. In the absence of gene N 
product, most transcripts terminate just beyond these 
genes at sites tL  and t. Those transcripts which 
escape termination at tRi  terminate at tR2•  The N 
gene product interacts with specific sites (nut) 
allowing RNA polymerase to overcome termination 
(Friedmann and Gottesman, 1983) and continue leftward 
beyond t L  into the non-essential genes and rightward 
through the DNA replication genes 0 and P and 
through t R2  into gene Q. 
The product of gene cro is essential for lytic 
development and inhibits synthesis of the repressor 
(CI product) . It also represses synthesis of early 
transcripts from2L  and ER  when the products of these 
genes are no longer required. 
The product of Q like that of N is an anti-
terminator, and is required for transcription of 
the late genes of A. Since the linear A chromosome 
circularises on infection, 0-dependent transcription 
from 2R'  continues through S and R into A and on 
through J. The anti-termination activity of gpN 
is essential for activation of gene Q. However, 
E t R2  is deleted, leakage of transcription through 
Rl is enough to provide 0, P and Q functions. 
Depending on the conditions, 10-50% of infections 
with A phage give rise to lysogeny, where the 
repressed A genome integrates into the chromosome 
of the host via a specific site on A DNA called att. 
The prophage is trapped on the chromosome by the action 
of the A ci repressor which binds to the 	and p. 
operator regions and prevents further transcription 
of the x genes responsible for the lytic cycle (Wu 
et al., 1972). If the repressor is inactivated, the 
genome is expressed as described above and the prophage 
excises allowing replication and maturation of 
phage particles. 
The large region of non-essential DNA in the 
genome (about 20 kb in A wild-type) is central to 
the use of A as a vector. In vector molecules at 
least part of the non-essential region is deleted 
to make space for the donor DNA. 	However, deletiàn 
of the entire non-essential region results in a 
loss of infectivity since encapsidation of A DNA 
hasa minimum as well as a maximum size limit 
(Weil et al., 1973). Usually molecules must be 
80-105% of normal length, so infectivity can be 
maintained by replacing non-essential regions with 
other DNA sequences. A small fragment is more 
readily cloned in an insertion type A vector. 
Such a vector has a single restriction target, 
preferably within a' gene so that insertional 
inactivation will allow, recognition of recombinants 
by a changed but non-lethal phenotype (e.g. clear 
plaques are obtained on insertional inactivation 
of the ci gene since this prevents establishment of 
repression) . DNA fragments greater than 10 kb can 
be cloned in a replacement vector, replacing non-
essential DNA between widely spaced targets. 
Packaging of linear A DNA molecules can be 
achieved in vitro (Becker and Gold, 1975) using 
concentrated cell extracts of induced lysogens 
containing prophage with complementing capsid 
defects. In vitro packaging can be used under 
conditions which are s.ize selective in order to 
enrich for recombinants generated by insertion of 
DNA into a vector with a small genome. 
To achieve expression of cloned DNA, fragments 
are usually incorporated into the central non-essential 
region of x between J and N so that transcription of 
the cloned genes is mediated by the major x promoters 
PL and 	. 	Genes inserted in the correct orientation 
downstream of 	are transcribed from this promoter 
(Franklin, 1971) . Inserted sequences do not usually 
impede transcription from p in the presence of the 
anti-termination activity of gene N (Adhya et al., 
1974; Franklin, 1974). Alternatively, genes inserted 
in the opposite orientation can be effectively tran-
scribed from PRI (Wilson and Murray, 1979) 
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1.4.b. 	Amplification of gene products 
A number of factors contribute to the efficiency 
of expression of cloned genes. Firstly, the coding 
sequence must be cloned without interruptions. 
This is not usually a problem for prokaryotic 
genes, however an intron has recently been discovered 
in the T4 td gene (Chu et al., 1984). For maximum 
amplification, transcription must be mediated by 
an efficient and tightly controlled promoter, 
particularly if accumulation of a particular gene 
product is likely to be detrimental to the host or 
vector (Hershfield et al., 1974; Shimitake and 
Rosenberg, 1981). Prokaryotic promoters share 
two regions of homology, one 35 base pairs upstream 
of the transcription initiation site (consensus 
5'TTGACA) and another 10 base pairs upstream 
(consensus 5'TATAAT, the Pribnow box) (Rosenberg 
and Court, 19.79;., Siebenlist.at_al.,.1980)... These 
probably represent the bases most intimately involved 
in polymerase binding and orientation. The number 
of nucleotides separating the two consensus sequences 
is important. Altering the optimum distance of 
16-19 nucleotides in the lac or B-lactamase 
promoters changes the 'strength' of the promoter. 
The most widely used systems for promoting high levels 
of cloned gene expression are: the lac promoter of 
E.coli which is regulated by the lac repressor 
and induced by IPTG; the trp promoter of E.coli which 
is regulated by the trp repressor and induced by 
3-indolylacetic acid or tryptophan starvation; the 
constitutive -1actamase promoter of pBR322; and 
the leftward 	and rightward PR promoters of A. 
The latter are regulated by the ci repressor, 
usually in a temperature sensitive ci mutant 
induced by a temperature increase. 
Transcription termination is usually effected 
in a GC-rich region with 2-fold symmetry (a stem 
loop) before the termination site, followed by an 
AT-rich sequence at the actual site of termination 
(Rosenberg and Court, 1979). A number of protein 
termination factors are also involved, notably Rho 
(Roberts, 1970), as well as anti-termination factors 
such as gpN of A (Greenblatt, 1981). Terminators 
may be inserted downstream of cloned genes to avoid 
adverse effects on replication or transcription of 
the vector (Nakaxnura..andinouye,.i982)-._.............. 
Amplification is usually augmented by increasing 
the gene copy number (Miller-Hill e al., 1968) , either 
by cloning in a high copy number plasmid or in A, 
where lytic infection allows multiplication of the 
recombinant phage. In the latter case, an integration-
proficient A phage can be propagated as a prophage 
where transcription from the major A leftward 
and rightward promoters is repressed. Expression of 
a gene cloned in the centre of the A prophage is 
initiated from PL or 2R'  only on indudtion of the 
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lysogen causLng the prophage to excise and undergo 
multiple rounds of replication. 
Efficient translation of transcripts depends 
upon the presence of a good ribosome binding site 
(rbs) which in E.coli usually consists of an 
initiation codon, AUG, and a sequence of 3-9 bases 
complementary to the 3' end of 16S rRNA (Shine and 	-. 
Dalgarno, 1975). This sequence is probably involved 
in binding of the 30S subunit to mRNA. Since an 
early T4 rbs is recognised by the E.coli translational 
machinery, translation of a cloned T4 early gene 
will presumably initiate efficiently from its own 
rbs. 
The structural features of protein modification 
are not well understood. Bacterial proteins can 
undergo a number of modifications following 
translation e.g. hydrolysis of the N-terminal formyl 
methionine., .orc1eavage...of.hydrophobic.signal 
sequences (Davis and Tai, 1980). It is possible 
that some phage encoded proteins may require 
modification by phage encoded functions. For example, 
glucosylation and phosphorylation do not occur to any 
great extent in E.coli. 
The. first systems employing A to amplify 
expression of cloned genes involved insertion of a 
gene including its own promoter. The yield of 
polypeptide could be enhanced simply by delaying 
cell lysis so that DNA replication could increase the 
number of gene copies, and the time available 
for expression would be extended. This was originally 
achieved by a mutation in the A S gene (Muller-Hill 
et al., 1968) which prevents cell lysis but permits 
DNA replication and protein synthesis to continue 
for some hours. Mutations in Q and N proved even more 
efficient since these block all late functions including 
lysis and packaging of phage DNA (Moir and Brammar, 
1976). This approach has been used to amplify both 
E.coli DNA ligase (Panasenko et al.., 1977) and DNA 
polymerase I (Kelley et al., 1977). In both these 
cases the functional gene could not be cloned in a 
multicopy plasmid, presumably because overproduction 
of their protein products was deleterious. 
Since cloned genes will not all have a 
functional promoter within the cloned sequence, Moir 
and Brammar (1976) investigated ways of optimising 
gene expression from EL.• 
early- leftward transcription (Figure 1.6) through 
gene N and beyond att. 	x E1-, is a very strong 
promoter, reportedly 8-10 times more efficient than 
lac (McKenney et al., 1981) in terms of transcriptional 
initiation.. It is subject to control, primarily 
repression by the ci and the cro gene products. 
In addition, the nutL site downstream of the XPL 
allows the N gene product in association with RNA 
polymerase to overcome transcriptional termination 
in sequences downstreamof EL (Franklin, 1974; 
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Adhya et al., 1974). Moir and Brarnmar (1976) used 
a cro A in order to prevent modulation of tran- 
scription from EL (Franklin, 1971; Sly et al., 1971) 
and also mutations in Q and S to inhibit lysis. 
Cells infected at hi.gh multiplicity with a 
A trp cr0 Q S phage in which trp genes were 
transcribed from EL contained up to 20% of their 
soluble protein as products of the trp operon. 
However cro phage are defective in DNA replication 
(Folkmanis et al., 1977), so a good amplification 
of gene copy number is not achieved. Consequently 
the use of a cr0 vector has not been very 
successful in some cases, e.g. induction of a cr0 
AA prophage (Murray and Kelley, 1979) where 
the DNA polymerase gene was transcribed from EL 
after inactivation of heat-labile repressor. In this 
case the DNA polymerase gene was transcribed more 
successfully from i.ts.own promoter inacro phage 
where efficient DNA replication compensated for a 
lower rate of leftward transcription. A temperature-
sensitive cro mutant is available (Matsubara, 1976), 
but it is difficult to optimise conditions for 
derepressed transcription from EL  and good 
amplification of copy number by DNA replication. 
Therefore, it is often easier to use 2 in a 
L 
plasmid vector (see below). 	- 
Another alternative is to use the Q-dependent 
late promoter 2R' which is active after DNA replication. 
An example is transcription of the T4 DNA ligase 
gene from ER'  in a phage defective in gene E, which 
encodes the major capsid protein, and in gene S 
to prevent lysis. However, transcription from 
must traverse a large part of the A genome before 
reaching the inserted gene, resulting in over- 
expression of a large number of unwanted A proteins. 
XEL can be cloned in a suitable plasmid 
vehicle in the presence of the repressor gene. 
Bacteria containing about 20 copies of such a 
plasmid can be grown in the absence of expression 
from EL  until subsequent inactivation of heat-labile 
x repressor will allow transcription from 
One of the advantages of 2L  in contrast to e.g.. 
the lac promoter of E.coli is that sufficient A 
repressor is produced from a single copy of the ci 
gene to repress transcription from multiple plasmid 
borne copies of 
2L• 
 A temperature-sensitive c1857 
gene can be maintained either on the host chromosome 
or on a compatible plasmid so that transcription from 
can be switched on by raising the temperature. 
Bernard et al. (1979) showed that heat induction of 
plasmids containing LaA downstream of 
2L  controlled 
by c1857, produced up to 6.6% of the soluble cell 
protein as the product of trpA. 
Remaut et al. (1981) described plasmid 
expression vectors including XEL  together with the 
nutL sequence upstream of the insertion, site for 
foreign DNA. EL was controlled by maintaining the 
plsmid in a defective, cro A lysogen containing a 
chromosomal c1857 gene and a functional N gene to 
provide anti-termination activity in conjunction 
with the nutL site. Synthesis of up to 10% of 
total soluble cell protein was achieved for Lr2A 
or -lactamase, particularly where the plasmid was 
induced in an N-expressing host. 	Presumably 
anti-termination increases transcription efficiency. 
More recently Remaut et al. (1983) have constructed 
improved EL  vectors derived from runaway replication 
mutations (Uhlin et al., 1979) where heat induction 
inactivates c1857 repressor, but also leads to 
amplification of plasmid copy number. Here T4 DNA 
ligase expression exceeded 20% of the total soluble 
cell protein. 
The use of plasmids carrying AEL  has been 
successful in -amplifying expression ofthe Xcii-
protein, a phage regulatory protein which is extremely 
toxic to E.coli (Shimitake and Rosenberg, 1981). 
A lysogen carrying a defective A prophage expressing 
c1857 could be transformed at high efficiency with 
plasmids expressing the cii protein, whereas non-
immune cells could not be transformed. Synthesis 
of cli protein as about 4% of total cell protein 
was achieved on induction by a temperature shift. 
1.5 T4 POLYNUCLEOTIDE KINASE 
Many T4 encoded enzymes have now been assigned 
physiological functions, but the in vivo role of poly-
nucleotide kinase (pnk) has not been determined. 
However, the ability to catalyse the transfer of the 
terminal phosphate of ATP to a 5'-hydroxyl terminus of 
DNA or PNA has meant that the enzyme has found wide use 
in experimental molecular biology. Its main application 
has been in the investigation of DNA and RNA sequences 
as a means of labelling oligonucleotides with 32P for 
their analysis by gel electrophoresis (Murray, 1973; 
Maxam and Gilbert, 1977). End-labelling of nucleotides 
has also proved invaluable in the synthesis of specific 
DNAs such as the gene for yeast alanine tRNA (Khorana 
et al., 1972) , which was only. possible using labelled 
oligonucleotides to monitor ligation by T4 ligase. 
Polynucleotide kinase was independently discovered 
in T2 (Novogrbdsky and HurWitz/I966) axd'T4(RIchardson 
1965) as an activity which could catalyse the transfer of 
the y-phosphate of ATP specifically to 5 1 -hydroxyl 
terminiof DNA, RNA and olignucleotides. No pnk activity 
has been found in uninfected bacteria, but similar 
activities are present in mammalian nuclei (Novogrodsky 
et al., 1966). The T4 pnk also has an indigenous 
3 1 -phosphatase activity (Cameron and Unhienbeck, 1977; 
Sirotkin et al., 1978). This activity was first discovered 
by Becker and Hurwitz (1967) but initially it was not 
realised that it was associated with the pnk enzyme. 
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The 3 1 -phosphatase activity strongly prefers DNA to RNA 
as substrate and selectively removes 3'-phosphoryl termini 
from DNA or deoxyribonucleotides (Becker and Hurwitz, 1967; 
Cameron and Uhienbeck, 1977). 
Depew and Cozzarelli (1974) screened isolates of 
heavily mutagenised T4 for those unable to induce the 
3'-phosphatase activity. They found one such mutant, 
pT1, which multiplied normally on all laboratory strains 
of E.coli suggesting that the activity was not essential. 
However, after testing a number of clinical strains of 
E.coli they found one, CT196, which was restrictive for 
2Tl. 	Unfortunately this host also had a reduced 
plating efficiency for wild-type T4, so CT196 was 
crossed with Hfr strains of E.coli K12 and a hybrid 
strain CTr5x was isolated which restricted T4 pseTl but 
not T4 	This allowed the isolation of another 
mutant, ET2, and mapping of the pseT mutations between 
gene 63 and gene 31. Chan and Ebisuzaki (1970) had 
isolated a number of mutants unable to induce the 
5'-knase activity, but since they were unable to find 
a phenotype associated with the deficiency they could not 
map the mutations. 
The first connection between the kinase and 
phosphatase activities was made by Cameron and Uhienbeck 
(1977) who reported that a 3'-phosphatase activity 
co-purified with 5'-pnk, and that both seemed to be associated 
with the same polypeptide. Sirotkin et al., (1978) showed 
that most 	T mutants, isolated because they were 
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restricted on CTr5x, lacked both the 5'-'kinase and 3'-
phosphatase activities. In fact Depew and Cozzarelli 
were unfortunate in not discovering that ET is the 
gene for pnk since they assayed cells infected with their 
ETl mutant for kinase activity and found it to be normal. 
So far, 2Tl is the only mutation isolated which 
inactivates the 3'-phosphatase but not the 5'-kinase. 
A second mutant 2T47 fails to induce 5'-kinase and not 
the 3'-phosphatase. These two mutants both fail to make 
late proteins in CTr5x and do not complement each other 
for this defect, suggesting that the two functions are 
required for normal late expression in this strain 
(Sirotkin etal., 1978). 
Detailed studies have been made of the polynucleotide 
kinase activity (Kleppe and Lillehaug, 1979; Richardson, 
1965) and the physicochemical properties of the protein 
(Lillehaug, 1977; Panet et al., 1973). SDS gel electro-
phoresis of the homogeneous protein gives oie polypeptide 
band of an apparent Mr of 33 kd (Panet et al., 1973; 
Lillehaug, 1977) 	The molecular weights of the active 
enzyme and the subunit have also been estimated from 
sedimentation equilibrium data as 147 kd and 33.2 kd 
respectively (Lillehaug, 1977) . It seems therefore that 
the active species consists of 4 subunits. N-terminal 
amino acid analysis (Lillehaug, 1977) showing that 
phenylalanine is the only N-terminal residue, suggests 
that the subunits are identical. Analytical ultra-
centrifugation experiments show that in low ionic strength 
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buffer the enzyme dissociates into 4 subunits (Lillehaug, 
1977), while high ionic strength or the presence of 
polyamines or the enzyme substrates favours stabilisation 
of the tetrameric form and stimulates kinase activity 
(Lillehaug and Kleppe 1975a and 1975b). 
The kinase activity is almost lost in the absence 
of sulphydryi agents such as 2-mercaptoethanol, indicating 
that the enzyme is dependent upon reduced -SH groups 
for activity. Each monomer appears to have two -SH 
groups, one exposed on the surface and one more buried. 
The enzyme precipitates in the absence of 2-mercaptoethanol 
at low ionic strength suggesting that -SH groups are 
involved in stabilisation of the tertiary structure 
(Lillehaug, 1977) . However, the determination of the 
number of -SH groups was not affected by the presence of 
the substrates (ATP or 3'-monophosphate), so cysteine 
residues are probably not part of the active site. The 
enzyme also requires Mg 2 for activity. The circular 
dichroism spectrum of the protein indicates a highly 
helical organisation. The c-he1ical content was 
estimated to be between 45 and 55% and s-pleated sheet 
about 25% (Lillehaug, 1977) 
Substrates of the kinase reaction e.g. (Up) 4 U, 
protect both the 3 1 -phosphatase and the 5'-kinase 
activities from heat inactivation, while compounds which 
are only substrates for the 3'-phosphatase e.g. p(Up) 5 
cannot protect the 5'-kinase activity (Cameron and 
Uhlenbeck, 1977). This indicates that the activities 
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may be closely connected on the protein but are not 
manifestations of the same reaction. The existence of 
the pseTl and £T47  mutants which lack the 3'-phosphatase 
and the 5 1 -kinase activity respectively (Cameron et al., 
1978; Sirotkin et al., 1978) again suggests that separate 
active sites exist. 
The 5 1 -polynucleotide kinase activity can phosphorylate 
DNA, PNA and oligonucleotides. While mononucleosides are 
not substrates, a nucleoside 3'-monophosphate will be 
phosphorylated to yield the 3'-5'-diphosphate (Lillehaug 
and Kieppe, 1975a) . Sano (1976) reported that CTP and 
GTP are equally effective as phosphate donors, as is ATP. 
The kinase prefers single-stranded 5'-hydroxyl terniini, 
so blunt-ended or 5'-termini with 3' overhangs, or single-
stranded nicks in DNA are poor substrates (Lillehaug 
et al., 1976). The 5'-kinase reaction is reversible 
(Van de Sande et al., 1973) [y- 32P]ATP is produced from 
a 5'-[ 32 P] labelled -oiigonucleoti'de in-the presence.of--
ADP. However, the forward reaction has maximal activity 
at pH 9-10 while the reverse reaction has a pH optimum 
of 6. 
The 3'-phosphatase activity selectively removes 
3'-phosphoryl groups from DNA or deoxyribonucleotides 
(Depew and Cozzarelli, 1974) and will use a mononucleoside 
3'-phosphate as a substrate yielding the nucleoside 
(Becker and Hurwitz, 1967; Cameron and Uhlenbeck, 1977). 
The activity is also a cyclic 2'-3'-phosphatase, 
however, there is little effect on 3'-phosphoryl RNA. 
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The optimum pH for the 3 1 -phosphatase reaction is pH 6 
(Becker and Hurwitz, 1967) 
The dual activities of the enzyme suggest that both 
the 5'-kinase and the 3'-phosphatase are involved in the 
same pathway in viva. 	They have the potential to convert 
3'-phosphate or 2',3'-cyclic phosphate, and 5'-hydroxyl 
terminated polynucleotides into substrates f or RNA ligase, 
which requires 5'-phosphate and 3 1 -hydroxyl ends. 
There is some similarity between this model and the 
eukaryotic BNA splicing enzymes where RNA is cut next to 
an intron to yield a cyclic 2',3'-phosphate. A phos-
phatase cleaves this cyclic phosphate to a 2'-phosphate, 
and the 5'-hydroxyl end is phosphorylated to yield a 
5'-phosphate terminus (Knapp et al., 1977). The termini 
are then ligated to give a polynucleotide with a 2'-
phosphate branch (Konarskaet_al., 1982). 	The T4 
phage encodes enzymes with all these activities except 
an intron-specific endonuclease to make the first cut. 
Also the phage encoded phosphatase cuts both the 2' and 
3' linkages of the cyclic phosphate so that the final 
polynucleotide would not have a 2 1 -phosphate branch 
(Uhienbeck, cited in Snyder, 1983) . T4 pseT and the 
RNA ligase gene (g63) are closely linked on the genetic 
map (Figure 1.1) as are many T4 genes of related 
function. 
E.coli CTr5x, the restrictive host for pseT is 
also restrictive for PNA ligase mutants (ni) (Runnels 
êt al., 1982) ad the defects exhibited by pseT and rh 
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mutants are similar (see below). pT and rli mutants 
also share a common suppressor stp (Depew and Cozzarelli, 
1974; Runnels et al., 1982), a T4 gene which maps close 
to ru. A mutation in stp relieves the effects of rh 
and pT mutants. Depew and Cozzarelli (1974), found 
that pT mutations reduced the rate of T4 DNA 
replication by half in E.coli CTr5x at 37 °C, and that the 
T4 DNA made was shorter than normal and had an increased 
frequency of interruptions. They postulated that 3'-
phosphatase groups introduced into T4 DNA, possibly by 
an endonuclease coded for by the stp gene could be 
repaired by the host repair system in a normal E.cohi 
strain, but not in CTr5x. Therefore in CTr5x the phage 
encoded 3'-phosphatase would be essential for removing 
3 1 -phosphate ends which are not substrates for DNA 
ligase, polymerases or many exonucleases and are known 
to inhibit several of these activities (e.g. Goulian et al., 
1968; Lehman and"Nussbaum, - 1968).. However it has not 
been proven that 3'-phosphoryl termini occur in T4 
infected cells in vivo, and no mechanism is known which 
produàes 3'-phosphoryl termini in uninfected cells. 
Sirotkin et al. (1978) and Runnels et al. (1982) 
confirmed the observation of defects in T4 DNA replication 
in 2T or rli mutants, but they also noticed a defect 
in late gene expression which was 3-5 fold lower than 
normal even though early protein synthesis remained 
unchanged. The defect in T4 DNA replication occurs 
before there is any effect on' gene expression suggesting 
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that pnk and RNA ligase affect. replication directly, 
rather than the appearance of an early gene product 
involved in replication. However, such a protein may have 
escaped detection on gels (Runnels et al., 1982). The 
effect on late gene expression seems to be at least 
partly at the transcriptional level (Sirotkin et al., 
1978). Mixed competitor hybridisation studies with RNAs 
from T4 pseT2 	infected CTr5x showed that RNA late in 
infection was deficient in sequences equivalent to normal 
T4 late mRNA. Usually when T4 replication is blocked by 
a mutation in a phage gene, the true-late gene products 
fail to appear but synthesis of early gene products 
continues. However, late in infection of CTr5x with 
pseT or rli mutants, synthesis even of early proteins 
stops so that little or no protein synthesis can be 
detected in the late period (Runnels et al., 1982) 
This is similar to the situation observed when T4 DNA 
c ontaining cytosine, replicates in the presence of an 
active alc/unf gene (Snyder et al., 1976) , or when wild 
type T4 infects a host with a mutation in the lit gene 
(Cooley et al., 1979). E.coli lit mutants are defective 
in their ability to support late (replication-coupled) 
gene expression of T4 at 30 °C, and some lit mutants 
restrict the growth of ET mutants, but not wild-type 
T4, at 37 °C. However in the case of cytosine-containing 
T4 mutants or host lit mutations, only T4 late gene 
expression and not DNA replication are affected. 
In all these situations the' effect on late' gene' expression 
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is more severe at low, temperatures. The defects in late 
gene expression and DNA replication which arise on 
infection of CTr5x with pT or rli mutants only 
occur when cells are grown and infected below 37C. 
At 30 °C, replication is about 10% of normal while there 
is almost no synthesis of late proteins. At 42 °C gene 
expression and phage production are normal in CTr5x. 
Therefore, several lines of evidence suggest that the 
closely linked ET, g63 and alc/unf genes of T4, and 
the host lit gene, may all affect the same requirement 
for T4 gene expression. Possibly they participate in 
the accumulation during replication of a DNA template which 
is competent for late gene expression. 
A different theory of pnk and RNA ligase activity 
in vivo has also gathered considerable popularity. 
David et al. (1979), labelled permeablised. T4-infected 
E.coli cells with ('y- 32P] ATP and found labelling of 
RNA which they - presumed- was mediated -by-the T4-induced 
pnk enzyme. The RNA was still labelled after treatment 
with alkaline phosphatase to remove end phosphates 
suggesting that 
32P was trapped in the RNA after 
ligation of ends by the T4-induced RNA ligase. The 
label was located specifically in small tRNA-sized 
RNA5 presumably of host origin. The infection of E.coli 
CTr5x resulted in the isolation of some cleavage products 
of a tRNA-like RNA (David et al. 1982). Four oligonucleo-
tides were obtained, at least two of which could be put 
together to form a tRNA-like molecule with an anticodon 
48 
for isoleucine (David et al., 1982) . The cleavage site 
was next to the anticodon in a position equivalent to 
cleavage during removal of introns in some species of 
yeast tRNA (Goodman et al., 1977). The cleavage fragments 
persist later into infection of CTr5x with 2T or ni 
mutants than in T4+  infections, and they do not appear 
on infection with stp mutants. Again this suggests 
that stp encodes a nuclease which in this case cleaves 
the isoleucine tRNA of E.coli CTr5x, thereby blocking 
translation in general unless religation is affected by 
the action of T4 pnk and RNA ligase activities. However 
this does not explain why defects in infections with pT 
or ni mutants are more pronounced at low temperatures. 
More recently Chu et al. (1984), and Belfort et al. 
(1985) have described a T4 gene which produces a 
transcript including an intron within the coding sequence. 
This gene, td, encodes thymidilate synthase which is 
art of a multi-enzyme complex converting NDPs anddNDPs, 
released from degradation of the host genome, to dNTPs. 
Nucleotide sequence analysis of the td gene revealed an 
intron of 1017 bases interrupting the coding sequence 
for the mature protein (Chu et al., 1984). The mechanism 
by which processing to remove the intron occurs is not 
yet understood. However the cloned td gene is expressed 
in E.coli in the absence of T4 and the mature protein 
isproduced (Chu et al. 1985). Free intron RNA appears on - 
T4 infection even in the presence of chloramphenicol, 
however the production of mature td transcripts is inhibited 
by chioramphenicol (Belfort et. al., 1985). This indicates 
that intron splicing is independent of protein synthesis 
while efficient exon ligation may be dependent on host 
or phage protein synthesis. However, if pnk and RNA ligase 
are involved in processing, there must be an alternative 
mechanism in uninfected E.coli. 	So far only a 2'-5' E.coli 
RNA ligase has been reported (Greer et al., 1983) and 
a 2',5' linkage seems unlikely since sequencing with 
reverse transcriptase proceeds normally across the td 
mRNA splice junction (Belfort et al., 1985). The E.coli 
CTr5x strain' may have a mutation in a host RNA ligase. 
Alternatively it may encode the tRNA-like substrate of 
RNA ligase described by David et al. (1982). 
One possibility which may connect the apparently 
separate affects on DNA metabolism and RNA processing 
is that it is not the pnk and RNA ligase which act upon 
DNA, but rather an RNA which they process. The enzymes 
may be involved in processing several RNAs, only some 
of which are essential for T4 development. 
1.6 AIMS AND STRATEGIES 
The aim of this work is to identify the DNA sequence 
encoding the T4 pnk gene (2T) and to clone the intact 
coding sequence with a view to amplifying expression of 
the protein product. 
The ET gene has been mapped between g63 (RNA 
ligase) and g3l (Depew and Cozzarelli, 1974) . The T4 
mutant pTl which has a deletion of 3.5 kb (Kutter 
et al., 1984) has lost all known markers of pT and lacks 
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three EcoRI fragments of 2.27 kb, 0.1 kb and 1.1 kb 
in this region (Mileham et al., 1980) . These three 
fragments were cloned in A vectors by Mileham et al. (1980) 
and the recombinants provide a source of DNA for the 
initial nucleotide sequencing of the 2T region. 
The recognition of recombinants including aT 
cannot rely on marker rescue techniques since the pseT 
gene is non-essential to T4. It is therefore necessary 
to rely on cloning a functional gene and to screen for 
kinase activity in infected cells. Cloning of the pseT 
gene in either a A or plasmid vector would separate the 
kinase gene from T4 genes that encode nucleases, and 
further manipulation should facilitate high levels of 
expression of the enzyme. 
• The availability of quantities of homogeneous 
protein would assist in analysis of the structure and 
mechanisms of the enzyme by both physical and biochemical 
techniques suchas-X-ray-crystallography and substrate • 
binding kinetics. Additionally cloned genes are more 
readily subjected to specific site-directed mutagenesis, 
and analysis of altered proteins may indicate which 
sequences or structures are necessary for the 5'-kinase 
and 3'-phosphatase activities. 
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C H A P T E R 2 
MATERIALS AND METHODS 
2 .1. MATERIALS 
(a) Media 
L-broth 
Difco Bacto Trypt one 	 lOg 




Distilled water 	 to 1 litre 
This was adjusted to pH 7.2 with NaOH 
before autoclaving. 
L-agar 
Difco Bacto Trypt 




This was adjusted to 
before autoclaving. 
ne 	 lOg 
extract 	5 g 
10 g 
15 g 
to 1 litre 
pH 7.2 with NaOH 
'I 
BBL agar 
Baltimore Biological Labs. 
trypticase 	 10 g 
NaCl 	 5g 
Difco agar 	 10 g 
Distilled water 	 to 1 litre 
BBL top agar 
As for BBL agar but only 6.5 g Difco 
agar per litre. 
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Phae Buffer 
KH2 PO4 3 g 
Na 2HPO4 	(anhydrous) 7 g 
NaCl 5g 
0.1 M MgSO4 10 ml 
0.01 M CaC1 10 ml 
1% w/v Gelatin 1 ml 
Distilled water to 1 litre 
5 x Sizizen salts 
(NH4 ) 2 SO4 	 10 g 
K2HPO4 	 70 g 
KH2PO4 	 30 g 
Na3C 6 H 5 0 7 .2H 2 0 	 5 g 
MgSO4 .7H 20 	 1 g 
Distilled water 	 to 1 	litre 
Minimal agar 
Difco agar 	 6 g 
Distilled water 	 to 300 ml 
80 ml sterile 5 x Spizizen salts were 
added after autoclaving and the agar 
supplemented with 0.2% glucose and 
2 g/ml vitamin B 1 and made up to 
400 ml with sterile water. 
Z. 
5 
4 x M9 Salts 
Na2HPO4 	 28 g 
KH2 PO4 	 12 g 




Distilled water 	 to 1 litre 
M9-Maltose Medium 
4 x M9 salts 	 250 ml 
20% maltose 	 15 ml 
1 M MgSO4 	 lml 
Distilled water 	 to 1 litre 
All media were sterilised by autoclaving 
at 15 lb/square inch for 15 mm. 
is 
2.1.b Enzymes and Chemicals 
DNA polymerase (Klenow fragment) was purchased 
from Boehringer, T4 DNA ligase from New England Biolabs., 
DNA polymerase I from NBL Enzymes, restriction endo-
nucleases from New England Biolabs., or Bethesda Research 
Laboratories, RNAses I and T 1 , calf intestinal phosphatàse, 
lysozyme and micrococcal nuclease from Sigma, spleen 
phosphodiesterase, pancreatic DNAse and venom phospho-
diesterase from Worthington. 
M13 17-mer primer and hybridisation probe primer 
were from New England Biolabs., cytidylyl-(3'-5 1 )--uridine 
(Cpu) from Sigma, deoxynucleoside triphosphates (dNTPs) 
and dideoxynucleoside triphosphates (ddNTPs) from P-L 
Biochemicals. Synthetic oligonucleotides were provided 
by E. Kawashima (Biogen, Geneva) and J. Keyte 
(Biochemistry, Leicester). 
L - [ 35 S]methionine (specific activity > 30 TBq/nmol) 
Deoxycytidine .5.' - [ ci -.32.P] triphosphate ..(..- 'll0. TBq/nmol),. 
32 	- Adenosine 5 - [y - P]triphosphate (-110 TBq/nmol) were 
from Amersham International. Deoxyadenosine 5' - [c 35 S]-
thiotriphosphate (18.5 TBq/nmol) was from New England 
Nuclear. 
DEAE-sephadex (A50 and G50) was from Pharmacia, 
DEAE-cellulose (DE52), phosphocellulose (P11) and 
AE-cellulose paper (AE81) from Whatman. 'Dowex' 
50W-x8 (H) was from BDH. Nitrocellulose filters were 
from Schleicher and Schiill, HP5 film from Ilford, 
Cronex intensifier screens and X-ray film from Du Pont. 
All chemicals were Analar grade. 
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21.c. Bacterial Strains 
E.coli K12 Relevant features and use 
CR63 supD; permissive host for T4 amber mutants 
•c600 supE; amplification of A Warn Earn Sam phages 
NM594 O; non-permissive host for A amber mutants 
ED8689 °hsdR; non-permissive host for 	amber mutants 
ED8654 supE sqpF hsdR; permissive host for A amber mutants 
NM538 supF hdR; permissive host for A amber mutants 
NM514 hf 1 hsdR; selection of c1 	recombinants 




0 uvrA; host for analysis of polypeptides 
C600 	(ACM21) supE (ACM21); source of ACM21 DNA 
ED8689 	(ACM21) p ° hsdR (XCM21): amplification of pnk 
C600 	(A) supE 	(Ar); 	selection of Aimm 434 phage 
434 C600 	(Aimrn 	) 
434 A supE (A:imm 	); 	selection of Airnm 	phage 
Reference 
Appleyard et al. (1956) 
Appleyard (1954) 
Weigle (1966) 
Wilson et al. (1977) 
Murray et al. (1977) 
Frischauf et al. (1983) 
Murray (1983) 
Gough & Murray (1983) 
Jaskunas et al. (1975 
Ui 
2.1.d. Phage Strains 
(i) 	x vectors and 
derivatives 
NM607 
Relevant features and/or use 
Immunity insertion vector for EcoRI fragments 	Murray et al. (1977) 
NM607 including T4 fragment 46 
	
Mileham et al. (1980) 
NM607 including T4 fragment 21 	 U 	 SI 
(srl x l-2)A c1857 nin5 vector for EcoRI 
fragments 
NM459 including T4 fragment 21 
NM459 with fragment 21 in opposite 
&ientation to NM1104 
Deletion derivative of NM1104 
wam403 EamllOO SamlOO derivative of NM1104 
Immunity insertion vector for Ec0RE or Hindill fragments Murray (1983) 
NM1149 including fragment 21 
Wam403 EamllOO lacZ c1857 nin5 SamlOO 
NM1070 including fragment 21 in place of lacZ 
b519 Qam73 Sam7; Smal left arm for CM6 
EamliDO NM459; EcoRI right arm for CM6 



















A imm 434 
Relevant features and/or use 
c126; selection of A lysogens 









M13 vectors  
T4 
Defective in polynucleotide kinase 
polypptides 
g42; 
alc7, am51. (g56) , NB5060 (denB-rIi) 
am87 (g42); 100% cytosine DNA 
H. R. Revel (pers. commun.) 
Sirotkjn, et al. (1978) 
Hugs &Brbwn (1973) 
Wilson et al. (1977) 
M13mp8, M13mpll (Messing, 1983) and M13mp18 (Yanisch-Perron et al., 1985) were used 




10 mM Tris, 1 mM EDTA adjusted to appropriate 
pH with HC1. 
Hanahan competent cells: 
TFB buffer 
10 mM K-MES pH 6.2 
100 mM RbC1 or KC1 
45 mM MnC1 2 .4H 2 0 
10 mM CaCL. . 2H0 
3 mM HACoC1 3 (Hexamino Cobaltic chloride) 
1 14 MES was adjusted to pH 6.3 using KOH, 
sterile filtered and stored at -20 °C. TFB 
was filtered and stored at 4°C. 
DMSO 
Spectroscopically pure dimethyl suiphoxide 
was saturated with nitrogen and sto±ed at -70 °C 
in ámall aliquots. 
DTT 
2.25 M DTT in 40 mM Potassium acetate, pH 6.0 
was filtered and stored at -20 °C. 
Packaging reaction: 
Buffer A 
20 mM Tris.HC1 pH 8.0 
3 mM MgC1 2 
0.05% (v/v) 2-mercaptoethanol 
1 mM EDTA pH 7.5 
110 41 H 2  0 
6 41 0.5 M Tris.HC1 pH 7.5 
300 10.05 M. Sperrnidine, 0.1 M putrescine, 
neutralised with Tris base 
9 41 lm MgC12 
75 41 0.1 d ATP 
1 41 2-mercaptoethanol 
Filter hybridisation: 
Denaturation buffer 
0.5 M NaOH 
1.5 M NaCl 
Neutralisatjon buffer 
0.5 M Tris 
3.0 M NaCl 
neutralised to pH 7.0 with 42m1/litre HC1 
20 x SSC 
3.OMNaC1 
0.3 M Na 3 C 6 H5 0 7 
1 x dNTP buffer 
4.x buffer 	210 mM Tris.HC1 pH 7.5 
21 mM MgC1 2 
20 4g/m1 BSA 
1 x buffer 	100 41 4 x buffer 
4 41 2mM dATP/dTTP/dGTP 
1 41 2-mercaptoethanol 




4 x SSC 
1 x Denhardt solution 
20 x Denhardt solution 
0.4% w/v BSA 
0.4% w/v Ficoll 
0.4% w/v Polyvinylpyrrolidone 
Gels for DNA: 
10 x TEE Buffer 
432 g Tris 
220 g Boric acid 
37.2 g EDTA 
made up to 4 litres with distilled water 
TBE loading dye 
20 g Sucrose 
0.1 g Bromophenol - blue -' 
10 ml 10 x T.BE 
made up to 100 ml with distilled water 
30% Acrylamide stock 
29 g Acrylarnide 
1 g N,N'-methylene bisacrylamide 




3% ammonium persuiphate 
(AMPS) 
10 x TBE 
Range of separation 
(nucleotides) 
% 	3.5 5.0 12.0 20.0 
(ml) 	11.6 16.6 40.0 66.6 
73.6 71.3 47.9 21.3 
	
2.1 	2.1 	2.1 	2.1 
10.0 	10.0 	10.0 10.0 




10 mM Tris 
0.1 mM EDTA 
adjusted to pH 8.0-8.5 with HC1 
100 mM Tris 
50mMMgCl 2 . 	 -. 
adjusted€o pH 8.5 with HC1 
Termination mixes 
Stock 10 mM: ddTTP 61 mg/10 ml 
ddCTP 58 mg/lu ml 
ddGTP 62 mg/10 ml 
ddATP 62 mg/10 ml 
Stock 50 mM: dTTP 312 mg/10 ml 
dCTP 296 mg/10 ml 
dGTP 316 mg/10 ml 
dATP 295 mg/lU ml 
all made up in TE buffer. 
Termination mix 
0.5 InN dTTP 	(41) 
0.5 mM dCTP 
0.5mMdGTP 
10 mM ddTTP 
10 mM ddCTP 
10 mM ddGTP 
10 mM ddATP 
TE 
25 500 500 500 
500 25 500 500 





1000 1000 	1000 	500 
Sequence chase mix 
0.25 mM dTTP 
0.25 mM dCTP 
0.25 mM dGTP 
0.25 mM dATP 
made up in TE buffer using the 50 mM stocks 
Kienow polymerase- mix 
per clone: 4 4Ci [Y-35 SIATP, 
1.5 units Kienow polymerase 
in a total volume of 9 gl with 
10 mM Tris.HC1 pH 8.5, 10 mM 
DTT. The appropriate quantity 
of mix was made up immediately 
before dispensing into reactions. 
Formamide dyes 
100 ml De-ionised formamide 
0.1 g Xyiene cyanol FF 
0.1 g Bromophenol blue 
2ml 0.5MEDTA 
40% Acrylamide stock 
380 g Acrylamide 
20 g N,N'-methylene bisacrylamide 
made up to 1 litre with distilled water and 
de-ionised. 
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made up to 
el mix 
40% Acrylamide 
10 x TBE r 
Urea 
1 litre with distilled water 
2.5 x TBE gel mix 
150 ml 40% Acrylamide 
250 ml 10 x TBE 
	
460 g 	Urea 
50 g 	Sucrose 
50 mg Bromophenol blue 
made up to 1 litre with distilled water. 
SDS-PAGE for proteins: 
SDS sample buffer 
2 ml Glycerol 
0.4 g SDS 
5 ml 0.25 M Tris.HC1 pH 6.8 
2 ml Distilled water 
1 ml 2-mercaptoethanol (added just before 
use) 
Acrylamide Stock solution 
44 g Acrylamide 
0.3 g N,N'-methylene bisacrylamide 
Separating gel buffer (A) 
0.75 M 	Tris.HC1 pH 8.8 
0.2% w/v SDS 
Spacer gel buffer (B) 
0.25 M Tris.HC1 pH 6.8 
0.2 % w/v SDS 
Separating gel mix 
13.5 ml Gel buffer A 
9.2 ml Acrylamide stock 
3.6 ml Distilled water 
0.95 ml 10 mg/ml AMPS 









Gel buffer B 
Acrylamide stock 
Distilled water 
10 mg/mi AMPS 
TEMED 
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10 x Laemmli buffer 
30 g Tris 
144 g Glycine 
10 g SDS 
made up to 1 litre with distilled water. 
Lowry-Folin assay: 
Reagent A: 2% Na 2CO3 (anhydrous) in 0.1N NaOH 
to 	8: 0.5% Cu50 4 .5H20 in 1% Na 3C 6 H 5O7 
to 	C: 1 ml of B + 50 ml of A 
Is 	D: Folin-Ciocalteu Reagent diluted 
1:1 with water. 
2.2 	METHODS 
2.2.a. Plating cells 
A fresh overnight culture was diluted 20 fold into 
L-broth and grown at the required temperature for 2 h. 
Cells were pelleted by spinning for 10 min at 3,000 rpm 
in a bench centrifuge and resuspended in a half volume 
of 10 mM MgSO4 before storage at 4 °C. 
2.2.b. A and T4 phage plate lysates 
A single plaque was picked into 1 ml of phage 
buffer containing a drop of chloroform, mixed and left 
for 10 mm. 0.1 ml of the suspension was added to 0.1 ml 
of a fresh overnight supplemented with 10 mM MgSO 4 
or 0.2 ml of plating cells and the phage adsorbed for 
10 min before plating out on to a fresh wet L-agar 
plate in 2.5 ml. of molten BBL top agar. The plate was 
incubated, usually at 37 °C, until confluent lysis was 
achieved (after 4-6 h)., when 3 ml of L-brothwere. 
added to the plate which was left at 4 °C overnight. The 
broth was decanted, mixed with a few drops of chloroform 
and the debris pelleted by spinning in a bench centrifuge. 
The cleared supernatant was titrated and stored at 4 °C. 
2.2.c. Phage titration and spot tests 
After serial dilutcon in phage buffer, 0.1 ml of 
phage suspension was mixed with 0.2 ml of plating cells, 
adsorbed for 10 min then plated out in 2.5 ml of 
molten BBL top agar on to a BEL plate. After overnight 
incubation at the appropriate temperat ire, usually 37°C, 
the plaques were counted and the number of plaque 
forming units (pfu) per 1 ml of phage lysate calculated. 
For spot tests on an appropriate indicator strain 
0.01 ml aliquots of serial dilutions of phage were spotted 
on to a bacterial lawn from a 0.1 ml pipette. Spots were 
allowed to dry before the plate was incubated overnight 
at the appropriate temperature. 
2.2.d. Phage crosses 
9 2 x 10 8  plating bacteria and 2 x 10 phage (a total 
multiplicity of infection (moi) of 10 consisting of 5 
of each phage) were mixed in less than 1 ml volume and 
adsorbed for 15 mm. Cells were pelleted and resuspended 
in 1 ml of prewarmed L-broth before diluting 100-fold 
into warm broth. The culture was shaken at 37°C for 
li h. after which a few drops of chloroform were added. 
Phage were assayed on appropriate indicator bacteria to 
check for bQth parental phages and recombinants.. Titres 
were usually .10 pfu/ml. 
2.2.e. Construction of X lysogens 
Fresh plating cells were infected with phage at 
a moi of 1-2 and allowed to adsorb. The cells were 
diluted in L-broth and grown for 30-40 min at 37°C, or 
32°C if the phage has a temperature-sensitive repressor. 
The cells were pelleted and resuspended in 10 mM MgSO 4 
before plating out on L-agar plates in the presence of 
10 9 pfu Xclear (c1). Colonies which grew after over-
night incubation were spot-tested for sensitivity to 
A vir. Titres were 10 8  pfu/ml. 
2.2.f. T4 and A phage liquid lysates 
A fresh overnight of cells, usually C600 for A 
and CR63 for T4, was diluted 50-fold into 200 ml L-broth 
(supplemented with 10 mM MgSO 4 for A) in a 2 litre flask. 
The cells were shaken, usually at 37 °C until they reached 
an 0D650 of 0.45-0.6 (2-3 x 10 8 cells/mi). Phage were 
added to a moi of 0.1-1 for A or 0.05 for T4 and incubation 
was continued at 37 °C. The OD usually reached a maximum 
of 1.8 and then dropped as the cells lysed (after 2 h 
for T4 or up to 4 h for A). 	When the OD reached a 
minimum,chlorofornj (1 ml/500 ml culture) was added and 
the flask shaken at 37°C for a further 15 mm. The 
lysate was clarified by centrifugation, assayed at 
-7 	-8 
10 and 10 dilutions, and checked on appropriate 
indicator strains. Titres of 5 x 10 10 -1 x 10 11 were 
obtained for A. 
For ACM21 DNA pèaiãt1àns it was necessary to 
induce a lysogen, C600 (ACM21) (see Section u) and to 
concentrate the cells into a smaller volume before - 
lysing with chloroform. 
2.2.g. Preparation of CsCl purified phage and phage DNA 
Phage in the cleared lysate (see above) were 
precipitated with polyethylene glycol (PEG) 6000. First 
4 g/100 ml of NaCl were added followed by DNAse I and 
RNAse I, both to 1 g/ml. After standing at room 
temperature for at least 1 h, 10 g of solid PEG 6000/100 ml 
were added and dissolved by gently swirling. The flask 
was stood at 4°C for a minimum of 2 h, usually overnight. 
The PEG precipitate was recovered by centrifugation at 
10,000 rpm for 10 mm, and resuspended in 5 ml of phage 
buffer per 100 ml of starting volume by swirling gently 
at 4°C for 2-3 h. Debris was removed by centrifugation 
at 5,000 rpm for 10 min before concentration of the 
phage on a CsC1 step gradient. 
A step gradient was made in an MSE 14 ml 
polycarbonate tube; 1.5 ml of 31%w/w CsC1 solution (3.1 g 
CsC1/6.9 ml phage buffer) was pipetted into the tube 
and underlayed with 1.5 ml of 45% w/w solution (4.5 g 
CsC1/5.5 ml phage buffer) using a pasteur pipette. 
Finally these two steps were underlayed with 1.5 ml of 
56% w/w solution (5.6 g CsC1/4.4 ml phage buffer). 
The phage solution was overlayed on to the gradient and 
phage buffer was added to fill up the tube. Gradients 
were spun-in a 6 x14 Ti swing-out rotor in an MSE 
Superspeed 65 ultracentrifuge at 33,000 rpm for 2 h 
and stopped without braking. The phage band was 
collected in a 1 ml syringe by piercing the tube just 
below the band. Phage were stored in CsC1 for long 
periods at 4°C. 
Concentration on a step gradient provided 
sufficiently high titre lysates for infection experiments. 
Such lysates were dialysed for 2 h against phage buffer 
to remove CsC1 and stored at 4°C, titres were about 
1012 pfu/ml. 
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The phage from a step gradient also provided an 
adequate source of DNA for restriction enzyme analysis, 
however, where DNA was to be used as a cloning vector 
a further equilibrium gradient purification was carried 
out. The phage band was mixed with 41.5% w/w pre-
clarified CsC1 solution (20.75 g CsC1/29.25 ml phage 
buffer) in an MSE 5 ml polycarbonate tube and spun in 
a 6 x 5 Ti swing-out rotor in an MSE Superspeed 65 
ultracentrifuge at 33,000 rpm for 24-36 h at 4 °C. 
The phage band was collected in a syringe as before. 
Before DNA was extracted the concentrated phages 
were dialysed against 10 mM Tris.HC1, pH 8.0, 1 mM 
EDTA for 2 h to remove CsC1. The phage protein was 
extracted 3 times with an equal volume of phenol 
pre-equilibrated with 0.5 M Tris.HC1 pH 8.0, mixing 
gently by inversion in Eppendorf tubes or siliconised 
Corex tubes for large volumes. The phases were separated 
by spinning - in -- a"bench centrifuge and the lowerphenol 
layer was removed using a drawn out pasteur pipette and 
discarded. The aqueous phase was extracted once with 
ether, or until it became clear. Finally, the DNA was 
dialysed against 10 mM Tris.HC1 pH 8.0, 1 mM EDTA for 
24 h with several buffer changes. The concentration of 
the DNA was determined by measuring the OD at 260 nm 
(an 0D260 of 1 is equivalent to 50 g/ml) . 
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2.2h. Preparation of M13 replicative form (RF) DNA 
Early log phase cells, usually NM522 were prepared 
by diluting a fresh overnight 100-fold and growing to 
0D600 of 0.05-0.2. A single plaque waS transferred to 
2 ml of cells and the culture was shaken at 37 °C for 
12-18 h. 1.5 ml was transferred to an Eppendorf tube, 
spun for 5 min to pel1t cells and the supernatant 
titrated. Titres were 10 11 pfu/ml. 50 ml of early 
log phase cells were infected with phage at a final 
concentration of 10 9 pfu/ml and shaken at 37 °C for 
16-18 h. Cells were pelleted and the supernatant titrated 
to check that there were enough phage to infect a 
large culture. 
An overnight culture was diluted 100-fold in 
250 ml of L-broth in a 2 litre flask and grown at 37 °C 
to 0D600 of 1 (2-3 h). Phage were added to iolo  pfu/ml 
of cells and grown at 37 °C for a further 2 h. Cells 
were sedirnented by centrifugation at 3,500 rpm for 15 
min at 4 °C and the pellet resuspended in 50 ml of 50 mM 
Tris.8C1, pH 85, 1 mM EDTA before repelleting at 3,500 
rpm for 15 mm. The pellet was resuspended in 18 ml 
of 15% sucrose, 50 mM Tris.HC1 pH 8.5, 50 mM EDTA. 
The suspension was kept on ice and pipetted gently to 
disperse before adding 4.5 ml of freshly prepared 5 mg/mi 
lysozyme in the above buffer. The cells were mixed gently 
while standing on ice for 10 min and were then lysed by 
addition of 13.5 ml of 0.l% Triton X-lOO, 50 mM 
Tris-HC1 pH 8.5, 50 mM EDTA and gentle vortexing before 
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incubation at 37 °C for 10-15 mm. At this point the 
solution was very viscous. 
Centrifugation at 12,500 rpm for 45 min at 4 °C 
gave a greyish pellet and a clear supernatant. CsCl 
(0.95 g/ml) and ethidium bromide (0.59 mg/mi) were added 
to the supernatant which was loaded into MSE 10 ml 
polycarbonate tubes and overlayed with paraffin oil 
before caps were fitted. Gradients were generated by 
spinning the tube in a 10 x 10 Ti fixed angle rotor in 
an MSE Superspeed 65 ultracentrifuge at 45,000 rpm for 
20 h at 20 °C. Two bands were visible in UV light, the 
upper band consisting of nicked plasmid, linear plasntid 
and E.coli DNA while supercoiled closed circular plasmid 
M13 DNA formed the lower band. The lower band was 
collected in a syringe by piercing the side of the tube, 
and transferred to 'another 10 ml. tube which was filled 
with a solution consisting of 1.059 g CsCl, 0.59 mg 
ethidium bromideperm1 of. di-stilled-water.-- -The tube 	- 
was spun as described above, the single band collected 
in a volume of about 05 nil, and passed down a small 'Dowex' 
resin column made in a pasteur pipette plugged with 
siliconised glass wool. The DNA was eluted with 3 
volumes of TE buffer pH 7.5. Remaining traces of 
ethidium bromide were removed by 5 or, 6 extractions with 
an equal volume of a 1:1 ratio n-butanol/isopropanol 
solution (this solvent solution had been saturated with 
NaCl saturated TE buffer). 
The DNA was dialysed overnight at 4°C against TE 
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buffer pH 7.5 to remove CsC1 and was precipitated with 
0.4 volume of 5 M aminonium acetate, 2 volumes of iso-
propanol and recovered by centrifugation. The final 
concentration of DNA calculated from the 0D260 was 
500-1000 ig per litre of culture. 
2.2.i. Restriction enzyme digestion and ligation of DNA 
DNA was digested with restriction endonucleases 
under conditions recommended by the suppliers, usually 
in a total volume of 10 41. Reactions were stopped 
after 1-3 h of digestion by heating at 70 °C for 10 mm, 
or if the enzyme was not heat labile, particularly in 
the case of Smal, by isopropanol precipitation. This 
was done by adding 0.4 volume of 5 M ammonium acetate 
and 2 volumes of isopropanol and standing at room 
temperature for 15 min before spinning at 10,000 rpm for 
10 min to pellet the DNA. The pellet was washed with 
1 ml of co1dethanOl,repel1eted.at10;o00 rpm and dried 
in a vacuum desiccator before resuspending in an appropriate 
volume of TE buffer. 
DNA was ligated using T4 DNA ligase usually in a 
10 41 volume containing 50 mM Tris-HC1 pH 7.8, 10 mM 
MgC1 21' 20 mM DTT, 1 mM ATP, 1-100 units T4 DNA ligase 
(dependent on whether 'blunt' or 'sticky' ends were to 
be ligated). The ligation was incubated at 10 °C for 
several hours, usually overnight. Recombinant phages 
were recovered by transfection or packàging. 
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2.2.j. Transfection and packaging 
A reconthinants were recovered as plaques by 
transfection of cells made competent in the uptake of 
DNA by a modification of the method of Lederberg and 
Cohen (1974). A fresh overnight was diluted 50 fold 
into L-broth and grown at 37 °C to an 0D650 of 0.5. 
The cells were pelleted in a bench centrifuge at 4 °C, 
washed in a half volume of ice cold 0.1 M MgC1 2 , 
immediately repelleted and resuspended in a twentieth 	- 
volume of ice cold 0.1 M Cad 2 . The cells were kept on 
ice for at least 30 mm (up to several hours). DNA 
diluted in 0.1 ml of a 1 x SSC10.1 M Cad 2 (ratio 3:4) 
solution was added to 0.2 ml of competent cells and kept 
on ice for 30 mm. After heating for 2 min at 42°C cells 
were returned to ice for a further 30 min before samples 
were plated out in 2.5 ml of molten BBL top agar on 
BEL plates and incubated, overnight, usually at 37 °C. 
Transfection efficiencies weréabout 106  pfu/g DNA.......... 
M13 recombinants were recovered by transfection 
of cells made competent by a modification of the method 
of Hanahan (1983). A fresh overnight of NM522 was 
diluted 500 fold and grown to an 0D 650 of 0.6. The 
cells were stood on ice for 15 min before pelleting 
and resuspending in a third volume of TFB buffer. 
The cells were kept on ice for 15 mm, repelleted and 
resuspended in a twelfth volume of TBE buffer. While 
cells were kept on ice 7 iii DMSO per 200 41 cells were 
added. After 5 min 7 41 2.5 M DTT per 200 41 cells 
/. 
were added and after a further 10 mm, 7 41 DMSO per 
200 41 cells. After 5 min 200 41 of cells were added 
to the DNA in chilled Eppendorf tubes which were kept 
on ice for 45 min before heating at 42 °C for 11 min and 
plating out aliquots in 2.5 ml BBL top agar containing 
0.2 ml NM522 plating cells and indicator for B-galactosidase 
(see 'below) on minimal plates. Transfection efficiencies 
were 10 7 pfu/g. 
Packaging mixes for A were supplied by A. J. B. 
Campbell. The freeze thaw lysate (FTL) and sonicated 
extract (SE) were thawed on ice and added to incubation 
buffers in the following order: 7 41 buffer A, 
1-2 41 A DNA (between 0.2-0.5 g) , 1 41 buffer Ml, 6 41 
SE and 10 41 FTL. The reaction was incubated for 60 mm 
at 25°C, and diluted with 500 41 of phage buffer. 
Aliquots were plated out on BBL plates with appropriate 
indicator bacteria.. 
2.2.k. Selection of recombinants 
Recombinants of A immunity vectors e.g. NM1149 
were recovered on a hf 1 E.coli strain, NM514 which 
only allows ci phage to form plaques and hence selects 
for A molecules containing an insert in the ci gene. 
Those non-recombinant vector molecules still able to 
express ci repressor are repressed and unable to 
propagate lytically. 
A recombinants with amber mutations were 
recovered on appropriate suppressing strains and identified 
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7.; 
by their inability to grow on a 	° host. 
M13 recombinants were recognised as white plaques 
recovered by plating in BBL top agar containing 0.2 mg/mi 
of indicator (5-bromo-4--chioro-3 indoly1--D-galactoside, 
Xg) and 0.25 mg/mi of inducer (isopropy1--D-thiogalacto-
sidase, IPTG). Non-recombinant M13 vector molecules 
formed blue plaques. 
2.2.1. Preparation of filters for screening by 
hybridi sation 
Phage recombinants were detected by probing 
denatured phages baked on to riitrocellulose filters 
with appropriate radiolabelled DNA probes. 
Plaques were blotted from plates either 
directly or after transferring by toothpick to a lawn 
of bacteria marked out. as a grid. Appropriate phage 
were included as positive and negative controls. Use 
of dry BBL plates helped to prevent tearing of the top 
agar layer during blotting. 	Circular nitrocellulose . 
filters were cut to size and the orientation marked by 
notches or ink. A filter was placed on a cooled plate 
for 1 min and then placed, plaque side up on blotting 
paper soaked in denaturation buffer for 2 mm. The 
filter was transferred to blotting paper soaked in 
neutralisation buffer for a few minutes before a final 
wash in a tray of 2 x SSC. The filter was blotted dry 
and baked at 80 ° C under vacuum for 2 h and stored at 4 °C. 
Where the probe to be used was single-stranded 
M13 DNA, it was necessary to hybridise to.single-stranded. 
M13 DNA derived from phage lysates since cells within 
a plaque contain double-stranded RF DNA which will 
hybridise to the vector. A single plaque was picked 
into 1.5 ml of a 100-fold dilution of an NM522 overnight 
and grown for 41-51 h at 37 °C before pelleting cell 
debris. 3 .tl of the cleared supernatant was spotted on 
to a nitrocellulose filter marked out as a grid. The 
filter was treated and baked as described above. 
2.2.m. Radiolabelling of double-stranded probes by 
nick-translation 
Deoxycytidine 5 -(ci- 32 P]tripho'sphate (10 ij.Ci) 
was dried down under vacuum and resuspended in 20 l 
of 1 x dNTP buffer, 1 41 DNAse I (at 2 x 10 	mg/mi), 
1 41 DNA polymerase I (at 1 unit/.i) and 0.25-1.0 4g 
DNA (in - 2 l). After incubation for 1-3 h at 15 °C 
the reaction was stopped by the addition of 200 41 
of TE pH 8.0 and loaded on to a Sephadex G-50 column. 
The label-led-DNA• wa-s -- eiu-ted-with--TEbuf-fe-r- -and••co1iected 	-• 
as the iirst peak in a volume of 0.5-1.0 ml. The amount 
of label incorporated was determined with a liquid 
scintillation counter (5 41 samples on Whatman GF/C 
disks were dried and counted in a non-aqueous 
scintillant). 
Filters were prehybridised for 30 min at 37 °C 
in 30 ml of hybridisation buffer. The probe ( 's-' 10 6 
counts per filter) was added to 250 .i.g of sonicated calf 
thymus DNA,denatured at 95 °C for 10 min and immediately 
cooled on ice. The probe was added to the prehybridised 
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filter with 10-15 ml of fresh hybridisation buffer and 
the hybridisation was carried out at 37 °C overnight with 
gentle shaking. The filter was washed twice in 2 x SSC, 
0.1% SDS for 30 min at 37 °C, and twice in 1 x SSC, 0.1% 
SDS for 30 min at room temperature. Hybridisation of the 
probe to the filter was detected by autoradiography at 
-70 °C using pre-f lashed x-ray film. 
2.2.n. Radiolabelling of single-stranded M13 DNA 
1 41 of M13 hybridisation probe primer was 
boiled for 1 mm, cooled on ice then added to 2 41 
(2 ng) M13 single-stranded template DNA (see section 
q(ii)), 1 41 10 x Hincli buffer, 1 41 0.1 M DTT, 5 jl 
H2 0. This annealing mixture was incubated at 65 °C 
for 15 min and cooled to room temperature. Deoxycytidine 
5 1 -[a- 32P]triphosphate (10 j..Ci) was dried under vacuum 
and dissolved in the annealing mixture. Cold dNTPs 
were added as 1 il of a solution containing dGTP, dATP, 
dTTP all at 500 i.M together with 0.5 unit of Kienow 
polymerase. The reaction was incubated at 15 °C for 
90 min and the enzyme inactivated by addition of 1 41 
of 250 mM EDTA pH 8.3. This probe was kept on ice before 
use and not denatured. 
Filters were prehybridised at 65 °C for several 
hours in a solution containing 5 x Denhardt solution, 
5 x SSC, 50 J.Lg/ml denatured sonicated calf thymus DNA, 
0.1% SDS. The probe was added to the prehybridised filter 
in 10-15 ml of a solution containing 1 x Denhardt 
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solution, 5 x SSC, 50 .g/ml denatured sonicated calf 
thyinus DNA, 0.1% SDS. Hybridisation was carried out 
overnight at 65 °C with gently shaking. Filters were 
washed 4 times for 1 h in 0.5 x SSC, 0.1% SDS at 65 °C with 
shaking. 
2.2.o. Agarose gel electrophoresis of DNA 
Fragments from restriction endonuclease digests 
of DNA were analysed by separation on 0.7-0.8% agarose 
(Miles) gels made up in TBE buffer. 
Samples of DNA, usually 0.2-0.5 g in a 0.5 cm 
slot, were loaded in 1 x TBE loading dye. ADNA was 
always heated at 65 °C for a few minutes to melt the 
cohesive ends immediately before loading. Unsubmerged 
gels were run overnight at 15-20 mA and stained for 40 
min in a 1 g/ml solution of ethidium bromide. After 
destaining for 30 min in distilled water the gel was' 
photographed over a short wave, UV light transilluminator. 
'Mini-gels poured in small gel tanks or on 
microscope slides were often sufficient for checking 
restriction digests. These could be run in about 1 h 
at 100 V in TBE buffer, stained for a few minutes in 
ethidium bromide and the DNA visualised under UV light. 
2.2.p. Isolation of DNA fragments from agarose and 
polyacrylamide gels 
DNA fragments larger than 1 kb were isolated 
from agarose (Seakem) gels. The gel was stained with 
ethidium bromide and the DNA visualised on a low power 
UV transilluminator to minimise damage to the DNA. 
The appropriate band was excised from the gel, chopped 
into small pieces and loaded into dialysis tubing with 
1-2 ml of 0.5 x TBE buffer. The tubing was sealed after 
removing trapped air, and immersed in a shallow layer 
of 0.5 x TBE in an electrophoresis tank. An electric 
current of 100 V was passed through the bag for 2-3 h, 
and eventually the current was reversed for 1 min to 
release DNA stuck to the wall of the dialysis tubing. 
The buffer was recovered from the dialysis tubing 
the inside of which was rinsed out with 1 ml 1 x TBE 
buffer. The two solutions were pooled and the DNA was 
recovered on a DEAE cellulose (DE52) column made in a 
Gilson p1000 plastic tip plugged with siliconised glass 
wool. 0.6 ml of resin (sufficient to bind 20 i&g of 
DNA) was packed into the column and washed with 3 ml TE 
buffer pH 7.6 containing 0.6 M NaCl, 3 ml TE pH 7.6 
alone, 3 ml TEpH 7.6 containing 0.1 MNaC1. The DNA 
in gel buffer was then loaded on to the column and the 
flow-through reapplied. The column was washed twice 
with 1.5 ml of TE containing 0.3 M NaCl, and the DNA 
eluted with three 0.5 ml washes of TE containing 0.6 M 
NaCl. The eluate was precipitated with 2.5 volumes of 
ethanol at -20 °C overnight, adding tRNA as carrier where 
necessary. The DNA was pelleted by spinning for 10-30 
min at 10,000 rpm, washed once with 95% ethanol and 
repelleted. The pellet was dried under vacuum and 
resuspended in a small volume of TE buffer. 
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DNA fragments of less than 1 kb were isolated 
from polyacrylamide gels essentially by the method of 
Maxam and Gilbert (1977). A polyacrylamide gel of an 
appropriate concentration for maximum separation (Maniatis 
et al., 1982) was made up in TBE buffer from a 30% stock 
solution of acrylamide (see solutions) and cast between 
vertical gel plates separated by spacers. A slot former 
was inserted and the acrylamide allowed to polymerise for 
1 h. The gel was then attached to an electrophoresis 
tank filled with 1 x TBE buffer and up to 1 j.i.g of DNA 
was loaded into 0.5 x 0.2 cm wells in 1 x TBE loading 
dye. The gel was run for several hours at between 
1 and 8 V /cm ensuring that it did not overheat and 
thereby denature the DNA. The gel was stained for 40 
min in a solution of 0.5 g/ml of ethidium bromide in 
1 x TBE buffer. The DNA was visualised over a. UV 
transilluminator and the appropriate band excised. 
Polyacrylamide quenches fluorescence and more than 10 ng 
of DNA in a band is necessary for detection. The gel 
slice was chopped into small pieces and transferred to 
a siliconised test tube containing 1 volume of elution 
buffer (0.5 M arnmonium acetate, 1 mM EDTA). The tube 
was sealed with parafilm and incubated at 37 ° C over-
night on a rotating wheel. The fragments of acrylamide 
were removed by filtering through.siliconised glass 
wool held within an Eppendorf tube from which the tip 
had been removed. This Eppendorf was supported in a 
small siliconised glass tube which was spun at 3,000 rpm 
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in a bench centrifuge for 5 min so that the cleared 
solution collected in the glass tube after passing 
through the glass wool. 	The glass wool was rinsed 
once with a half volume of elution buffer in the same 
way. These solutions were pooled and extracted 3 or 
4 times with butanol saturated in TE buffer to remove 
ethidium bromide. Finally the solution was extracted 
once with phenol, precipitated twice with 0.1 volume 
3M sodium acetate, 2.5 volumes of ethanol, washed with 
70% ethanol and dried under vacuum. The DNA was 
resuspended in a small volume of TE buffer. 
2.2.q. Dideoxy chain termination. sequencing of DNA 
fragments cloned in M13. 
(i) Generation and cloning of random DNA 
Fragments 
About 10 4g of purified DNA fragment was 
circularised by ligating the 'sticky' ends in the 
presence --of - 20 -uni-ts ... of---T4--'DNA 1±ga-se in -a -total 
volume of 30 41. The ligated DNA in an 
Eppendorf tube.was sonicated at maximum power 
for 4 bursts of 40 sec in a cup horn sonicator 
(Heat Systems Ultrasonics, Inc. Model W-375) 
The tube was spun briefly after each burst to 
'concentrate' the solution in the bottom of 
the tube. The ends of the DNA fragments were 
repaired to provide blunt ends for ligation to 
Smal cut M13 vector DNA. To 28 41 of the 
sonicated DNA suspension were added 2 41 of sequence 
chase mix, 3 41 of TM buffer and 20 units of 
Kienow polymerase. THE DNA was incubated at 15 °C 
overnight and run on an agarose mini-gel next 
to a Sau3a digest of pAT153 which provided size 
markers. The smear of DNA in the size region 
300-600 bases was excised from the gel, 
recovered by electroelution in dialysis tubing 
(section 2.2.p) and dissolved in about 50 41 of 
TE buffer. 1-5 Al aliquots of the end repaired 
fragments were ligated to 20 ng Smal cut M13 
vector DNA and recombinants were recovered by 
transfection of NM522 cells. 
(ii) Growth of recombinant M13 phage and 
extraction of single-stranded template DNA 
A single white plaque from the transfection 
plate was picked into .50 l of .phage buffer 
and then serially di1üèd ôiO 6 	iiil'f 
• 
	
	this dilution was plated out with 0.2 ml of 
'NM522 plating cells in the presence of Xg 
and IPTG. A white plaque from this plate was 
picked into 1.5 ml of a 100-fold dilution of an 
NM522 overnight in a small sterile bottle. The 
culture was grown with. vigorous shaking at 37°C 
for 4.5-5.5 h, and then transferred to an 
Eppendorf tube and clarified by spinning at 
10,000 rpm for 5 .min. The supernatant was 
transferred. to a clean tube and 150 41 of 20% PEG 
6000, 2.5 M NaCl solution was added. The tube 
was kept at 4 °C for 15 min before pelleting the 
phage by spinning at 10,000 rpm for 10 mm. The 
supernatant was discarded, the tube spun briefly 
and all residual PEG solution removed with a 
drawn out pasteur pipette. The pellet was 
resuspended in 100 41 of TE buffer and extracted 
with 50 41 of TE equilibrated phenol. Finally 
0.1 volume of 3 M sodium acetate and 2.5 volumes 
of ethanol were added and the DNA was precipitated 
overnight at -20 °C. The DNA was pelleted by 
spinning at 10,000 rpm for 10 mm, washed with 
1 ml of cold ethanol and repelleted. It was 
finally dissolved in 30 41 of TE buffer and 
stored at -20 °C. 
(iii) Dideoxy chain termination sequencing 
-• 	- 	 The template--was- .annealed.to. .Ml3 17-mer 
sequencing primer. The primer mix consisting of 
2 I.Ll 17-mer primer (0.4 pmol) , 1 il TM buffer, 
2 41 H 2  0 was added to 5 41 of template DNA and 
annealed at 60 °C for 1 hour. The mix was allowed 
to cool slowly to room temperature before 2 41 
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The appropriate termination mix was added 
to each tube (see Solutions) aid finally 2 41 of 
Kienow polymerase mix was added to each tube. 
The drops were deposited on the sides of the 
tubes so that all reactions could be started 
simultaneously by a brief spin in an Eppendorf 
centrifuge (model 5413). After 25 min at room 
temperature 2 41 of sequencing chase mix was added 
to each tube, the racks spun again and incubated 
for a further 15 mm. At this point reactions 
were either stored at -20 °C or 2 Al of formamide 
dyes were added to each tube and the reactions 
boiled for 31 min before loading on to a 
separating gel. 
(iv) Buffer gradient polyacrylamide gel 
electrophoresis 
The use of a crude buffer gradient gel 
(Biggin et al. 1983) allowed at least 250 bases 
to be read from each clone. For each gel the 
following were prepared: 
7 ml 2.5 x TBE gel mix + 14 41 25% AMPS 
+ 14 41 TEMED 
35 ml 0.5 x TBE gel mix + 70 41 25% AMPS 
+ 70 41 TEMED 
Using a 10 ml pipette, 4 ml of 0.5 x TBE gel 
mix (2) then 6 ml of 2.5 x TBE gel mix (1) were 
taken up, mixed by pulling through an air 
bubble, and poured down between the vertical gel 
plates separated by 0.35 mm "plasticard" spacers. 
The flow into the plates was continued with the 
remainder of the 0.5 x TBE gel mix (2) from a 
30 ml syringe 1,intil plates were full. A 
"plasticard" slot former with 3 mm wide wells, 
1.5 mm apart was set between the plates which 
were clamped firmly and the gel was allowed to 
polymerise for 1 h. Sequencing reactions were 
boiled and samples loaded in order using a 
drawn out capillary tube. The gel was run at 
25-30 watts for about 2 h in 1 x TBE buffer. For 
clones with inserts in the Smal site of M13 the 
bromophenol blue marker was allowed to run off, 
and after 15 min the gel was removed. The gel 
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was left attached to the unnotched plate for 
support and fixed for 10 min in 10% acetic acid, 
10% methanol solution. It was then drained, 
transferred to damp blotting paper and . .covered 
with Saranwrap plastic film. After drying on a 
vacuum gel dryer at 80 °C the Saranwrap was removed 
and the gel placed in direct contact with x-ray 
film and left to autoradiograph overnight at 
room temperature. 
Gel readings were compiled and analysed on 
a VAX/VMS computer using the programmes of 
Staden (1982) and the University of Wisconsin 
Genetics Computer Group. 
2.2.r. 	Labelling of polypeptides following infection of 
UV irradiated cells 
An overnight of M159 cells grown in M9-maltose 
medium was diluted with fresh medium to an aD 6-50 of 0.1 
and grown at 37 °C to an 0D650 of 0.5 (4-5 h). 15m1 of 
cells were pelleted in a bench top centrifuge, the super-
natant removed carefully and the cells resuspended in 
4.5 ml of ice-cold M9-maltose medium supplemented with 
20 mM MgSO4 . 4 ml of the suspension was UV irradiated 
in an open petri dish for 71 min at 4,500 erg/mm 2 with 
constant gentle swirling. The irradiated cells were 
transferred to a foil-wrapped flask to exclude visible 
light and stood on ice for 10 mm. 
CsC1 purified phage which had been dialysed 
AM 
against phage buffer were diluted to 10 
11 pfu/ml and 5 41 
(5 x 108 pfu) placed in snap cap Eppendorf tubes on ice. 
50 ii.l (5 x 10) of irradiated cells were added and the 
phage adsorbed on ice for 10 mm. The tube was warmed 
at 37°C for 2 min before the addition of 200 il of pre-
warmed M9-maltose medium supplemented with 0.04 g/ml of 
cold L-methionine. 20 pCi of L-[35S]methionine were 
added 3 min later to label proteins synthesised early 
after infection by. A, or 20 min later to label proteins 
synthesised late in infection. For labelling T4 proteins, 
label was added after 4 rain. The tubes were incubated 
at 37°C for 10 min before adding 50 41 of 1 mg/ml cold 
L-methionine. After a further 10 min at 37°C the tubes 
were put on ice for a few minutes before pelleting the 
cells at 10,000 rpm for 10 min at 4°C. The supernatant 
was removed with a drawn out pasteur pipette and the 
pellet resuspended in 1 ml of ice-cold acetone, 
repelleted at 10,000 rpm and finally resuspended in 100 41 
of sample buffer. Samples were boiled for 2 min and 
the amount of label incorporated was checked by counting 
a 5 41 sample in a scintillation counter. Samples could 
be stored frozen at -70°C for a few weeks. 
2.2.s. SDS polyacrylamide gel electrophoresis of 
polypeptides 
36 x 25 cm gels were poured between glass plates 
separated by 1 mm spacers and sealed together with 1 mm 
bore silicone rubber tubing and bulldog clips. The 
appropriate quantity of acrylamide gel solution was made 
up as described without TEMED which was only added just 
before pouring. The. ratio of bis acrylamide to acrylamide 
in the stock solution. was chosen to give the optimum 
separation of polypeptides in the 30-40K region (Hancock 
et al., 1976). 	The separating gel was poured directly 
between the plates to within 4 cm of the top and overlayed 
with water saturated butanol. After 1 h the butanol was 
rinsed off first with ethanol and then water, and a slot 
former was inserted between the plates. The stacking gel 
was poured and allowed to polymerise for 1 h. The slot 
former, tubing and bottom spacer were removed and the gel 
clamped on to the electrophoresis tank which was filled 
with 1 x Laenimli electrophoresis buffer. The Wells 
were thoroughly washed out and the protein samples were 
loaded with a microsyringe after boiling for 2 mm. 
Usually 0.2-0.5 mg of protein, or 2-5 x 10 5 counts were 
loaded per well. The gel was run at 20-24 mA overnight. 
2.2.t. Sta±ning-änd autor'adiography'of-p•rotein ge1s 	- 
Where mg quantities of protein were present gels 
were stained with Coomassie blue (0.05% w/v in 10% acetic 
acid, 25% methanol) for 2 h and destained over a few 
hours with several changes of 10% acetic acid, 25% 
methanol. 
Silver staining was used for smaller quantities 
of protein. The gel was gently shaken throughout at 
room temperature; the gel was first washed for 30 mm 
in 45% methanol, 10% acetic acid, prefixed for 30 mm 
in 5% methanol, 7% acetic acid and fixed for 30 min in. 
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10% glutaraldehyde. It was then rinsed thoroughly in 
distilled water with repeated changes for over 1 h or 
overnight, then washed for 30 min in 5 g/ml DTT, and 
30 min in 0.1% AgNO3 . 	The gel was rinsed very quickly 
in distilled water and twice in developer (3% NaCO 3 ) and 
finally developed in 3% Na 2CO3 containing 100 41 of 37% 
formaldehyde (HCOOH) per 100 ml of solution. After 
developing to the required intensity 5 ml of 2.3 M 
citric acid were added, the gel washed thoroughly in 
distilled water and stored sealed in a plastic bag with 
0.03% Na2CQ3 . 
Where radiolabelled proteins were used the gel was 
fixed for 2 h in 10% acetic acid, 25% methanol then 
dried on to blotting paper in a heated Bio-Rad Slab gel 
dryer (model 224) and autoradiographed by exposure to 
X-ray film at room temperature for 1-4 days. 
2.2.u. Phage infection and prophage induction to obtain 
pnk expression 
(i) Infection 
ED8689 (j ° ) cells were grown at 37 °C to 
an aD650 of 0.4 ("'2 x 108 cells/ml) and phage 
were added at a moi of 5 (or as high as possible) 
Where T4 or X phage capable of cell lysis e.g. 
XCM8 were used, infection was allowed to proceed 
at 37 °C for 10-15 mm. Where phage had anther 
mutations preventing cell lysis e.g. XCM21,infection 
proceeded for 2-3 h. Cells were pelleted and 
supernatants discarded. The pellets were stored 
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at -20°C or were resuspended in 50 mM Tris.HC1 
pH 7.4, 1 mM 2-mercaptoethanol for cell disruption 
by sonication. 
(ii) Induction 
An overnight of a lysogen grown at 32°C was 
diluted 50 fold and grown at 32°C to an 0D 650 
of 0.5. The cells were pelleted and resuspended' 
in 1/5 volume of L-broth. The concentrated 
cells were heated at 42°C for 10 min in a 
shaking water bath, diluted to the original 
volume with L-broth at 37°C and grown at 37°C 
for 2-3 h before pelleting as described above. 
2.2.v. 	Purification of polynucleotide kinase protein 
The procedure was basically.that described by 
Richardson (1965). All steps were carried out at 4°C 
unless otherwise stated, all centrifugations were at 
10,000 rpm for 30 min at 4°C. 
Cell disruption 
2-3 g of cell paste derived from a cell 
infection or prophage induction were mixed with 
10 ml of 50 mM Tris.HC1pH 7.4, 1 mM 2-mercaptoethanol. 
The suspension was sonicated 8 times for 30 sec 
with constant cooling on ice and debris was 
removed by centrifugation. 
Streptomycin precipitation 
The supernatant was made 0.8% in streptomycin 
sulphate (2 ml of 5% streptomycin solution in 10 ml) 
by dropwise addition over 30 mm. After stirring 
for a further 15 mm, or overnight, the suspension -
was sedimented by centrifugation and the supernatant 
discarded. The pellet was resuspended in 12 ml 
of 0.1 M potassium phosphate buffer (KPO 4 ) pH 7.51,  
0.01 M 2-mercaptoethanol. 
Autolysis 
The suspension was incubated at 37 °C for 
11, h with stirring then 0.0336 ml of 1 M MgCl 2 
was added and incubation at 37 ° C continued for 
1 h. The autolysate was chilled on ice for 1 h 
and sedimented by centrifugation. 
Axnmonium sulphate fractionation 
The supernatant was made 10% in ammonium 
sulphate by gradual addition of well ground solid 
(1.2 g/12 ml) over 30 min with constant stirring. 
After a further 1 hof stirringthe' suspensionwas 
sedimented by centrifugation and the supernatant 
transferred to a clean tube and a further 20% 
of ainmonium sulphate added (2.4 g/12 ml) over 
30 mm. After a further 1 h the suspension was 
sedirnented, the supernatant discarded, and the 
pellet dissolved in 10 ml of 0.1 M KPO 4 pH 7.5, 
0.01 M 2-mercaptoethanol. This suspension was 
diàlysed against 0.01 M KPO 4 pH 7.5, 0.01 M 
2-mercaptoethanol for 5 h. 
DEAE-Sephadex fractionation 
A 1.5 x 10 cm glass column was packed with 
DEAE-Sephadex (A50) in equilibrating buffer 
(0.01 M KPO4 pH 7.5, 0.01 H 2-mercaptoethanol) 
The column was washed with -"300 ml of equilibrating 
buffer and the dialysed protein suspension applied. 
The column was washed with another 100 ml of 
equilibrating buffer and the protein was eluted 
with equilibrating buffer made 0.1 H in Rd. 
5 ml fractions were collected and assayed for kinase 
activity or, where the defective protein was 
purified, aliquots of fractions were analysed on 
SDS-PAGE by silver staining. Appropriate fractions 
were pooled and dialysed against 0.05 M KPO 4 
pH 7.5, 0.01 M 2-mercaptoethanol. 
Phosphocellulose fractionation 
A 1 x 10 cm glass column was packed with 
phosphocellulose (Pll)inequilibratingbuffer 
(0.05 M KPO 4 , pH 7.5, 0.01 M 2-mercaptoethanol) 
and washed with 300 ml of equilibrating buffer. 
The dialysed DEAE-ephadex fractions were loaded 
on to the column which was washed with a further 
10 ml of equilibrating buffer. The protein was 
eluted with 20 ml of equilibrating buffer made 
0.05 M in KCl, 20 ml of buffer 0.1 M in KC1, 20 ml 
of buffer 0.25 M in KC1 and 20 ml of buffer 0..5 M 
in Rd. Ten 2 ml fractions were collected at 
each step of the elution and these were again 
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assayed for kinase activity or analysed on 
silver stained SDS-PAGE. 
Fractions containing enzyme were pooled 
and dialysed overnight at 4 °C against 50% glycerol 
(Analar grade), 25 mM Tris.HC1 pH 7.5, 10 mN 
2-mercaptoethanol. The enzyme could then be 
stored at -20 °C and retained activity for some 
months. 
2.2.w. Lowry-Folin Assays for Protein Concentration 
Protein concentration was assayed by the method 
of Lowry et al. (1951) . Infected cells or induced 
lysogens were disrupted by sonication and pelleted to 
remove debris. 1, 3 and 5 41 aliquots of the cleared 
supernatant were diluted in 0.4 ml distilled water and 
2 ml of reagent C added to each sample. The solution 
was mixed immediately ana stood for 10 min before the 
additionof 0.5 ml of reagentD.,.After mixing the 
solution was stood for 30 650 
measured. The OD reading was related to protein con-
centration by reference to a standard curve derived 
from a series of bovine serum albumin samples in the 
range 0-200 .g/ml. 
2.2.x. Assay for kinase activity 
The assay was based on the conversion of a 
dinucleoside monophosphate, cytidylyl-(3 15 ) -uridine 
(Cpu), to the dinucleotide (pCpU) by the incorporation 
32 of a labelled phosphate from [y-P]ATP (Murray, 1973). 
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This quick simple assay was, ideal for analysis of large 
numbers of crude cell extracts or fractions from pnk 
purification. However, analysis of crude extracts 
prepared by disruption of cells by sonication showed that 
kinase activity was manifest as the appearance of 
radioactive pC due to the action of a nuclease upon the 
primary product, labelled pCpU. 
Cell pellets derived from 25-50 ml of culture 
were resuspended in 0.4 ml of 50 mM Tris.HC1, pH 7.4, 
1 mM2-mercaptoethanol in Eppendorf tubes and sonicated 
in 6 bursts of 3 seconds using a Dawe Soniprobe sonicator 
(model 7540A) ensuring that the tubes always remained 
cool. Debris was removed by centrifugation. 2.5 41 of 
clear supernatant (or fraction from the purification 
procedure) was incubated with 25 mM Tris-HC1 pH 7.5, 
5 mM MgC1 2 , 10 mM 2-mercaptoethanol, 0.1 mM ATP, 1 mg/mi 
CpU, 0.1-1 4ci (y- 32P]ATP in a 10 41 volume at 37 °C for 
30 min... Theproducts were analysed by ionophoresis on 
AE-ceilulose paper at pH 3.5. 
2.2.y. Preparation of substrates, and assays for 5'-kinase 
and 3 1 -phosphatase specificities of purified pnk 
(i) 5'-kinase assay 
5 '-hydroxyl deoxyribooligonucleotides were 
obtained from a digest of salmon sperm DNA with 
pancreatic DNAse (DNAse I) and calf intestinal 
phosphatase (CIP). Salmon sperm DNA was dis- 
solved to 1.5 mg/ml in TE buffer pH 7.5. 10 
of the DNA was incubated in 0.01 M Tris.HC1 
pH 7.5, 0.01 M MgC1 2 , 0.1 mg/mi DNAse I, 0.1 mg/mi 
CIP in a 100 1. volume at 37 °C for 3 h . The 
reaction was heated at' 70 °C for 10 mm. 
5 '-hydroxyl ribooligonucleotides were 
obtained from digestion of yeast tBNA with RNAse 
T1 . 5 . 4g  of tRNA were incubated with 0.01 M 
Tris.HC1 pH 7.5 and 20 units of RNAse T 1 in a 
50t1vo1umeat37 0Cfor2h. 
Aliquots of 5'-hydroxyl substrates were 
incubated with pnk under the conditions 
described in Section x. 	These phosphorylated 
oligonucleotides were further digested to single 
nucleotides with venom phosphodiesterase to 
investigate the specificity of labelled 
'phosphate incorporation. A 10 41 aliquot of 
kinase treated oligonucleotides was incubated 
with 0. 0l N Tris pH 8 .5, 0.1 mg/mi venom 	* 
phosphodiesterase at 37 °C for 40 mm. 
(ii) 3'-phosphatase assay 
5 1- [ 32 P]dCMP and 3'-( 32 P]dCMP, the 
substrates for this assay were isolated from 
appropriate digests of nick-translated Xc1857 
DNA (i.e. labelled with (a- 32P]dCTP). 5' - [ 32 P]dCMP 
was obtained from sequential digestion of the 
labelled DNA with pancreatic DNAse and venom 
phosphodiesterase. An aliquot of DNA was 
97 
incubated with 0.01 M Tris.HC1 pH 7.5, 0.01 M 
MgC1 2 , 0.1 mg/mi DNAse I in a 50 iii. volume at 
37 °C for 1 h. An aliquot of this digest was 
incubated with 0.01 M Tris.HC1 pH 8.5, 0.1 mg/mi 
venom phosphodiesterase in a 50 41 volume 
at 37 °C for 40 mm. 
3 1 -[ 32 P]dCMP was obtained from a sequential 
digest of labelled DNA with micrococcai nuclease 
and spleen phosphodiesterase. An aliquot of 
DNA was incubated with 0.3 M glycine buffer 
pH 9.2, 0.1 MCaC12 , 0.3 mg/ml micrococcal 
nuclease in a 30 41 volume at 37 °C for 1 h. 
The pH of the reaction was reduced to 6 by 
addition of acetic acid then an aliquot was 
incubated with 0.1 M. sodium succinate . HC1 
pH 6.5, 1 unit/ml spleen phosphodiesterase in a 
100 il volume at 37 °C for 1 h. 
The reaction products were separated by 	- 
ionophoresis on AE81 paper at pH 3.5 and the 
labelled spots located by autoradiography with 
X-ray filxtt at -70°C. The 3' - [ 32 P]CMP and 
51_[ 32  P]CMP spots were cut out and eluted from 
the paper and incubated with 0.06 M sodium 
succinate.HC1 pH 6.5, 0.01 M MgC1 2 , 0.01 M 
2-mercaptoethanol and enzyme at 3 °C for 1 hr. 
The products of all assays were analysed 
by ionophoresis on AE81 paper at pH 3.5. 
Mm 
2.2.z. High voltage paper ionophoresis, and solvent 
elution 
Separation of components of digests and assays 
was achieved by high-voltage ionophoresis on AE-cellulose 
(AE81) paper at pH 3.5 (Sanger et al., 1965; 
Murray, 1970). 5 1 aliquots of the samples were 
spotted on to AE81 paper, 9 cm from one end and 0.5 cm 
apart (leaving a 4 cm gap down the sides of the paper 
where a marker dye could be loaded). A mark was made 
23 cm from the origin and when spots were dry the paper 
was soaked in 0.5 x pH 3.5 buffer (1 x buffer is 1% 
pyridine, 10% acetic acid). The paper was lowered into 
the electrophoresis tank and run in 1 x pH 3.5 buffer 
at 3 kV. TheATP remained cl6se to the origin whereas 
the four mononucleotides were well resolved when the 
fast xylene cyanol marker dye (equal amounts of xylene 
cyanol FF, orange G, and acid fuchsin in distilled water) 
had migrated 23 cm. After drying the paper, radiolabelled 
spots werd detected by autoradiography with x-ray film 
at -70°C. Non-radioactive mononucleotide markers were 
visualised under UV light. 
Separated spots could be eluted from the paper with 
alkaline triethylamine carbonate. (CO 2 was passed into a 
mixture of 70 ml of water and 30 ml of redistilled tn-
ethylamine until saturated. The pH was adjusted to 
10 with tniethylamine.) 	The radiolabelled. spot was 
cut out as a rectangle with one pointed end which was 
rested against a drawn out capillary tube while the other 
end was sandwiched between glass slides standing in a 
trough of triethylamine. Capillary action draws solvent 
into the capillary from the paper. The solvent, containing-
the radiolabelled nucleotide species was spotted on to 
polytherie and dried under vacuum without allowing the 
solvent to bubble The spot was dissolved in water and 
redrIed 3 times before finally resuspending in 0.01 M 
Tris.HC1 pH 8.5 and digesting with venom phosphodiesterase. 
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C H A P T E R 
RESULT S 
3.1 CLONING AND EXPRESSION OF THE pT GENE 
The location of 2T in the T4 genome is inferred 
by the absence of T4 EcoRI fragments 21 (2.27 kb) , 33 
(1.1 kb) and 46 (0.1 kb) (Figure 3.1) from the kinase 
deficient deletion strain T4Tl (Mileham et al., 1980). 
An analysis of heteroduplex molecules indicates that 
pseTl is 3.5 kb in length (Kutter et al., 1984) so it 
is unlikely that pseThl extends very far outside of 
EcoRI fragments 21, 33 and 46. An open reading frame 
(OPF) of about 1000 bases, sufficient to encode a 33 kd 
polypeptide, could be contained entirely within the 
2.27 kb or the 1.1 kb EcoRI fragments. The initial 
approach therefore was to analyse polypeptides expressed 
by the larger EcoRI fragments, and to determine the DNA 
sequence with the intention of identifying the ET 
gene. 
3.1.a. Correlation of a T4 33 kd polypeptide with pnk 
activity in infectedce1is 
UV irradiated cells (M159) were infected with 
T4 phage (see Section 2.2.r) and polypeptides 
labelled with [ 35S]methionine were separated on 
15% linear SDS polyacrylamide gels and detected 
by autoradiography (Figure 3.2). In infections 
with phage known to express an active pnk (wild-type 
T4D or T4amN122) a 33 kd polypeptide was present, 
whereas this polypeptide was missing in infections 
with the ET strain T42T2 (Figure 3.2). In 
io: 
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Figure 3.1 
Organisation of the pT region of the 
T4 genome. The figure shows: physical distance 
in kilobase pairs from the rIIA-rIIB join = 0 
(Wood and Revel, 1976); the map position of 
T4 deletion pseTl (Mileham et al. 1980; Kutter 
et al., 1984); a genetic map of T4 showing gene 
order, rectangles represent genes whose lengths 
have been determined by DNA sequence; the 
direction of transcription; the nunthersalloted 
to the relevant EcoRI fragments (Kutter et al., 
1984); restriction sites for EcoRI, BglII and Smal. 
addition to the correlation between the presence 
of a 33 kd polypeptide and kinase activity, a 
smaller polypeptide of about 20 kd exhibited different 
mobilities when infections with the 	strains T4D 
or T4amN122 were compared with a T4T2 (pT) 
infection. The T4 2T2 and T4arnN122 strains were 
therefore crossed and a sample of amber recombinants 
unable to form plaques on a suppressor-free strain 
(ED8689) were assayed for induction of kinase 
activity on infection of non-irradiated cells (ED8689) 
(Figure 3.3). 	Recombinants with the amN122 mutation 
in T4 gene 42 (dcMP-hydroxymethylase) are defective 
in DNA synthesis. Since DNA synthesis is involved 
in switching of f early genes, amN122 mutants continue 
to synthesise pnk throughout infection which improves 
the yield. The infected cells were sonicated to 
release cell proteins and samples of the cleared 
crude cell lysates were asaye.d for kinas.e activity 
by their ability to convert a dinucleoside mono-
phosphate Cpu, to the dinucleotide pCpU, by the 
incorporation of labelled phosphate from [1- 32 P]ATP. 
Products of the reactions were separated by ionophoresis 
at pH 3.5 on AE81 cellulose paper. In Figure 3.3, 
( 32P)pCpU is only seen as the product of an assay 
using purified T4 encoded pnk. In assays of crude 
cell extracts, a nuclease degrades [ 32P]pCpU to 
[ 32 P]pC. This nuclease activity is detected when 
purified pnk is added to crude cell extracts. 
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Figure 3.2 
Expression of a 33 kd polypeptlde by recombinant 
T4 and A phages. Autoradiographic analysis of 
labelled polypeptides following infection of UV 
irradiated cells (M159) with T4 or A phage. 
Polypeptides were separated by electrophoresis 
through a 15% linear SDS polyacrylamide gel. 
Infections with T4 were labelled from 3-7 mm 
and those with A derivatives from 3-13 min or 
20-30 mm. The positions of standard marker 
proteins are indicated: phosphorylase b, (94 kd); 
bovine serum albumn (67 kd); ovalbumi.n (43 kd); 
carbonic anhydrase (30 kd): soybean trypsin 
inhibitor (20.1 kd.). The tracks are: 
(a) uninfected cells (M159); (b)-(q) a series 
of T4 am phage derived from a cross of T4amN122 
and T4T2; (h) T4D (wild-type); (i) T4T2 
(a RT strain) ; 	(j) T4amN122; 	(k) ANM1108 
labelled 3-13 mm; (1) ANM1108 labelled 20-30 
mm; (m) ANM1108 deleted for fragment 21 labelled 
3-13 mm; (n) ANM1108 deleted for fragment 21 
labelled 20-30 mm. The position of the 33 k& 
polypeptide and of the 20 kd polypeptide with 
varying mobility are indicated. 
The presence of kinase activity on infection with the 
T4 recombinant phages was compared with the pattern 
of polypeptides obtained on infection of UV irradiated 
cells (Figure 3.2). A T4 recombinant was found 
(Figure 3.2, track (b)) which expressed a 33 kd poly- 
peptide and a 20 kd polypeptide with mobility identical 
to that of the corresponding T4 pLeT2 	T) poly- 
peptide. Since this recombinant T4 phage induced 
kinase activity on infection of non-irradiated cells 
(Figure 3.3, track (e)), kinase .activity in T4 
infections appeared to correlate exclusively with 
expression of the 33 kd polypeptide. 
3.1.b. Expression of a 33 kd polypeptide by a A recombinant 
including T4 EcoRI Fragment 21 
The source of fragment 21 DNA was ANM1210, the 
recombinant derivative of XNM607 isolated by Mileham 
et al. (1980) . 	This recombinant includes fragment 21 
within the coding sequence of th&cI gene. DNA 
inserted into the ci gene can be transcribed leftward 
from RE like the ci gene itself but there is no 
published evidence to suggest that the anti-sense 
strand of the ci gene is transcribed rightward from 
a A promoter. Alternative A vectors offer potential 
for transcription irrespective of the orientation 
of the inserted DNA. EcoRI fragment 21 was therefore 
transferred from ANM1210 to the central region of 
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Figure 3.3 
Assay for kinase activity in crude extracts-
of non-irradiated cells (ED8689) infected with T4 
phage. The assay involves the conversion of the 
substrate Cpu to the dinucleotide pCpU by transfer 
of a labelled phosphate from [y- 32P]ATP. A 
nuclease in crude extracts degrades pCpU to pC 
(see section 3.1.a). Products of the reaction 
were separated by ionophoresis on AE81 cellulose 
paper at pH-3.5. Tracks are: (a) uninfected 
cells (ED8689); 	(b) T4D (wild-type); 
(c) T4ainN122; (d) T4pT2 (a ET strain); 
(e)-(j) a series of T4am phage derived from a 
cross of T4axnNl22 and T4pT2, these correspond 
to tracks (b) , (g) , (c) , () , (d) and (i) 
respectively of Figure 3.2. In Figure 3.2, 
kinase activity in T4 phage infections seems to 
correlate with the presence of a 33 kd polypeptide 
and the higher mobility form of the 20 kd polypeptide 
(see section 3.1.a). However, the T4 recombinant 
used in track (b) of Figure 3.2 expresses a 33 kd 
polypeptide and the lower mobility form of the 20 
kd polypeptide but does induce kinase activity 
(track (e) of this figure). Track (k) is an assay 
with purified T4 encoded pnk; track (1) is an assay 
with distilled water. The positions of [y-32P]ATP and 
of the labelled products of the kinase reaction., 
pCpU or pC are indicated. 
in the recombinant phage XNM1104 (Figure 3.4). 
UV irradiated bacteria (M159) were infected with 
recombinant A phage and [35S]methionine labelled 
polypeptides were analysed by SDS polyacrylamide gel 
electrophoresis (Figure 3.2) . XNM1108, the Warn Earn 
Sam derivative of XNM1104,but not a derivative of 
XNM1108 deleted in vitro for fragment 21, expressed 
a 33 kd polypeptide. This polypeptide migrated 
in a position corresponding to the 33 kd 2T 
polypeptide expressed by T4D (wild_type): and T4amN122 
but absent in infections with the 	T phage, 
T4 pseT2. This would be consistent with the 
location of the pT gene in fragment 21, although 
on some gels the polypeptide expressed by the 
recombinant ANM1108 appeared to have a very slightly 
faster mobility than the T4 ET polypeptide 
(Figure 3.2) , raising the possibility that XNM1108 
might encode a - truncated polypeptide; 	- 
3.1.c. Orientation and lodation of the ORF encoding the 
33 kd polypeptide 
The orientation of fragment 21 in ANM1104 and 
ANM1108 was deduced from the position of the asyrnrnetri-
cally located Smal site (Figure 3.1). A recombinant, 
XCM1 (Figure 3.4) which carried fragment 21 in the 
opposite orientation to that in ANM1104 (and ANM1108) 
was isolated by ligation of fragment 21 purified from 
an EcoRI digest of XNM1210 to EcoRI cut ANM459. 
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Figure 3.4 
Transcription patterns of vector NM459. 
The vector has a single EcoRI site (R) to the left 
of att. The genome circularises on infection and 
fragments inserted at the EcoRI site may be 
transcribed early from the leftward X promoter p L 
and late from the rightward promoter 2R'• 
Transcription from ER'  requires activation by gpQ, 
a product of early rightward transcription, and 
must traverse more than 20 kb of the intervening 
X genome before reaching the insert. ANM1104 
and XCM1 are derivatives including T4 fragment 21 
which encodes a 33 kd polypeptide. The respective 
orientations of the T4 fragments in XNM1104 and 
XCM1 were determined from Smal digests (S indicates 
a SmaIsite) . XCM6 is like XCM1 but is deleted 
for the DNA between the two leftmost Smal sites; 
this phage no ionger expresses the 33 kd polypeptide. 
The open arrows show major leftward transcripts, 
the solid arrows the major rightward transcripts. 
T4 DNA is shaded. 
and XCM1 resulted in fragment sizes of either 2.63 
and 6.98 (Figure 3.5 tracks (c) and (d)) or 3.30 
and 6.31 (Figure 3.5 track (e)) respectively for Smal 
digests of the phage DNAs. 
In A, leftward transcription is mediated 
early from the powerful 2L  promoter, and rightward 
transcription is dependent on the subsequent 
activation of the A late promoter ER'•  The 
direction of transcription of the ORF in ANM1104 or 
XCM1, which was required for expression of the 33 kd 
polypeptide was deduced from the timing of expression 
of the polypep.tide following infection of UV irradiated 
cells (M159) with those phages. Polypeptides were 
separated on. 15% linear SDS polyacrylamide gels. For 
'NM1104, little expression of the polypeptide was 
detected when labelling was from 3-13 min after 
infection, whereas much more was detected when 
labelling was from- -20-30- m-in---af-ter---i-n-fection•---.........- ........... 
(Figure 3.6) . This implied that transcription of 
the coding sequence required or was enhanced by 
activation of the late A promoter £R'•  XCM1 expressed 
the 33 kd polypeptide more efficiently during the 
3-13 min period following infection (Figure 3.6) 
indicating that transcription of the ORF was mediated 
by the A early promoter EL These data identify the 
orientation of the sequence encoding the 33 kd 
polypeptide in relation to the A promoters, and 
this can be related to the T4 map by the position of the 
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Figure 3.5 
The orientation of fragment 21 in A 
recombinants. Smal digestion of A recombinant 
DNAs including fragment 21. Fragments were 
separated by electrophoresis through a 0.8% agarose 
gel. Tracks are: (a) EcoRI digested Ac1857 
giving marker fragment sizes (kb) of 21.7, 7.52, 
5.83, 5.64, 4.85 and 3.48; 	(b) Smal digested 
xNM459; (c) Smal digested XNM1104; (d) Smal 
digested ANM1108; (e) Smal digested ACM1; 
(f) Smal digested ACM6; (g) SinaI digested ANM1149; 
(h) Smal digested NM1210; (i) Hindill digested 
Ac1857 giving marker fragment sizes (kb) of 
23.6, 9.64, 6.64, 4.34, 2.26, and 1.98. The 
origin of Smal restriction fragments is shown in 
the accompanying diagram. 
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asymmetrically located Sinai site in fragment 21 
(Figure 3.1). The coding sequence is transcribed 
anti-clockwise with respect to the T4 genome (i.e. 
left to right in Figure 3.1), as would be expected for 
a gene which is expressed early in the T4 life cycle. 
Some idea of the location of the sequence 
encoding the 33 kd polypeptide was gained from XCM6, 
a recombinant which was deleted for the smaller of 
the two Smal-EcoRl fragments derived from fragment 21 
(Figure 3.4). To obtain this recombinant, Smal cut 
fragment 21 was incubated in a mixed ligation with 
Smal cut XNM1112 (to provide a Smal left arm) and 
EcoRI cut ANM1222 (to provide an EcoRI right arm). 
The right arm of NM1112 and the left arm of XNM1222 
carried amber mutations so that recombinant phage 
including these arms, or religated parental phage, 
would only grow on a host suppressor strain. 
Recombinant-s were there-fore--select-ed--on- a-suppressor---
free strain (NM594) and those including the larger 
Smal-EcoRl fragment were identified by digestion 
with Smal (e.g. XCM6 in Figure 3.5). On infection 
of the UV irradiated cells, XCM6 failed to express 
a 33 kd polypeptide (Figure 3.6) either early or 
late in infection suggesting that the Smal site 
is within the gene coding for the 33 kd polypeptide. 
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The timing of expression of the 33 kd 
polypeptide by A recombinants including fragment 
21 or fragment 21. Autoradiographic analysis of 
35 labelled polypeptides following infection of 
tJV irradiated cells (M159). Polypeptides were 
separated by electrophoresis through a 15% linear 
SDS polyacrylamide gel. Tracks are (a) uninfected 
cells (M159); (b) xNM459 vectors labelled 3-13'; 
(c) XNM459 vector labelled 20-30'; (d) XNM1104 
labelled 313 1 ; ( e) xNM1104 labelled 20-30'; 
(f) ACM1 labelled 3-13 1 ; ( g) ACM1 labelled 
20-30 1 ; 	 ( h) XCM6 labelled 3-13 1 ; 	 ( i) ACM6 
labelled 20-30'; (j) ANM1149 vector labelled 
3-13'; 	(k) ANM1149 vector, labelled 20-30 1 ; 
(1) XCM8 labelled 3-13'; (m)ACM8 labelled 
20-30'; 	(n) XCM21 labelled 3-13 mm; (o) ACM21 
labelled 20-30 1 . The positions of standard 
marker proteins are indicated (see figure 3.2). 
The position of the 33 kd pnk polypeptide is 
also shown. 
3.1.d. A clones including fragment 21 do not induce 
kinase activity 
Crude cell extracts from non-irradiated cells 
(ED8689) infected with A phage at high multiplicity 
were assayed for kinase activity by the ability to 
transfer 32 P from [y- 32P]ATP to the dinucleoside 
monophosphate Cpu (Figure 3.7). No activity was 
detected in extracts from suppressor-free cells 
(ED8689) infected with ANM1108 (Figure 3.7 track 
(1)), a phage that on infection of UV irradiated 
cells produced large amounts of a 33 kd polypeptide 
(Figure 3.2). The polypeptide encoded by A recoxnbinants 
including fragment 21 was therefore defective as the 
result of either a mutation or incorrect processing, 
or alternatively was not the product of the 2T gene. 
Repeated attempts were made to clone a T4 
fragment extending from the Smal site in fragment 21 
to a downstream !IIor PstI site (see Figure 3.1) -. 
to determine whether DNA downstream of fragment 21 
encoded an alternative 33 kd polypeptide. These 
attempts were unsuccessful perhaps because the 
recombinants included DNA encoding functions that 
were deleterious to phage or host propagation. 
The 1.3 kb EcoRI fragment upstream of fragment 21 
(Figure 3.1) had not been cloned in A or plasmid 
vectors (Mileham et al., 1980). In addition T4T1 
had been reported to be alc '(Snyder et al., 1976) 
which indicated that the alc/unf gene might be located 
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Figure 3.7 
Assay for kinase activity in crude cells 
extracts (ED8689) after infection with X recombinarits 
including fragment 21 derived from ANM1210 or 
fragment 21 derived directly from T4 DNA. 
Radiolabelled products of the kinase reaction were 
separated by ionophoresis on AE81 cellulose 
paper at pH 3.5. Tracks are: (a) T4D (wild-type); 
(b) T4amN122; 	(c) T4T2 (a 	strain); 
(d) NM1149 vector; (e)-(k) seven different 
lysates of XCM8 which includes EcoRI fragment 21 
derived directly from T4 DNA; (1) - XNM11O8; 
XNM1108 deleted for EcoRI fragment 21; 
uninfected cells (ED8689); (o) purified T4 
encoded pnk; (p) distilled water. The positions 
of [Y- 32P]ATP and of the labelled products of 
the kinase reaction, pCpU or pC are indicated. 
close to fragment 21 and may even extend into this 
fragment. Sequences upstream of fragment 21 were 
therefore considered unlikely to encode a 33 kd pseT 
polypeptide. 
3.1.e. The DNA sequence of EcoRI fragments 21 and 46 
All of the DNA sequence information was derived 
from sequences cloned in M13 vectors using the 
dideoxy chain termination method (section 2.2.q.). 
T4 EcoRI fragments 21 and 46 were purified from 
EcoRI digests of XNM1210 and XNM1207 respectively. 
Fragment 21 was ligated to EcoRI cut M13mpll and 
fragment 46 was ligatedtoEcoRl cut M13mp8. Both 
strands of fragment 46, and the extreme ends of 
fragment 21 were sequenced. 
To obtain sequence for the rest of fragment 
21, the fragment was sonicated to generate random 
fragments 300-600 base pairs in length. After 
repairing the ends with'polymerase, - these fragments ------ - - - 
were ligated to Sinai cut M13mp8 vector. Initially 
about 60 of these recom.binants were sequenced, and 
the random stretches of fragment 21 DNA sequence 
were compiled and ordered on a VAX-VMS computer using 
the programmes of Staden (1982.) . By this method, 
some parts of the sequence were covered more often 
than others and in some areas, sequence could not be 
obtained on both strands. To complete these gaps, 



























































1201 TTTGATGTTGATGGTACACTAGCTAAAATGAATGGTCGTGGTCCTTATGACCTTGAAAAA  
PheAsPValAspGlymrLeuAiaLysMetAsflGlyArgGlyproTyrAspLeuGluLys 
1261 TGCGATACCGATGTTATCTCCTATGGTTGTTGCTGTCTGATGTATGCTCTTATG 
CysAspThrAspVall leAsnProMetVaiValGluLeu5erLysMe tTyrAiaLeuMe t 
Figure 3.8 
The DNA sequence of the. contiguous EcoRI 
fragments 21 and 46 with the amino acid sequence 
of the 900 base ORP encoding the 33 kd polypeptide.. 
EcoRI fragments 21 and 46 were derived from 
XNM1210 and XNM1207 respectively (Mileham et al., 
1980). Restriction sites for EcoRI, Smal and 
XbaI are shown above the DNA sequence and the 
translation of the .ORF is shown below. 
probes to screen the 'library of random fragments in 
M13 to find the required complementary sequences. 
One section (between bases 302 and 464 in Figure 
3.8) which was not represented at all in the library 
on one strand was sequenced from the M13mpll recombinant 
including the intact fragment 21 using specific 
synthetic oligonucleotides 
(5 '-GTTCGACAAAGCCTA and 
5 '-AAACAGTTCATCCTAAT) 
instead of the usual universal primer. 
The orientation of fragment 21 in relation to 
the physical and genetic map of T4 was indicated by 
the unique Smal site (see Figure 3.1) . The orientation 
of fragment 46 was determined from the sequence of 
an Alul fragment derived from an Alul digest of the 
T4 8.2 kb SqlII fragment (see Figure 3.1) which 
includes EcoRI fragment 21 and 46. Fragments from 
'the A1uL'digest were'igated to'Smai-- cut-'Ml3mpi8 	- - 	- - 
vector DNA. An M13-AluI fragment recombinant which 
hybridised to both ANM1210 and XNM1207, i.e. over- 
lapped fragments 21 and 46 was chosen for sequencing 
the junction between the two fragments. 
The sequence reve1ed only one large ORF of 
900 bases (Figure 3.8) which was contained entirely 
within fragment 21. Several smaller ORFs, none 
larger than 320 bases occurred in this region (Figure 
3.9) , however, no large ORF extended over fragments 
21 and 46 and into fragment 33 since stop codons 
IC 
Figure 3.9 
200 	400. 	600 
I I I 
800 	1000 	1200 	1400 	1600 	1800 	2000 	2200 






	 5 , 
FRAMES of: KINCON.SEQ Check: 8556 from: i to: 2393 
Figure 3.9 
A map indicating sizes of the ORFs in 
all six reading frames of the contiguous 
sequence of EcoRI fragments 21 and 46. 
blocked all frames in fragment 46. 
The direction of transcription predicted for 
the 900 base ORF corresponded to that determined 
for expression of the 33 kd polypeptide in XNM1104. 
The proposed ATG initiation codon for the ORF was 
situated 75 bases upstream of the Sinai site in 
fragment 21. This was consistent with the loss of 
expression of the 33 kd polypeptide in the A 
recombinant XCM6 which is deleted for T4 DNA upstream 
of this SinaI site (Figure 3.4) 
The large ORF located entirely within fragment 
21 therefore appeared to encode the 33 kd polypeptide 
expressed by Arecombinants e.g. ANM1104. Expression 
of the 33 kdpolypeptide did not confer kinase 
activity on infections with these A recombinants, 
therefore either the 33 kd polypeptide is a defective 
pnk polypeptide or the pT polypeptide is encoded 
by an alternative ORF .' Some supportforthe . ..former---........ --
interpretation was derived from the analysis of the 
polypeptides expressed by the T4pT strains 
(Figure 3.2); there was only a single polypeptide 
band in the 33 kd £T polypeptide region which 
was missing in T4T2 (T) infections. One 
possibility for the expression of a defective 2T 
polypeptide was indicated by the DNA sequence. 
Lillehaug (1977) reported that the N-terminal amino 
acid of the pnk subunit was phenylalanine, however 
the first phenylalanine in the sequence of the 900 
lic 
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Figure 3.10 
!II digestion of T4 alc7 DNA. Fragments 
were separated by electrophoresis through a 
0.8% agarose gel. 	Tracks are: (a) EcoRI 
-digested Xc1857 DNA giving marker fragment 
sizes (kb) of: 	21.7, 7.52, 5.83, 5.64, 4.85, 
and 3.48; (b) and (c) BglII digested T4 alc7 
DNA; (d) Hindill digested Xc1857 DNA giving 
marker fragment sizes (kb) of: -23.6, 9.64, 
6.64, 4.34, 2.26 and 1.98. The position of the 
T4 8.2 kb BglII fragment, which includes T4 
EcoRI fragments 21, 46 and 33 (Figure 3.1) is 
indicated. 
EcoRI digestion of recombinants including an 
active £T gene.. Tracks are (a) EcoRI digested 
Xc1857 DNA (see above); (b) EcoRI digested 
XCM8; (c) an EcoRI digest of a second recombinant 
derivative of XNM1149 which encodes an active 
pnk (Figure3.16, track (o)) but also includes 
an unidentified EcoRI fragment of 3.7 kb; 
(d) EcoRI digested XNM1070; (e) EcoRI digested 
XCM21; (f) an EcoRI digest of a second 
recombinant derivative of ANM1070 which is like 
ACM21; (g) Hindlil digested Xc1857 DNA. 
The positions of the lacZ fragment of XNM1070 
(6.6 kb) and of fragment 21 (2.2kb) are indicated. 
base OPF within fragment 21 was at residue 20. 
This raised the possibility of a failure of post-
translational processing. However, the pseT 
polypeptide expressed by T4ET phage, and the 33 kd 
polypeptide expressed by 	1104 or XNM1108 have 
very similar mobilities, which did not support the 
idea of an T4 dependent removal of 20 amino acid 
residues from the inactive 33 kd polypeptide. 
Processing by the addition of a terminal phenylalanine 
remained a possibility. The alternative explanation 
for a defective 33 kd polypeptide, i.e. a mutation 
within the cloned ORF, was investigated by the isolation 
of further clones containing fragment 21 derived from 
a different DNA preparation. 
3.1.f. Isolation of clones encoding an active pnk 
The 8.2 kbBglII fragment (Figure 3.10A), which 
includes T4 EcoRI fragment 21, was purified from 
T4 a1c7DNA.anddigeste.dw.ithEcoRL.. ..The.resu1ting 
fragments were cloned in the immunity region of 
vector XNM1149 (this differs from XNM607 only in 
that it may be used for either EcoRI or Hindlil 
fragments) . Recombinants recovered as clear plaques 
on a hf 1 host (NM514) were screened by hybridisation 
to a probe made from purified fragment 21 to identify 
those including an alternative T4 2.27 kb EcoRI 
fragment (fragment 21) . Two reconthinants including 
fragment 21+  were recovered and high titres lysates 
were prepared (sections 2.2.f and 2.2.g). Crude 
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Figure 3.11 
The orientation of fragment 21 in A recombinants 
encoding an active pnk. Smal digestion of A recombinant 
DNAs including fragment 21+. Fragments were separated 
by electrophoresis through a 0.8% agarosè gel. 
Tracks are: (a) EcoRI digested Ac1857 giving marker 
fragment sizes (kb) of 21.7, 7.52, 5.83, 5.64, 4.85 
and 3.48; (b) Smal digested ACM8; (c) Smal digested 
A1149; (d) Smal digested XCM21; (e) a Smal digest 
of a second recombinant of ANM1070 including 
fragment 21 which is like ACM21; (f) Smal digested 
ANM1070; (g) Hindill digested Ac1857 giving marker 
fragment sizes (kb) of 23.6, 9.64, 6.64, 4.34. 2.26 
and 1.98. The origin of Smal restriction fragments 
is shown in the accompanying diagram. 
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Figure 3.12 
The origin and transcription of XCM21. The 
structure of ACM8, the first recombinant encoding an 
active pnk is shown. Fragment 21 is inserted in 
the orientation in which pT cannot be transcribed 
from 2RE•  Transcription of the 2T gene may depend 
on a promoter sequence within the insert, although 
transcription from a A promoter has not been ruled 
out. In ACM21 T4 fragment 21 derived from ACM8 
is inserted between the EcoRI site within the lacZ 
DNA and the EcoRI site of the A DNA thereby replacing 
most of the lacZ DNA. Transcription of p!T will 
depend on, or be augmented by ER'  following 
amplification of the induced prophage. The amber 
mutations in genes E and W prevent the formation of 
virus particles, and that in S blocks cell lysis. 
Small arrows indicate EcoRitargéts, the A promoters 
and deletions are designated by their usual symbols. 
T4 fragment 21 is indicated as a shaded insert and 
the curly arrow beneath indicates the direction of 
transcription of pT (the orientation of fragment 
21 in ACM8 and ACM21 was determined from Sma 
digests). Large open arrows show major leftward 
transcripts, and solid arrows the major rightward 
transcripts. 
extracts from cells infected with each of these 
recombinants were assayed for kinase activity. In 
contrast to infections with XNM1108, phage including 
fragment 21+ were found to induce kinase activity 
(Figure 3.7). Smal digestion of DNA from one of 
these phage, XCM8 (Figure 3.11) gave the orientation 
of fragment 21 as that shown in Figure 3.12, i.e. 
transcription of the ORF encoding the 33 kd poly-
peptide would not be effected from 	Since 
transcription of 2T from 	is ruled out, but 
expression of kinase activity was detected, fragment 
21+ may carry a functional promoter or alternatively 
transcription from ER'  or some unknown promoter is 
responsible for expression of the 33 kd polypeptide. 
No precedents for rightward transcription of DNA inserted 
in the ci region have been reported but it is possible 
that the b538 deletion, which removes 8.3 kb of the 
central region 
terminators which normally prevent transcription from 
reaching DNA inserted in the immunity region. 
3.1.g. The DNA sequence of the functional pnk gene 
Fragment 21 was purified from an EcoRIdigest of 
XCM8 DNA (Figure 3.10B). An AluI digest of this 
fragment was ligated to Smal cut ml3mpl8. A sample 
of these M13 recombinants was used to obtain the 
DNA sequence of the ORF within fragment 21. 
Unfortunately the AluI fragment including the last 
63 bases of the ORF was not recovered as an M13 
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Figure 3.13 
The DNA sequence of the region where a 6 base 
pair deletion had occurred in fragment 21 derived 
from XNM1210. Alul fragments cloned in M13mp18 
were sequenced by the dideoxy chain termination 
method and separated by electrophoresis through a 
buffer gradient polyacrylamide gel. Tracks are: 
(a) an Alul fragment from a digest of fragment 21 
derived from xNM1210; (b) an Alul fragment from 
a digest of fragment 21 derived from XCM8. The 
order of tracks is given at the top of the figure. 
Sequence in the immediate region of the deletion 
is shown, lower case letters denote those bases 
GTCCTG 
IIIIII 
CAGGAC which are not present in fragment 21 
derived from XNM121O.. 	- 	- 
recombinant. To obtain this sequence, it was 
therefore necessary to use a synthetic oligonucleotide 
(5'-TTCTGGAAACACATTGC) as a primer for an M13mp18 
recombinant including the larger of the two Smal-EcoRl 
fragments derived from fragment 21 k . Both of the 
Smal-EcoRI fragments were obtained from a Smal 
digest of fragment 21 and ligated to Smal and EcoRI 
cut M13mp18. Sequence obtained from both these 
clones using the usual universal sequencing primer, 
also contributed towards confirming the sequence 
of the ORF. 
The sequence of the ORF encoded byfragment 
21 differed from that of the kinase deficient strain 
XNM1210 by the addition of a sequence of six bases, 
GTCCTG (Figure 3.13). The sequence of the ORF 
given in Figure 3.14 includes these six bases 
(746-751, underlined). Appendix I gives the complete 
sequence of the contiguous EcoRI fragments 21 and 
46 with translations of all ORFs and a map of 
restriction sites. The polypeptide encoded by 
fragment 21+ therefore includes an extra Pro-Gly 
dipeptide as residues 11 and 12 (Figure 3.14) 
The molecular weight of this polypeptide was 
calculated from translation of the DNA sequence 
as 34.6 kd. The mobility of the 33 kd polypeptide 
encoded by xNM1108 is slightly higher than that of 
T4 encoded pnk polypeptide in SDS polyacrylamide 
gels (Figure 3.2). This can probably be accounted 
II: 
1570 	 1590 	 1610 	 1630 	 1650 	 1670 
GTAGrTGAAATGTGGCGTCGTATCGGTGTTGAATGCTGGCAAGTCGCTTCGGGAGATTTTTAATGGCTTGGCACCATGAAACTTGGGCTATTGTTATTGTAAATAGCGGTTTAGTTGGTA 
VaIvaIGIl*MetTrpAryArgIIeGlyvaIGluCysTrpGInvaIAlaserQlyAsppheEnd 
1690 	 1710 	 1730 	 1750 	 1770 	 1790 
:T AG TA A I 0 GO C A A ITT T GIG TAT IT A CIA G T GA A A AT A GAG CAT G G GAG GA AT G T CT TA A A TI A A GAG A A A A GA AT CCC GA T G TI GA A CIA G TAG TA A A GA A A ACT A A ACT G CC T T TA C 
1010 	 1830 	 1850 	 1870 	 1890 	 1910 
1930 	 1950 	 1970 	 1990 	 2010 	 2030 
CT 
2050 	 2070 	 2090 	 2110 	 2130 	 2150 
TA G AA GTAGTGTTTAGCCAAATTATCGCTAATAATATGTTTGAAAAACTTGATAACGCAGCTGAGCTTCGAATCCATGCTCAAGTGACTCATGTATTGAACACTTTGCTTCCAGACCAGG 
2170 	 2190 	 2210 	 2230 	 2250 	 2270 	EcoRl 
FOG A ljT C TAT I G C C A IT A C ACT G TAT C C A GOT ICC G C G C A TAT C All 0 IC G TAT II GO IC TI GA I OCT GAG CIT GIl A IC A A AG G C GA TAT IC G CIII GA A IC IC A A ACT G C G GA A TIC A 
2290 	 2310 	 2330 	 2350 	 2370 	 EcoRl 
AAGCGATTTAATGGTTTACTTTACGGTAGAGCTATAATATCACAACTCTACCAAAACAAATGAGGAAAACAAAATGTTGCTAAGTGAAAAACCGATTACTGTTAAAGGAATTC 
E:oFfl 	10 	 30 	 50 	 70 	 90 	 110 
GAATTCAGTATAA 
	
130 	 150 	 170 	 190 	 210 	 230 
AGCCAG 250 
	 Xbal 	 270 	 290 	 310 	 330 	 350 
370 	 390 	 410 	 430 	 450 	 470 
-35 	 -10 
490 	 510 	 530 	 550 	 570 	 590 
IAA ATGTAAATGATTTCATGGCATCAATTTGAACATCTCAAAGGATTGATTTATGAATCCGAGATGGCTGCAATGATTTATGGACGCCAGATTCAGCGGTTAGAATCTTTACCTCCAACT ___  
-35 	 -10 	 -35 
610 	 630 	 650 	 670 	 690 	 710 
AAT GATGTTTTATTAGCTCAATCACGTGCTAATCTCAAAAATGAATATCAAAATAAGTGGGGTAAAGCATCTAAAGACCTACATGATTATATTCAATCATTAGTTGAGAAAAAATAAATG 
-10 	 . 	 -10 	 Met 
730 	 750 	 7.70 	 790 	 Smal 	 810 	 830 
850 	 870 	 890 	 910 	 930 	 950 
Ar GO CO CAT GA A GA AC G C GA T GAG I A CA AG TA TA CC A A A A A GA A A GA A GG TAT C G TA AC TGGT AT G CA Gil T GA TA CA G CIA A A AG TAT IC TOT AC GG I GG C GAIT CT G IT A A GGG A GT A 
970 	 990 	 1010 	 1030 	 1050 	- 	 1070 
lie! IeSerAspThrAsnLeuAsIlProGluAr9ArgLeuA1aTrpGIuThrpheA1aLy5GIuTyrQ)yTrpLysva1Gj u HjsL y svaI PheAspVal ProlrplhrGluLeuvalLys 
1090 	 1110 	 11 , 30 	 1150 	 1170 	 1190 
CGTAA 
ArgAsrtSer - LysArgGl ylhrLysAlaValProl leAspVal LeuArgSerMetTyrLysSerMetArgGlLjTyrLelJGl yLeuProVallyrAsriGlylhrproGlyLysproLysAla 
1210 	 1230 	 1250 	 1270 	 1290 	 1310 
GTTA 
val 
IJ30 	 1350 	 1370 	 1390 	 1410 	 1430 
CTTAT000T rA TCAAAT 
1430 	 1470 	 1490 	 1510 	 1530 	 1550 
Figure 3.14 
Figure 3.14 
• Sequence of the contiguous EcoRI fragments 21 
and 46 with the amino acid sequence of the 906 
base ORF encoding pnk polypeptide. The fragment 
21 originally isolated in XNM 1210 by Mileham 
et al. (1980) that encoded a 33 kd polypeptide 
with no kinase activity, did not include the 6 
bases GTCCTG (bases 746-751) underlined. The 
restriction sites for EcoRI, Smal and XbaI are 
shown and some possible -10 and -35 promoter 
sequences are indicated. The -10 region immediately 
upstream of the ORF appears to lack a -35 region 
corresponding to an early or middle promoter 
consensus (Rosenberg and Court, 1979; Brody et al. 
1983). The initiationcodon is notpreceded by a 
perfect Shine and Dalgarno sequence (Shine and 
Dalgarno, 1974) but like many ORFs of phage A 
(Sanger et al.,1982) by a pronounced purine-rich 
region. Base 450 remains ambiguous and is read 
as T or C in independent clones. 
for by the difference in their amino acid sequence. 
3.1.h. Purification of pnk expressed by Arecombinants 
and characterisation of its enzymic activities 
Active pnk was purified from cells infected with 
XCM8 and the inactive 33 kd polypeptide was purified 
from cells infected with XNM1108 by the same procedure 
(see Section 2.2.v.) 
The active protein purified from ACM8 infections 
was incubated in the presence of [y-32P]ATP with 
oligodeoxyribonucleotides generated by digestion of 
salmon sperm DNA with DNAse I and calf intestinal 
phosphatase, or with oligoribonucleotides derived 
from an RNAse T 1 digest of yeast RNA. Incorporation 
of 32P into both species (Figure 3.15A) demonstrated 
that the protein had the expected kinase activity. 
Subsequent venom digests of the kinase labelled 
oligonucleotidesdemonstrated that the label was 
incorporated into all four deoxyribonucleotides or 
ribonucleotides (Figure 3. 15A). 
The 3'-phosphatase activity was detected 
by the ability to release 32P from 3'-[32P]CMP but 
not 5 1- [ 32 P]CMP. The specifically labelled sub- 
strates were isolated from appropriate digests of 
cI857 DNA which had been nick-translated in the 
presence of [c 3 '-P]dCTP (see section 2.2.y). 
The protein purified from XCM8 infections showed 
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Specificity of the 5'-kinase activity of pnk 
purified from ED8689 cells infected with XCM8. 
32 P labelled products of the incubations were 
separated by ionophoresis on AE81 cellulose paper 
at pH 3.5. Tracks are: (a) Xc1857 DNA digested 
with pancreatic DNAse (DNAse I) and incubated 
with pnk and then venom phosphodiesterase. The 
positions of 5'-dNMPs are indicated; (b) DNA 
digested with pancreatic DNAse and incubated with 
pnk; (c) DNA digested with pancreatic DNA5e; 
(d) yeast tRNA digested with INAse T 1 and 
incubated with pnk and then venom phosphodiesterase. 
The positions of 5'-NMPs are indicated; (e) yeast 
tRNA digested with RNase T1 and incubated with 
pnk; (f) yeast tRNA digested with RNase T 1 ; 
(g) distilled water incubated with pnk; (h) Cpu 
32 
incubated with pnk; (i) ( P]pCpU eluted from a 
previous separation by paper ionophoresis; 
(j) incubation of [ 32P]pCpU with venom phos-
phodiesterase. The positions of pCpU and pC 
are indicated. 
Specificity of the 3'-phosphatase activity of 
pnk purified from ED8689 cells infected with XCM8, 
or of 33kd polypeptide purified from infection 
with xNM1108. Tracks are: (a) 5'-[32P]dCMP. 
digested with calf intestinal phosphatase, the 
position of the released phosphate is indicated; 
5 1 -[ 32 P]dCMP incubated with distilled water; 
5'-[ 32P]dCMP incubated with pnk from the XCM8 
infection; (d) 5'-[ 32P]dCMP incubated with 33 kd 
protein from the XNM1108 infection; (e) 3 1 -[ 32 P]dCMP 
incubated with distilled water; (f) 3'-( 32P]dCMP 
incubated with pnk from the XCM8 infection; 
(g) 3 1 -[ 32P]dCMP incubated with 33 kd protein 
from the ANM1108 infection. 
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purified from XNM1108 infections did not (Figure 3.15B). 
Direct assays on crude lysates were not done since it 
was assumed that contaminating host phosphatases would 
obscure the results. Instability of the purified 
defective protein was therefore not ruled out as a 
possible cause of 3'-phosphatase inactivity. 
A sample of pnk purified from infections with 
XCM8 was sent to Dr.' R. Mattaliano (Biogen, Cambridge, 
Mass.) for N-terminal amino acid sequence analysis 
by micro-techniques. These results are presented 
in the Discussion. 
3.2 AMPLIFICATION OF POLYNUCLEOTIDE KINASE PROTEIN 
The enzymic activities and substrate specificities of 
pnk purified from cells infected with XCM8 were indistinguish-
able from those of the T4 encoded enzyme. However, XCM8 
was not a convenient, source for routine preparations of 
the enzyme since high titre phage lysates were required 
to infeèt bacteria - and - infected - ceiis had to be harvested 
before lysis, i.e. after only 10-15 min of infection. The 
necessity for phage infections can be avoided in 2 ways; use 
of an integration-proficient X phage which is defective 
in lysis -and can be propagated as a lysogen, or use of a 
high copy number plasmid vector. Onthe assumption 
that the pT gene has been cloned on a fragment 
including a functional promoter, a high copy number 
plasmid system may be susceptible to deleterious effects 
of constitutive pnk over-expression. It would be 
necessary to construct a series of fusions of fragment 
21 in the plasmid. vector in order to position the 
pT gene downstream of a controllable promoter without 
the upstream pLeT promoter sequences. 
The method previously used for T4 DNA ligase 
(Murray et al., 1979) was chosen as the simpler 
approach, that is to position fragment 21 in the centre 
of an integration-proficient, temperature-inducible 
vector that is deficient in both lysis and packaging. 
Propagation of this phage as a prop.hage, i.e. as a 
single copy per host chromosome, and with the major 
A promoters repressed should minimise adverse effects 
of pnk overproduction until the phage is induced. 
Following induction of such a lysogen the A genome would 
replicate to give 100 or more copies per bacterium, and 
transcription of the amplified . pseT gene would result 
followiig 	ctivatioflof 	 .............. -- -- 
system would be more convenient than infecting with 
high titres lysates, but would only be successful if 
the putative promoter upstream of p.LeT in fragment 21 
is not sufficiently strong that deleterious levels of 
pnk are present in the uninduced lysogen. 
Fragment 21 was purified from an EcoRI digest of 
ACM8 DNA and ligated to EcoRI cut XNM1070 vector 
(Warn Earn lacZ att int c1857 Sam). Fragment 21 would 
replace the EcoRI fragment of NM1070 that encodes most 
of the lacZ polypeptide (Figures 3.10B and.3.12) 
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The plaques recovered were hybridised to a probe made 
from purified fragment 21 DNA. Positives were checked 
for A immunity by plating out on hetero-immune (C 600 (Ximin 434 )) 
and homo-immune (C.600 (A)) lysogens, and for inability to 
grow on a suppressor-free strain (NM594). NM1070 phage 
including fragment 21+  always gave minute plaques. 
Lysates were made, and although their titres were not very 
high, it was possible to infect ED8689 cells with 5 
different lysates and demonstrate the presence of kinase 
activity in crude cell extracts (Figure 3.16). Infection 
of UV irradiated cells (M159) with one such phage xCM21 showed 
-expression of the 33 kd pnk polypeptide late in infection (Figure 3.6). 
Due to the difficulty of preparing high titre 
lysates, DNA could not be prepared from infection with 
e.g. ACM21. Therefore the supE host C600 was lysogenised 
with XCM21 and with a second recombinant, and induction 
of these lysogens (see sections 2.2.f and 2.2.g) provided 
phage for DNA. extract-ion.- - SmaI- digests of -these. two-----
recombinant DNAs resulted in loss of the 32.31 kb 
ANM1070 vector left arm and appearance of 20.73 and 
6.98 kb fragments (ACM21 in Figure 3.11) which when 
compared with Smal digests of XNM1104 and ACM1 in 
Figure 3.5 show that fragment 21 is in the same 
orientation as fragment 21 in XNM1104. Fragment 21 
in ACM21 (Figure 3.12) therefore cannot be transcribed 
from the early x promoter 2L 
XCM21 includes amber mutations in the W E and S 
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Figure 3.16 
Assays for kinase activity in crude cell 
extracts of ED8689 infected with Xrecombinants 
encoding an active pnk. Radiolabelled products 
of the kinase reaction were separated by ionophoresis 
on AE81 cellulose paper at pH 3.5. Tracks are: 
(a) T4D (wild type); (b) T4pT2; (c) uninfected 
cells (ED8689);. (d) and (e), (f) and (g), (h) 
and (i), (j) and (k), (1) and (m), are 5 recombinant 
derivatives of XNM1070 including fragment 21 
derived from XCM8. Each was assayed after 
15 min of infection (d) , (f) , (h) , (j) and (1) 
and after 2 h of infection (e), (g), (i), (k) and 
(m). Track (n) is XCM8; track (0) is a second 
recombinant derivative of XNM1149 (see Figure 3.10B, 
track (f)) including fragment 21; track (p) is 
distilled water; track (q) is purified T4 encoded 
pnk. The positions of [Y- 32P]ATP and of the 
labelled products of the kinase reaction, pCpU or 
pC are indicated. 
In order to employ these features to further amplify pnk 
expression it was necessary to propagate the phage in 
a suppressor-free background; the suppressor-free host 
ED8689 was therefore lysogenised with XCM21. A second 
lysogen including the vector XNM1070 as the prophage 
was also isolated. 	The lysogens were propagated at 
32 °C and induced by inactivation of the heat-labile 
c1857 repressor (see section 2.2.u), to achieve the 
expression of phage encoded polypeptides. 
Crude cell extracts derived from induction of 
the lysogen ED8689 (XCM21) and from infection of ED8689 
cells by T4D (wild-type) phage were assayed for kinase 
activity. The crude lysates were first adjusted to 
equivalent total protein concentrations as determined 
by Lowry-Folin assays (see section 2.2.w) and were then 
further diluted serially. Aliquots of these dilutions 
were assayed for kinase activity in terms of the 
conversion of the dinucleo.side monophosphate .CpU to .................... 
the dinucleotide pCpU by the transfer of 32P from 
[Y -32P]ATP. As previously mentioned (section 3.1.à) a 
nuclease activity in crude cell extracts degrades pCpU to 
pC. Consequently in the presence of 5'-kinase activity, 
a radiolabelled spot migrating with the mobility of . 
5 1 -dCMP was seen on separation of reaction products by 
ionophoresis. This pC spot was gradually lost as the 
T4D crude extract was diluted (Figure 3.17). In contrast, 
when reactions were carried out with serial dilutions 
of the induced lysogen ED8689 (XCM21), the pC spot was 
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Assay for kinase activity in crude cell extracts 
after infection of ED8689 cells with T4D (wild-type) , 
or after induction of a lysogen ED8689 (ACM21) 
iadio1abe1led products of the kinase reaction 
were separated by ionophoresis on AE81 cellulose 
parer a pH 3.5. Tracks are: 	(a) purified T4 
encoded pnk; (b) T4pT2 (a pseT strain); 
(c) to (i) 2-fold serial dilutions of a crude 
extract of an infection with T4D; (j) to (r) 
3 fold serial dilutions of a crude extract of 
the induced lysogen ED8689 (XCM21). The 
undiluted crude extracts in tracks (c) and (j) 
were adjusted to the same total protein con- 
centration before further dilution. The positions 
of[y.2 P]ATP and of the labelled products of the 
kinase reaction, pCpU and pC are indicated. 
replaced at i.ncreasing ditions by a spot mgratn 	n 
the position of pCpU. The pCpU spot was only lost after 
at least a 2000-fold dilution of the extract. 
Amplification of pnk activity in the induced lysogen crude 
extract appeared to be sufficiently great that the pCpU 
roduct of kinase activity remained after the contaminating 
nuclease activity had been lost by dilution. In crude 
extracts of the induced lysogen (particularly tracks (j)-(l) 
in Figure 3.17) there was sufficient kinase activity to 
use up all the available [y- 
32P]ATP phosphate donor. 
In the most concentrated extract (track (j) Figure 3.17) 
the accumulation of pCpU is presumably prevented in the 
presence of a high concentration of contaminating nuclease 
because the availability of phosphate donor limits 
the 5'-kinase activity. Since the lysogen extract was 
diluted at least 100 fold more than the T4D extract before 
the products of kinase activity could no longer be detected, 
the amplificationof kinase activity was lQO-fold that 
in T4D infections. 
Expression of pnk polypeptide on induction of 
the lysogen ED8689 (XCM21) was observed after Coomassie 
blue staining of polypeptides separated on 15% linear 
SDS polyacrylamide gels (Figure 3.18A) . The lysogen 
including XNM1070 expressed the lacZ polypeptide 
(-galactosidase) under the same conditions. In Figure 
3.18A, the pnk polypeptide had separated into a doublet. 
This was rectified in later gels (Figure 3.18B) by 
increasing the reducing agent (-mercaptoethano1) 2 fold 








A.' 	Analysis of polypeptides after induction of a X 
prophage including fragment 21. The polypeptides 
were separated on a 15% linear SDS polyacrylamide 
gel and stained with Coomassie blue. Tracks are: 
crude extracts from an induced lysogen ED8689 
(xCM21); (b) crude extracts from an induced lysogen 
ED8689 (XNM1070); (M) standard marker proteins 
(see legend to Figure 3.2) giving marker sizes (kd) 
of 94, 67, 43, 30, 20.1 and 14.4 (c-lactalbuinen). 
The positions of -galactosidase expressed by 
vector XNM1070 and of pnk expressed by XCM21 are 
indicated. In this gel pnk migrates as a broad 
(doublet) band due to insufficient reducing agent. 
B. 	Analysis of polypeptides at stages during the 
purification of pnk from crude cell extracts 
(section 2.2.v), after induction of'alysogen ED8689 
(XCM21). The polypeptides were separated on a 15% 
SDS polyacrylamide gel and stained ith Coomassie 
blue. Tracks are: (a) total protein in a crude 
cell extract after induction of the lysogen; 
protein precipitated from the crude cell extract 
in 35% ainmoniunt sulphate; (c) protein precipitated 
from the crude cell extract in 35-55% ainmonium sulphate; 
(d) protein remaining in the supernatant after 35-55% 
ammonium sulphate precipitation; (M) standard marker 
proteins (see above). The position of pnk is indicated. 
a 
in the loading dye. Figure 3.18B also shows the location 
of pnk polypeptide in the initial stages of its purification 
from the induced lysogen ED8689 (XCM21) (see section 2.2.v). 
The majority of pnk polypeptide was precipitated in 35% 
ammonium sulphate. Accurate measurements of protein 
concentration in purifidd protein preparations were not 
made. However, some idea of the pnk level as a percentage 
of total protein in the induced lysogen was gained from 
a densitometer scan of separated polypeptides in a 15% 
linear SDS polyacrylamide gel (Figure 3.18B). After 
Coomassie blue staining, individual tracks in the gel 
were subjected to scanning with a Fisons Vitatron 
TDL-lOO densitometer. A scan of separated total protein 
(Figure 3.18B track (a)) is shown in Figure 3.19 where 
peaks represent quantitatively the polypeptide bands. 
Comparison of the area under the peak corresponding to 
the pnk polypeptide band with the total area under the 
curve, indicated that pnk polypeptide constituted at 
least 7% of the total soluble cell protein in this 
crude extract of the induced lysogen ED8689 (XCM21). 
In order to investigate the stability of the lysogen 
ED8689 (XCM21) cells were subcultured through seven 
successive cycles. Each time,an overnight was diluted 
1000 fold, grown to saturation at 32°C and used to noculate 
a newovernight. Aliquots of the culture at each stage 
were plated at 32°C and 42°C. After seven cycles, over 
90% of bacteria remained lysogenic, i.e. did not give 
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Figure 3.19 
A trace representing total protein in a crude 
lysate after induction of ED8689 (XCM21). This 
was derived from a densitometer scan of 	- 
polypeptide bands in Figure 3.18B, track (a). 
The positions of standard marker proteins are 
shown. Comparison of the total area under the 
curve and of the area of the peak corresponding 
to the pnk polypeptide band indicates that 
pnk constitutes about 7% of total cell protein 
in this crude extract. 
grown up and induced and crude cell lysates were tested 
for kinase activity. All gave high levels of activity. 
This indicates that the prophage is relatively stable 
and it should be possible to maintain ED8689 (XCM21) as 
a lysogen for long periods. 
1; 
C H A P T E R 
DISCUSSION 
4.1 CLONING AND EXPRESSION OF PNX 
Since the ET gene is non-essential it was 
necessary to identify clones by their ability to confer 
kinase activity on host cell extracts. 	The identification 
of the coding sequence for pnk was impeded by the fact 
that T4 EcoRI fragment 21 cloned in a x vector by Mileham 
et al. (1980) carried a defective pseT gene. Recombinants 
including fragment 21 expressed a polypeptide of 33 kd, 
the appropriate size for the pnk subunit, but did not 
induce kinase activity. In infections with T4 phage, 
only one 33 kd polypeptide could be detected that was 
missing in infections with pseT2 (ET) phage. This 
suggested that the 33 kd polypeptide encoded by T4 EcoRI 
fragment 21 was the pnk subunit. The 33 kd polypeptide 
encoded by fragment 21 seemed to have a slightly higher 
mobility than T4 encoded pnk polypeptide on SDS poly-
acrylamide gels. This raised the possibility that the 
sequence encoding the pnk subunit may extend outside 
fragment 21, although a lack of essential processing or 	- 
a mutation in the coding sequence could be the cause of 
inactivity. 
DNA sequencing of fragment 21 revealed an ORF 
of 900 bases in the orientation required for expression 
of the 33 kd polypeptide. The sequence did not extend 
into the flanking fragments. The position of the Smal 
site 75 base pairs downstream of the start of the ORF 
was consistent with the lack of expression of the 33 kd 
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polypeptide in cells infected with ACM6. These data 
suggested that the ORF within fragment 21 encoded the 
33 kd polypeptide identified in infections with A 
recoinbinants. No obvious reason for the inactivity of 
the polypeptide could be deduced from the DNA sequence, 
except that the sequence was not consistent with a report 
that the N-terminal residue of pnk was pheny1alanine 
(Lillehaug, 1977). A phenylalanine occurred at position 
20 of the 33 kd polypeptide, but a difference in size of 
19 amino acid residues (about 2.2 kd) between the T4 
encoded pnk polypeptide and the 33 kd polypeptide should 
have been noticeable on SDS polyacrylamide gels. 
Processing by the addition of an N-terminal phenylalanine 
may occur. 
The pseT gene has been mapped downstream of the 
alc/unf gene (Sirotkin et al., 1978) and since the 
T4Ttl strain was reported to be alc, it was assumed 
that there was unlikely to bean ORF large enough to 
encode the pnk subunit between alc/unf and fragment 21. 
Unfortunately, repeated attempts to obtain recombinants 
including DNA downstream of fragment 21 were unsuccessful 
and the possible existence in this region of other ORFs 
capable of encoding a 33 kd polypeptide was not ruled 
out. 
The possibility of a small point mutation or 
deletion within the coding sequence lead to the reclon'ing 
of fragment 21+  derived from a different source of T4 
DNA. It was thought that mutations which would alleviate 
12 
deleterious effects of pnk expression or activity may be 
preferentially selected in cloned sequences. However, a 
new clone including fragment 21+  gave considerable kinase 
activity in T4 infections, and the DNA sequence of this 
fragment revealed the presence of an extra 6 base pair 
sequence iiithin the ORF. Fragment 21 purified from 
this recombinant, XCM8, was transferred to the central 
region of a x vector (xNM1070) where expression would be 
enhanced by transcription from A promoters. All such 
recombinants gave very small or minute plaques, many of 
which may have escaped detection. 	Expression of active 
pnk from A promoters did seem to be deleterious to 
phage propagation. Consistent with this was an apparent 
bias against cloning fragment 21 in the orientation in 
which pnk expression would be enhanced by transcription 
from the early A promoter 2L•  Even for those phage 
which were recovered, for example, XCM21, where 
expression - of- T - was - e'nh-ance&- by - transcr±ption"from 
2R" plaques were minute and lysates were difficult to 
prepare by infection. A high titre of ACM21 phage for 
DNA preparations was only achieved following induction 
of a supE lysogen including a XCM21 prophage and 
concentration of the cells before lysis. 
It would appear from the unexpectedly high 
expression of 2T in ANM1149 reconthinants, and the high 
background of early expression where transcription should 
be mediated exclusively from the' A late promoters, that 
fragment 21 includes a promoter upstream of pT. 
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However, experiments in vitro have not detected a strong 
promoter in this region (Gram et al., 1984). The DNA 
sequence in Figure 3.14 shows some possible early promoter 
sequences upstream of the pT coding sequence. A -10 
region occurs immediately upstream of the ATG, however, 
there is no obvious sequence relating to either an 
early or a middle type -35 promoter consensus sequence. 
One alternative possibility is that pseT is co-transcribed 
from a promoter sequence situated upstream ofan ORF of 228 
bases which stops adjacent to the 	T initiation codon 
(Figure 3.9 and Appendix I). 	The sequence immediately 
upstream of pseT does not possess a perfect Shine-Dalgarno 
consensus sequence, GAGGA (Shine and Dalgarno, 1974), 
however, pT like many ORFs of phage X (Sanger et al., 
1982) is preceded by a purine-rich region. 
Propagation of ACM21 as a prophage, i.e. as a 
single copy per host chromosome, and with the major X 
promoters repressed, should provide a.mens of stabilising 
the coding sequence i.e. of suppressing deleterious 
levels of pnk expression until expression is induced 
allowing excision and multiplication of the phage and 
enhancement of pseT transcription from x promoters. The 
suspected presence of a promoter on fragment 21 was one 
reason for not using a plasmid expression system. 
Unless the promoter was removed before introducing the 
fragment into a high copy number vector, constitutive 
expression of pnk may have prevented recovery of clones 
including an intact pT sequence. 
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There is no apparent explanation for the occurrence 
of a 6 base pair deletion, GTCCTG, in the original 
fragment 21 clone (XNM1210). The surrounding DNA sequence 
seems unlikely to include secondary structures capable of 
affecting replication or recombination. Although the 
deletion results in loss of 5'-kinase and apparently also 
3 1 -phosphatase activity, it does not relieve the deleterious 
phenotype associated with fragment 21. It was, for 
example, never possible to lysogenise E.coli with an 
integration-proficient phage carrying the defective 
gene (e.g. XNM1104), and it was difficult to grow and 
maintain a culture of E.coli carrying a plasmid including 
the defective gene (N. Murray, personal communication). 
4.2 THE STRUCTURE OF THE PNK POLYPEPTIDE 
The amino acid. sequence encoded by the cloned 
gene was searched for homology with protein sequences in 
the NBRF protein sequence database (National Biomedical 
Research Foundation, Georgetown University Medical Centre, 
Washington, D.C.). This revealed a striking homology 
between the N-terminal region of the pT sequence and 
the N-terminal region of pig and human adenylate kinase 
(Table 4.1A), an enzyme that catalyses the phosphorylation 
of AMP by ATP. Crystallographic analysis of various kinases 
has shown a common structural feature; the enzymes contain 
two lobes separated by a cleft (Anderson et al., 1979) 
The substrates bind in the cleft, and in hexokinase and 
adenylate kinase (Pal et al., 1977) the cleft is known to 
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Table 4.1 
Protein Residues Sequences 
A. 	E..coljATpase a 143-165 GG®VGLF GGAGVJGKTJVNMMELIR 
E.coli ATPase a 162-184 G Q®E L I I G D R G G K T A L A I D A I I T 
RecA-protein 58- 84 M G®I V E I Y G P E S S G K T T L T L Q V I A 
Adenylate kinase 7- 30 K S®I  I F V V G G P G S G K G T Q C E K I V Q 
Active pnk 1- 24 M K®I  I L T I G C P GIS G W A R E F I A KT 
Inactive pnk 1- 22 M K®I  I L T I G C S G K SIT W A R E F I A 
B. 	E.coliATPase a 227-249 M A E K F IT DEGRDVLLFVDNIYRYT 
E.coli ATPase a 265-287 M G E Y F R D R G G D A L I I Y D D L S K Q A 
Adenylate kinase 102-124 G E E F E R K I G Q P T L L L Y V®A G P E T 
Phosphofructokjnase 85-107 G I E Q L W K H G I Q G L V V I G G®G S Y Q 
C. 	Histone2b 100-123 LPGELAKHAVSEIGTKAVTKYTTSK 
Phosphoglycerate 
kinase 338-363 PVGVF.EWEAFARTKALMEDVVKATS 
Inorganic phosphatase 96-121 P Q T W E D P N V S H P E T K A V G D N N P I D V L 
Active pnk 115-140 P W T E LV K RN S K RT K A V P1 D V L R S MY 
Table 4.1 
shows alignment of homologous sequences in 
active and inactive pnk polypeptides and other 
adenine nucleotide binding proteins. The 
conserved feature; GXXXGK (T) XXXXXXI/V, usually 
preceded by a basic amino acid (encircled) is 
indicated by boxes. 
shows the second region of conserved sequence 
associated with adenine nucleotide binding in 
some proteins.. The boxes contain conserved 
basic or conserved hydrophobic residues. The 
conserved aspartic acid residue is encircled. 
This conserved region is not present in pnk. 
shows a region of pnk whichshareshomo1ogy 
with certain proteins. The significance of 
this conserved region is not clear. Table 4.1 
parts A and B are modified from Walker et al. 
(1982) 
narrow or close upon binding the substrates. This change 
in conformation seems to be important for enzyme specificity 
and for the mechanism of kinase activity. Analogues of 
glucose with bulky side chains are competitive inhibitors 
of the binding of glucose to hexokinase, but they are not 
substrates for the enzyme since although they bind in the 
correct orientation the bulky side chains prevent closing 
up of the two lobes of the enzyme (Anderson et al., 1979). 
Adenylate kinase is a 22 kd monomer and again the 
active site is contained within a cleft formed between 
the two lobes of the enzyme. AMP and ATP bind at opposite 
ends of the cleft with their phosphates extending towards 
each other in the centre of the cleft (Pai et al., 1977). 
Two markedly different confirmations of crystalline 
adenylate kinase have been described (Sachsenheimer 
and Schulz, 1977). In the A conformation the cleft has 
been narrowed by a few angstroms compared to the B 
conformation. This motion seems. largest atthe proposed.. 
AMP binding site, and Pai et al. (1977) concluded that 
the open conformation B is related to the native 
conformation of the enzyme, and that AMP binding causes 
the protein to switch to the A conformation in which 
the cleft is closed up. 
Crystallographic analyses of several kinases with 
diverse secondary and tertiary structures show the same 
bilobal character, but in most cases the enzymes have 
not been crystallised in the presence of the substrates. 
However, the substrate-induced closing of the cleft between 
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the two lobes is probably a common feature of kinase 
enzymes. This conformational change may be required to 
'embrace' the substrate and orient catalytic groups, 
or to exclude solvents and promote nucleophilic attack 
by the phosphate group acceptor on the phosphate group to 
be transferred. 
The substrates of adenylate kinase are the adenine 
nucleotides, AMP and ATP. According to kinetic 
experiments these substrates occupy two distinct positions, 
the AMP site and the ATP site (Noda, 1958; Rhoads and 
Lowenstein, 1968). The AMP site is very specific and 
the adenine is buried deep inside the protein, whereas 
the ATP site is less specific and can bind other nucleo-
tides (Secrist et al., 1972; Slotin and Hampton, 1975). 
The most essential difference between the A and B forms 
of crystalline adenylate kinase (Sachsenheimer and 
Schulz, 1977) is the opening of a pocket behind loop 
16-22 and helix. .23-30 (Figure 4 .1A). which is.•large enough 
to accommodate adenosine. The His36 at the active site 
of the enzyme (Cohn et al., 1971) is located at the 
entrance of this pocket. Pai et al. 1977 have shown 
that the B and A forms bind AMP and ATP respectively and 
are related to the inactive E conformation of the enzyme 
before and the active E* conformation after the induced-fit 
transition postulated by Koshland (1958) and Jencks (1975). 
Hence the B conformation (the native enzyme) has an open 







Sketches of adenylate kinase from Pai et al. (1977). 
represents the 3-dimensional structure of the 
whole protein. Helices are represented by cylinders, 
and the five strands of s-pleated sheet by arrows. 
The substrates AMP and ATP are shown bound to the 
enzyme. The side chains of Lys2l, Arginines 44, 
97, 128, 132, 138, 149 and Tyr95 are shown. 
shows adenylate kinase in crystal form B with 
a view into the deep pocket which has been assigned 
to the AMP binding site. The positions of Serl9, 
Lys2l, Cys25, His36 and Asp93 are indicated. This 
conformation of the enzyme has been related to 
the free enzyme. Crystal form A has been related 
to the active enzyme,. E*, which has undergone an 
induced-fit conformational change. In crystal 
form A the AMP .binding..pocket is ..closed.. by move-......... 
ments of loop 16-22 and helix 23-30. 
an open AMP site (Figure 4.1). The A conformation also has 
an open ATP site, a narrow phosphate cleft, and the 
adenosine pocket at the AMP site is closed. This 
corresponds to an induced-fit model where binding of 
AMP triggers the switch between these two quite stable 
conformations (Sachsenheimer and Schulz, 1977). 
The specific binding positions of ATP and AMP in 
pig adenylate kinase have been located by X-ray 
diffraction analysis which identifies the two adenosine 
pockets and the region of phosphate binding. The ATP 
binding site is between helices 69-84 and 100-107 
(Figure 4.1A) and is lined by Va167, Leu69, Va172, Leu73 
and Leu76 on one side and I.1e92, Tyr95, Arg97, Glnl01 
on the other (Pai et al., 1977). Model building 
suggests that Tyr95 is hydrogen bonded to the N atom of 
ATP and the 2'-OH and 3'-OH groups to Gin101 and Va167 
respectively. The pocket is open to the right and at the 
bottom (Figure 4.1A) whih m.....xp... am ... 
The phosphates of the substrates bind in conformation 
A to a site lined by numerous positively charged side 
chains, namely Lys2l and Arginine residues 44, 97, 128, 
132, 138 and 149, which probably interact with the 
negative charges on the phosphate groups. 
The large hydrophobic pocket which opens in the B 
conformation and is assigned to the binding of the 
adenosine moiety of AMP, is formed between the s-sheet, 
loop 16-22, helix 23-30 and the C-terminal helix (Figure 
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4.1B) . This pocket is lined by Leu99, hell, Va113, 
Leu116 and Leul18 on the s-sheet, ser19 and G1y20 on the 
loop and G1n24, 11e28 on one helix and Va186 on the other. 
The pocket is only accessible in the B conformation 
(Figure 4.1B) since in the A conformation the entrance 
is closed by a movement of loop 16-22 (Sachsenheimer 
and Schulz, 1977). The amino acid sequence of loop 
16-22 is Gly-Pro-Gly-Ser-Gly-Lys-Gly,' (von Zabern et al., 
1976) i.e. every second position is a glycine residue, 
which allows a large range of bond angles around the 
glycine carbon atom. Consequently ioop 16722 is very 
flexible and can perhaps fold around the incoming 
substrate. 
The region of homology between the amino acid 
sequences of pnk and adenylate kinase involves loop 
16-22. In addition this region conforms to a consensus 
sequence: 
GXXXXGK(T)XXXXXXI/V ; 	stia1ly preëdëd by a 
basic amino acid, which is conserved in a number of 
other adenine nucleotide binding proteins (Walker et al., 
1982) e.g. E.coli ATP synthases (Table 4.1A). Interestingly 
the deletion of a 6 base pair sequence in the ORF of the 
original cloned fragment 21 which expressed inactive 
pnk, has resulted in the loss of a Pro-Gly dipeptide 
within the region homologous to 1oop 16-22 of adenylate 
kinase (Table 4.1A). This deletion would seriously limit 
the flexibility of such a loop formed in pnk. If substrate 
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binding to pnk is analogous to AMP binding to adenylate 
kinase, it is possible that either the substrate molecule 
cannot bind to the defective pnk, or that the induced 
conformational change involving movement of a flexible 
loop cannot occur and the active E* enzyme conformation 
cannot be achieved. A lysine immediately following loop 
16-22 in adenylate kinase (Lys 21) is conserved in all 
examples of the consensus sequence proposed by Walker 
et al. (1982) (Table 4.1A) and this residue probably 
interacts with the ct-phosphate of AMP (Pal et al., 1977). 
Loop 16-22 is assumed to encircle this phosphate when 
AMP is bound. 
A second region of adenylate kinase which includes 
residues 110-120 is involved in AMP specific binding. 
Again this region conforms to a consensus sequence: 
R/KXXXXXL-hydrophobic-hydrophobic-hydrophobic-hydrophobic 
followed by an aspartic acid residue, which is observed 
in a number. of adeninenucleotidebinding_proteins.. .... .......... 
including phosphofructokinase and E.coli synthases 
(Table 4.1B). The aspartic acid residue (Asp119 in 
adenylate kinase) following the consensus sequence is 
particularly well conserved and may be involved in 
binding magnesium in adenylate kinase (Walker et al., 
1982). This consensus sequence is not present in pnk. 
This may reflect the difference in substrate specificity 
since pnk must bind substrate molecules which adenylate 
kinase cannot i.e. polynucleotides. The search for 
amino acid sequence homologies with pnk did however 
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reveal a new consensus including residues 127-131 of pnk 
(Table 4.1C) which is shared by human and horse phospho-
glycerate kinase and yeast inorganic pyrophosphatase. 
The sane sequence is also conserved in histone 2b from various species. 
The possible relevance of this conserved region remains to be elucidated. 
Phosphoglycerate kinase and inorganic pyrophosphatase 
both have phosphatase-like activities. 	Phosphoglycerate 
kinase catalyses the phosphoryl transfer reaction: 
Mg ++ 
1,3-diphosphoglycerate + ADP 
3-phosphoglycerate + ATP 
(Banks et al., 1979), while inorganic pyrophosphatase 
catalyses the hydrolysis of pyrophosphate to orthophosphate 
(Cohen et al., 1978) . 	The conserved peptide sequence may 
be related to 3 1 -phosphatase activity in pnk, or again 
it may be involved in substrate binding. The relevance 
of the histone 2b sequence is not clear. 
A topo1ogicl comparison QfadeflylaQ k j 
several dehydrogenases (Schultz and Schirmer 1974) 
suggested that substrate binding sites in adenylate kinase 
are equivalent to the NAD binding site in dehydrogenases, 
with ATP corresponding to the adenosine moiety of NAD. 
Tyr95 in the ATP pocket (Figure 4.1A) is equivalent 
to Tyr85 of lactate dehydrogenase and probably both bind 
to the adenine. There is also a close correspondence in 
the loop 16-22 region. In lactate dehydrogenase (Moras 
et al., 1975) the phosphate moiety of NAD is hydrogen bonded 
to the backbone of an equivalent loop, and in f1aodoxin 
(Burnett et al., 1974) the loop wraps around the phosphate 
moiety of FMN. However, Walker et al. (1982), were 
unable to find sequence homologies with dehydrogenases thought 
to show structural homologies with adenylate kinase in 
the region of the nucleotide binding site. This suggests 
that some structural homologies are related to efficiency 
of substrate binding rather than the result of divergent 
evolution. 
This thesis gives no experimental evidence that 
the lack of 5 1 -kinase and possibly also 3 1 -phosphatase 
activity in the defective pnk is the result of the 
disruption of a loop necessary for substrate binding, 
or for induced-fit conformational changes. The overall 
conformation of the enzyme seems unlikely to be markedly 
different from that of the active enzyme. Both proteins 
were successfully purified by the same method (see section 
2.2.v), so presumably the subunits of the defective kinase 
4 
associate into a tetrameriC species Acomparisonof 
computer predictions of the secondary structure of 
the pnk polypeptide and defective 33 kd polypeptide is 
shown in Figure 4.2 (L. Sawyer, personal communication). 
Residues 10-16, which may be involved in a loop structure 
analogous to loop 16-22 in adenylate kinase, occur in a 
region where turns are predicted in the secondary structure 
of the active pnk polypeptide (Figure 4.2B). Proline is 
a so-called helix-breaker amino acid residue since its 
nitrogen atom is in a rigid ring system and the permissible 
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A computer generated histogram showing 
predictions for regions of c-he1ix, 8-pleated sheet 
and turns in the peptide sequences of the active 
and inactive pnk polypeptides encoded by cloned 
genes (L. Sawyer, personal communication). Marks 
along the sequence are at intervals of 5 residues 
starting at the N-terminus. 
A.shows the defective pnk polypeptide. 
Horizontal lines superimposed on the histogram 
represent the extent of c-he1ix, 8-sheet and 
turns in the secondary structure of adenylate 
kinase. 
a. shows the active pnk polypeptide. 
Residues 10-16 thought to-be involved in 
forming a flexible loop occur in a region where 
turns are predicted in the active pnk polypeptide. 
This region in the defective polypeptide shows a 
reduced probability of turns in the polypeptide 
chain. 
rotation around the alpha carbon-nitrogen axis does not 
allow an a-helical structure, but causes a sharp bend in 
the polypeptide chain. Hence loss of a Pro-Gly dipeptide 
(residues 11 and 12 of active pnk polypeptide) in the 
defective pnk polypeptide reduces the probability of turns 
in this region (Figure 4.2A). 
The DNA sequence of the cloned 	gene is not 
consistent with reports that the N-terminal amino aci4 
of pnk is phenylalanine (Lillehaug, 1977). The first 
phenylalanine encoded by the DNA sequence is at position 
22 in the active pnk polypeptide. It is unlikely that 21 
N-terminal residues would be lost by processing since the 
mobilities of the polypeptides of active and inactive pnk 
are almost identical, and in addition this region includes 
the putative adenine nucleotide binding site. 
A sample of pnk purified as previously described 
(Section 2.2.v) from infection of a culture of ED8689 with 
XCM8 	was further• purified• by 
33 kd pnk polypeptide band from an SDS polyacrylamide gel. 
Dr. R. Mattaliano of the Biogen Research Corporation, 
Cambridge, Mass. USA, carried out peptide sequence analysis 
of the N-terminal region using this small sample. 20 
cycles of analysis gave the following sequence: 
N-terminal/Met-Lys-Lys-Ile-Ile-Leu-Thr-Ile-Gly-x-pro-Gly -
Ser-Gly-Lys-Ser-Thr-Trp-Ala-Arg. 
No score was obtained for cycle 10 but since cysteine is 
the only residue not identified in this technique it is 
inferred in this position by default. Clearly the peptide 
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sequence of the active pnk expressed by the cloned pseT 
gene is identical to that predicted by the DNA sequence. 
The purification of sufficient quantities of pnk from T4 
infected cells to allow a similar N-terminal sequence 
analysis is currently in progress. However, if the T4 
protein is modified by addition of an N-terminal phenylalanine, 
this event is not necessary for 5'-kinase or 3'-phosphatase 
activity. 
The level of enzyme activity produced by the XCM21 
prophage system is more than 100 times that in extracts 
of T4 infected cells, and for the first time pnk can be 
prepared without making high titre phage lysates. The 
four T4 encoded enzymes commonly used in the laboratory: 
DNA ligase (Murray et al., 1979), RNA ligase (Rand and Gait, 
1984), DNA polymerase (W. Konigsberg, personal communication) 
and polynucleotide kinase can now be prepared without 
recourse to T4 infected cells. The expression of pnk in 
the absenceof 
to purification, and use of currently available gel fil-
tration procedures should allow purification of large 
quantities of homogeneous protein. A more specific 
analysis of pnk in vitro in terms of reaction kinetics, 
substrate binding and structural analysis by crystallography 
may help in the elucidation of the relationship between 
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APPENDIX I 
The DNA sequence of the contiguous T4 
EcoRI fragments 21 and 46 (Figure 3.1). The 
open reading frames on both strands are translated 
below, and restriction enzyme target sites are 
shown above the T4 DNA sequence. 
154 
E 	 S F 
C F M B 	 N 
0 	 A N B U 
R N L V 	 4 
1 	 1. 1 1 H 
GAATTCAGTATkATTATATTGATGCGATGAATAATAAAAATCGTGAGGCAATTGCTGCTA 




C: 	 I1eG1nTyrAsnTyrI1eASpA1aMetASflASflLySASflArgG1UA1aI1.eA1aA1aIle 
1 ---------+ ---------+ ---------+ ---------+ ---------+ ---------+ 60 
 
 
if: 	 AsnLeuILeIleIleAsnhleArgHiSIleIlePheIleThrLeUCYSASnSerSerAsfl 
S H 
F IMH 	 F 
A NSH 0 
N PTA 	 K 
1 111 1 
TTGAGCGTGAAAATGAAAAACTGCGCAAAGATGCAAAGAAGGCGGATGTGGTGGCTCATA 




C: 	 G1uArgG1uAsnG1uLYSLeuArgLysAsPALaLYSLYSA1aASPVa1VaIA1aH1SLYS 
61 ---------+ ---------+ ---------+ ---------+---------+ ---------+ 120 
 
EndLeu 
if: 	 LeuThrpheIlePhePheGlnAlaPheIleCySLeULeUArgIleHiSHiSSerMet 
BS 	 BS 
SC F 	 SC 
TR 	 0 TR 
NF, K 	 NF 
11 	 1 11 
AGCCAGGATTGGTTGAAAAACAAATCAACAACTCCTTCAACAAGTTCGCAGAAGACATCC 




C: 	 Pr0G1yLeuVaIGLuLysG1r1I1eASflASnSeCPheASrILYSPheAIaG1UASPI leGiri 
121 ---------+ ---------+---------+ ---------+ ---------+---------+ 180 




AMA 	 M 
VB[J B 








C: 	 AspLeuSerLysEnd 
181 ---------+---------+---------+---------+---------+---------+ 240 
e: 
T 	 X M F X 	 H 
A B NO m A 
Q 	 A L K N 	 E 
1 1 11 1 3 
TTGTTCGACAAGCCTCTAGAkGTAAfiGAAAGAAACAGTTCATCCTAATTGGCCTGTGCA 





241 ---------+---------+---------+---------+---------+---------+ 300 
- 	- 	.- - 
EndPheTyrLeuPhePheCysAsnMet 
EndAsnAlaGinAlaPhe 









C: 	 MetMetLysLeuAsnTyrLeuGlyLysLeuLysLeuLeuMetValLysPro 
301 ---------+---------+---------+---------+---------+---------+ 360 
 
EndArgProLeuAsnPheAsnAsnl leThrPheGly 
LeuThrMet 	 EndGlnHisTyrLeuArg 
1 
BS 	 Fi 
SC I 	D 	M 
TR 	 N D B 
NF F E 	0 
11 	 1 	1 2 
/ 
CTGGGTCGGTATGCCATTTGAAGATTCTCAGGAATTTCGTATTTGGCTTTGATGT. 
361 ---------+---------+---------+ ---------+---------+---------+ 420 
GACCCAGCCATACGGTAACTTCTAAGAGTCCTTAGCATWCCGTTACTACATTT 
a: 
C: 	 GlySerValCysHisLeuLysIleLeuArgAsnPheValPheGlyLeuMetMetEnd  




R 	N MA 
S L Nil 
A 	A LU 
1 3 11 
ACGATATGTACATGACCAGAAAACTATGAXATGTTATTATCGTCAAGAGCTAAAAGAGG A  




C: 	 MetTyrMetThrArgLySLeUErld 
421 ---------+---------+---------+ ---------+---------+---------+ 480 
e: 	SerlleTyrMet 	 EndPheLeulle 
if: 
	
S 	 H 
N 	 F SI 
L A 	 BN 
A 	 N VT 
3 1 	 11 
TkAATGTAAATGATTTCATGGCATCAATTTGAACATCTCAAAGGATTGATTTATGTCC 
481 ---------+---------+---------+---------+---------+---------+ 540 
ATTTACATTTACTAJAGTACCGTAGTTAAACTTGTAGAGTTTCCTAACTTACTTAGG 
EndMetEndMetIleSerTrpHisGlnPheGluHisLeuLysGlyLeuIleTyrGluSer  
LysCysLysEnd 	 MetAsriPro 
C: 	 MetAlaSerlleEfld 




F H H 
N 	 A IH I 
U H N G 	 N 
4 	 A FA F 
H 2 11 1 
GAGATGGCTGCAATGATTTATGGACGCCAGATTCAGCGGTTAGAATCTTTACCTCCAACT 









M 	 A 
N L 
L 	 U 
1 1 
AATGATGTTTTATTAGCTCAATCACGTGCTAATCTCAAAAATGAATATCAAAATAAGTGG 
601 ---------+---------+---------+---------+---------+---------+ 660 
TTACTACAAAATAATCGAGTTAGTGCACGATTAGAGTTTTTACTTATAGTTTTATTCACC 
AsnAspValLeuLeuAlaGlnSerArgAlaAsnLeuLysAsnGluTyrGlrlASflLYSTrP 
MetMetPheTyrEnd 	 MetAsnlleLyslleSerGly 
C: 
601 ---------+---------+---------+---------+---------+---------+ 660 






N 	 A 
1. 3 
GGTAAAGCATCTAAAGACCTACATGATTATATTCAATCATTAGTTGAGAAAAAATAAATG 





661 -------------------+---------+---------+---------+---------+ 720 













BS 	 B 
SC RS 	BS 
TR 	 SC AP 
NF AA 	Ni 
11 	 11 22 
AAAAAGATTATTTTGACTATTGGCTGTCCTGGTTCTGGTAAGAGTACTTGGGCTCGTGAA 
721 ---------+---------+---------+------------------------------ 780 
TTTTTCTAATkACTGATAACCGACAGGACC?AGACCATTCTCATGCCCGCACTT 
LysLyslielleLeuThrl ieGlyCysProGlySerGlyLySSerThrTrPAlaArgGtU 
721 ---------+---------+---------+---------+ - ---------+ 780 
PheLeuAsnAsnGlnSerAsnAlaThrArgThrArgThrLeuThrSerProSerThrPhe 
H 	SS 
D I AHNNCCS 
D N VPCCRRM 
E F AAIIFFA 
1 	1 	1211111 
TTTATTGCTAAGAATCCCGGGTTTTATAATATCAATCGTGATGACTATCGCCTCTATT 
781 ---------+---------+---------+---------+---------+---------+ 840 
AAATAACGATTCTTAGGGCCCAAAATATTATAGTTAGCACTACTGATAGCGGTTAGATAA  
PheIleAlaLysAsnPrOGlyPheTYrASrLI leAsnArgAspAspTyrArgGlflSerl le 
MetThrIleAlaAsnLeuLeU 
781 ---------+---------+---------------------------------------- 840 
LysAsnSerLeul leGlyProLyslielleASpi leThrIleValIleAlaLeUArgASfl 
EridArgTrpAspl lel le 
H F 
IH N N M R 	A 
NH L U B S C 
PA A D 0 A 	C 
11 3 2 2 1 1 
ATGGCGCATGAAGAACGCGATGAGTAcAAGTATAcCAAAJAGAAAGAAGGTATCGTACT 


























A 	 R I 
L S N 
U 	 A F 
1 1 1 
GGTATGCAGTTTGATACAGCTAAAAGTATTCTGTACGGTGGCGATTCTGTTAAGGGAGTA 
901 ---------+---------+---------+---------+---------+---------+ 960 
CCATACGTCAAACTATGTCGATTTTCATAAGACATGCCACCGCTAAGACA.ATTCCCTCAT 
GlyMetGlnPheAspThrAlaLysSerIleLeuTyrGlyGlyAspSerValLysGlyVal 
901 ---------+---------+---------+---------+---------+---------+ 960 
IleCysAsnSerValAlaLeuLeul leArgTyrProProSerGluThrLeuProThrlle 
H 
I 	 N 
N L 
F 	 A 
1 3 
ATCATTTCAGATACTAACCTGAATCCTGAACGTCGCCTAGCATGGGAAACTTTTGCCAAA 




961 --------+---------+---------+---------+---------+---------+ 1020 
- 	 EndCysProPheSerrysG1 -yPhe 
EndGlySe rAspGlriValAspGlyLeuMe t 
MetGluSerValLeuArgPheGlySerArgArgArgAlaHi sSerValLysAlaLeuSer 
GAATACGGCTGGAAAGTTGkACATAAAGTGTTTGATGTTCCTTGGACTGAATTGGTTAAA 












N 	 R 
U S 






ArgAsnSerLysArgGlyThrLysAlaValProIleAspValLeuArgSerMetTyr Ly s 
Va1ThrG1nAsnA1aG1uLeULySG1flTYtG1flLeUMetPTYrLGlY leLys 
1081 ---------+---------+--------+ + + + 1140 
LeuGluPheArgProValLeuAlaThrGlylleSerThrLysArgGluIleTyrLeuLeu 
H 	BS 
t4S 	M 	 I Sc 
LP B N 	TR 
AH 	0 	 F NF 
31 2 1 	11 
/ 
AGCATGCGAGAGTATCTCGGTCTTCCAGTATATATGGGACTCCTGGTACCGCA 









R 	A 	 AA 
S L VU 
A 	U 	 A9 
1 1 26 
GTTATTTTTGATGTTGATGGTACACTAGCTAAAATGAATGGTCGTGGTCCTTATGACCTT 
/ 
1201 ---------+---------+---------+ - + + + 1260 
CAATAAAAACTACAACTACCATGTGATCGATTTTACTTACCAGCACCAGGAATACTGGAA  
ValIlePheAspValAspGlyThrLeuAlaLysMetAsnGlyArgGlyProTy rAs pLeu 
LeuPheLeuMetLeUMetValHiSEfld 	MetValValValLeUMetThrLeU 
C: 


















C: 	 MetArgTyrArgCysTyrGlnSerTyrGlyCysEnd 









1321 ---------+---------+---------+---------+---------+---------+ 1380 
 
EndLeuLeuGlyLeu - 
M 	 M 
B N 
0 	 L 
2 1 
ACGAAATATTATCGTATGACCCGTAAATGGGTTGAGGACATTGCTGGCGTTCCATTAGTT 




C: 	 MetGlyEnd 
1381 -------------------+----------+ ---------+---------+---------+ 1440 


















C: 	 MetSerAlaArgThrArgArgTyrPrOEnd 
1441 ---------+---------+---------+ ---------+ ---------+ ---------+ 1500 
HisLeuThrLeuA1aPheLeUA1aI1eG1YThrPheVa111eTY5P 1 
e: 
if: 	 EndArgSerCysProSerVa1ArgLeUSerSerThrThtLeU5erSnlYs 
M 	 A 
B L 
0 
2 	 1. 
TTCTGGAAACACATTGCACCGCATTTTGACGTGAAATTAGCTATTGATGACCGAACTCAA  









H 	 A 
G H 
A 	 A 
1 2 
GTAGTTGAATGTGGCGTCGTATCGGTGTTGAATGCTGGCGTCGCTTCGGGAGATTTT 













BN N 	 R 
AL L S 
NA A 	 A 
14 3 1 
TAATGGCTTGGCACCATGAAACTTGGGCTATTGTTATTGTAAATAGCGGTTTAGTTGGTA 
1621 ------ ---+---------+-------- ------------ + ---------+---------+ 1680 
ATTACCGAACCCTGGTACTTTGAACCCGATAACAATAACATTTATCGCCAAATCAACCAT 
End 	 MetLysLeuGlyLeuLeuLeuLeuEnd 
MetAlaTrpHi sHisGluThrTrpAlaIleVal I leValAsnSerGlyLeuValGlyThr 



















1681 ---------+---------+---------+---------+---------+---------+ 1740 
EndHisPheTyrLeuMet 
H 
I 	 N 
N C 
F 	 0 
1 - 	1 
AATTAAGAGAAAAGAATCCCGATGTTGAACTAGTAGTAAAGAAAACTA.AACTGCCTTTAC 
1741 ---------+---------+---------+---------+---------+---------+ 1800 
TTAATTCTCTTTTCTTAGGGCTACAACTTGATCATCATTTCTTTTGATTTGACGGAAATG 
AsnEnd 	 MetLeuAsnEnd 
LeuArgGluLysAsnProAspValGluLeuValValLysLysThrLysLeuProLeuPro 
1741 ---------+---------+-------------------+---------+---------+ 1800 












1801 ---------+---------+---------+---------+---------+---------+ 1869 
GTACCTTTTGAATACTTATTGGATCTTTTCTWTAGCAGACACTATTTTCTTTTT 
MetAsnAsnLeuGluLysl leTyrArgLeuCysASpLySI leGluLys 
MetGluAsnLeuEnd 
C: 	 TrpLysThrTyrGluErid 




H 	I 	 HSM. 
A N ATB 
C 	 EUO 
3 	2 312 
/ 
GAAAAGAAATATCTATTTTGTCTATGGCCTATTGTTGACGGGAGTAGGCCTAGATGTT 




C: 	 MetAlaTyrCySEnd 

















F 	 M 	M 
0 N B 
K 	 L 	0 
1 1 2 
ATTGATTGGCTTGAAGAAAATTATGTGAGGTAAATATGTTTCCGAcTTACTCTApTCG 




C: 	 MetPheProThrTyrSerLyslleVal 














C: 	 GluValValPheSerGlrlIleIleAlaAsnAsnMetPheGluLysLeuAspAsnAlaAla 




H 	 H 	 BS 
D A TBI N 	I N 	 Sc 
D L ABN 	L N 	L TR 
E U QVF A 	 F A 	 NF 
1 	1 111 	3 1 	3 11 
/ 
cTGAGcTTcGAATccATGcTcAAGTGAcTcATGTATTGAAcAcTTTGcTTccAGAccAGG 




C: 	 GluLeuArgIleHisAlaGlnValThrHi sValLeuAsnThrLeuLeuProAspGlriVal 





H 	 BS 	FH 	 S 
I SC N 	NIH F 
N 	 TR L UNH 	 A 
F NF A 	DPA N 
1 	 11 4 211 	 1 
TGGATTCTATTGCCATThCACTGTATCCAGGTTCCGCGCATATCATTGTCGTATTTGGTC 




C: 	 AspSerIleAlaIleThrLeuTyrPrOGlySerAlaHiSIleIleValValPheGlYLeU 




H 	 E 
D 	A I C 
D t. N 	 0 
E 	U F R 
1 1 1 	 1 
TTGATGCTGAGCTTGTTATCAAAGGCGATATTCGCTTTGAATCTCAAACTGCGGAATTCA 




C: 	 AspAlaGluLeuValIleLysGlyASpIleArgPheGlUSerGlflThrAlaGlUPheLYS 
2221 ---------+---------+---------+---------+---------+---------+ 2280 
 
 
A 	 M 
L N 
U 	 tJ 
1 1 
AAGCGATTTAATGGTTTACTTTACGGTAGAGCTATAATATCACAACTCTACCAAAACAAA  




C: 	 AlaIleErid 	 Met 




D 	 C 
0 0 
E 	 R 
1 1 
TGAGGAAAACAAAATGTTGCTAAGTGAAAAACCGATTACTGTTAAAGGAATTC 




C: 	 ArgLysThrLysCysCysEnd 
2341 ---------+ ---------+---------+ ---------+ ---------+--- 2393 
SerSerPheLeulleAsnSerLeuS'erPheGlyILeValThrLeuPrOIle??? 
EndThrphePheArgAsriSerAsnPheSerAsn??? 
EndLeuPheGlu 
167 
